image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
11a759812d7cebf2f4370ad01f17420ccce74eb88104e2d05b476397f75c73a5.png | simple | <table><tr><td> </td><td><i>T. muris </i>L1 assay</td><td>Adult <i>T. muris </i>assay</td></tr><tr><td>Duration of drug assay<sup>a</sup></td><td>24 hours</td><td>72 hours</td></tr><tr><td>Number of parasites per well</td><td>20 to 200</td><td>2 to 4</td></tr><tr><td>Dissection of animal host required</td><td>No</td><td>Yes</td></tr><tr><td>Subjective analysis</td><td>Yes</td><td>Yes</td></tr><tr><td>Viability marker alternative</td><td>No</td><td>Yes<sup>b</sup></td></tr><tr><td>Total operational hours</td><td>3.5 hours<sup>c</sup></td><td>6.5 hours<sup>d</sup></td></tr><tr><td>Applicability to high-throughput screening</td><td>No</td><td>No</td></tr></table> |
2298c76086b036e8184291952cada0a25ac091690045db63e34e867d6b6c7ddf.png | complex | <table><tr><td></td><td colspan="5">Air pollutant</td></tr><tr><td>Time lag</td><td>PM<sub>10</sub></td><td>CO</td><td>NO</td><td>NO<sub>2</sub></td><td>O<sub>3</sub></td></tr><tr><td colspan="6">Fibrinogen</td></tr><tr><td> I<sub>24–48</sub></td><td>0.4 (−1.1, 1.8)</td><td>0.0 (−1.7, 1.8)</td><td>0.1 (−1.0, 1.3)</td><td>0.4 (−1.7, 2.5)</td><td>−0.6 (−3.2, 2.1)</td></tr><tr><td> I<sub>48–72</sub></td><td>1.0 (−0.5, 2.4)</td><td>0.0 (−1.8, 1.9)</td><td>0.3 (−0.8, 1.4)</td><td>1.4 (−0.6, 3.4)</td><td>−1.4 (−3.8, 1.0)</td></tr><tr><td> I<sub>72–96</sub></td><td>0.2 (−1.6, 2.0)</td><td>−0.1 (−1.9, 1.7)</td><td>0.1 (−1.1, 1.4)</td><td>−0.4 (−2.3, 1.4)</td><td>0.5 (−1.7, 2.8)</td></tr><tr><td colspan="6">CRP</td></tr><tr><td> I<sub>24–48</sub></td><td>1.9 (−5.6, 9.4)</td><td>3.2 (−6.4, 12.8)</td><td>3.6 (−2.9, 10.0)</td><td>6.5 (−4.9, 17.8)</td><td>−0.5 (−14.7, 13.8)</td></tr><tr><td> I<sub>48–72</sub></td><td>5.8 (−2.0, 13.5)</td><td>−1.9 (−12.5, 8.7)</td><td>0.1 (−6.5, 6.7)</td><td>−0.1 (−11.0, 10.8)</td><td>3.7 (−9.7, 17.2)</td></tr><tr><td> I<sub>72–96</sub></td><td>3.4 (−6.2, 12.9)</td><td>−4.5 (−15.3, 6.3)</td><td>−4.6 (−12.0, 2.9)</td><td>−6.9 (−17.2, 3.5)</td><td>5.9 (−6.8, 18.7)</td></tr></table> |
e2decb6e7279df752d276055b78abe7177d5f4d11f067e4e110a1f36fddc93f6.png | simple | <table><tr><td></td><td>Q1 (cm.mmol.l<sup>-1</sup>) <2752</td><td>Q2 (cm.mmol.l<sup>-1</sup>) 2755-5040</td><td>Q3 (cm.mmol.l<sup>-1</sup>) 5043-8265</td><td>Q4 (cm.mmol.l<sup>-1</sup>) 8268-54948</td><td><i>P </i>for trends<sup>†</sup></td></tr><tr><td>Number of participants*</td><td>947</td><td>954</td><td>939</td><td>947</td><td></td></tr><tr><td>Age (years)</td><td>40.6(10.4)</td><td>46.5(11.7)</td><td>49.9(11.6)</td><td>52.1(10.8)</td><td></td></tr><tr><td>SBP (mmHg)</td><td>112.7(15.7)</td><td>120.9(18.7)</td><td>127.7(21.8)</td><td>133.2(21.9)</td><td><0.001</td></tr><tr><td>DBP (mmHg)</td><td>74.6(9.4)</td><td>78.3(10.1)</td><td>82.0(10.7)</td><td>84.3(10.8)</td><td><0.001</td></tr><tr><td>MAP (mmHg)</td><td>87.3(10.5)</td><td>92.5(11.8)</td><td>97.2(13.1)</td><td>100.6(13.2)</td><td><0.001</td></tr><tr><td>Pulse pressure (mmHg)</td><td>38.1(11.8)</td><td>42.5(14.5)</td><td>45.7(16.8)</td><td>48.9(16.8)</td><td><0.001</td></tr><tr><td>Pulse (beat per minute)</td><td>80.9(11.9)</td><td>81.0(12.1)</td><td>80.8(11.9)</td><td>81.7(12.0)</td><td><0.012</td></tr><tr><td>BMI (kg.m<sup>-2</sup>)</td><td>24.7(3.5)</td><td>27.9(3.6)</td><td>29.9(4.2)</td><td>31.7(4.5)</td><td><0.001</td></tr><tr><td>Waist-to-hip ratio (%)</td><td>78.5(6.5)</td><td>85.3(6.6)</td><td>88.5(6.8)</td><td>92.2(7.0)</td><td><0.001</td></tr><tr><td>Waist-to-height ratio (%)</td><td>49.9(5.2)</td><td>57.1(5.4)</td><td>61.3(5.9)</td><td>65.4(6.2)</td><td><0.001</td></tr><tr><td>Lipid accumulation product</td><td>17.8(1.6)</td><td>42.9(1.2</td><td>73.0(1.2)</td><td>135.6(1.4)</td><td><0.001</td></tr><tr><td>Triglycerides (mmol.l<sup>-1</sup>)</td><td>1.0(1.4)</td><td>1.4(1.3)</td><td>2.0(1.3)</td><td>3.2(1.4)</td><td><0.001</td></tr><tr><td>Total cholesterol (mmol.l<sup>-1</sup>)</td><td>5.0(1.0)</td><td>5.5(1.0)</td><td>6.0(1.1)</td><td>6.5(1.3)</td><td><0.001</td></tr><tr><td>Non-HDL-C (mmol.l<sup>-1</sup>)</td><td>3.8(0.9)</td><td>4.3(1.0)</td><td>4.9(1.1)</td><td>5.5(1.3)</td><td><0.001</td></tr><tr><td>HDL-C (mmol.l<sup>-1</sup>)</td><td>1.3(0.3)</td><td>1.2(0.3)</td><td>1.1(0.3)</td><td>1.0(0.3)</td><td><0.001</td></tr><tr><td>FPG (mmol.l<sup>-1</sup>)</td><td>5.0(1.3)</td><td>5.3(1.6)</td><td>5.9(2.3)</td><td>6.5(2.8)</td><td><0.001</td></tr><tr><td>2h-PCPG (mmol.l<sup>-1</sup>)</td><td>5.8(1.8)</td><td>6.5(2.3)</td><td>7.4(3.2)</td><td>8.7(4.2)</td><td><0.001</td></tr><tr><td>Assignment to intervention (%)</td><td>362 (38.2)</td><td>387 (40.6)</td><td>363 (38.7)</td><td>365 (38.5)</td><td>0.657</td></tr><tr><td>Diabetes</td><td>46 (4.9)</td><td>104 (10.9)</td><td>197 (21.0)</td><td>322 (34.0)</td><td><0.001</td></tr><tr><td>Hypertension</td><td>288 (28.3)</td><td>472 (42.5)</td><td>585 (62.3)</td><td>699 (73.8)</td><td><0.001</td></tr><tr><td>Smoking</td><td>44 (4.7)</td><td>37 (3.9)</td><td>30 (3.2)</td><td>28 (3.0)</td><td>0.748</td></tr><tr><td>Family history of premature CVD</td><td>92 (9.7)</td><td>107 (11.2)</td><td>129 (13.7)</td><td>131 (13.8)</td><td><0.010</td></tr><tr><td>Incident** CHD (95% CIs)</td><td>1.1 (0.6-2.2)</td><td>3.6 (2.4-5.2)</td><td>7.4 (5.7-9.7)</td><td>11.2 (8.9-14.0)</td><td><0.001</td></tr><tr><td>Incident** CVD (95% CIs)</td><td>1.3 (0.7-2.4)</td><td>4.1 (2.9-5.8)</td><td>8.3 (6.4-10.7)</td><td>13.0 (10.5-16.0)</td><td><0.001</td></tr><tr><td>Mortality** rate (95% CIs)</td><td>2.4(1.5-3.7)</td><td>2.5(1.6-3.9)</td><td>4.1(2.9-5.8)</td><td>4.5(3.3-6.3)</td><td>0.673</td></tr></table> |
cb340578be1a7b5094528ba3d7ce5bdbf8c20b7d623fee562bf2559cb0d4a982.png | complex | <table><tr><td></td><td>Sense</td><td>Antisense</td></tr><tr><td colspan="3">Reference gene</td></tr><tr><td> <i>Gapdh</i></td><td>5′-ggcaaattcaacggcaca-3′</td><td>5′-gttagtggggtctcgctcctg-3′</td></tr><tr><td colspan="3">Inflammation marker</td></tr><tr><td> <i>S100A8</i></td><td>5′-tgtcctcagtttgtgcagaatataaat-3′</td><td>5′-tttatcaccatcgcaaggaactc-3′</td></tr><tr><td> <i>S100A9</i></td><td>5′-ggcaaaggctgtgggaagt-3′</td><td>5′-ccattgagtaagccattcccttta-3′</td></tr><tr><td colspan="3">Mobilization markers</td></tr><tr><td> <i>CCL2</i></td><td>5′-ttggctcagccagatgca-3′</td><td>5′-cctactcattgggatcatcttgct-3′</td></tr><tr><td> <i>CX3CL1</i></td><td>5′-gtgccattgtcctggagac-3′</td><td>5′-catttctccttcgggtcag-3′</td></tr><tr><td> <i>KC</i></td><td>5′-tggctgggattcacctcaa-3′</td><td>5′-gagtgtggctatgacttcggttt-3′</td></tr><tr><td> <i>MIP</i>-<i>1α</i></td><td>5′-caagtcttctcagcgccatatg-3′</td><td>5′-tcttccggctgtaggagaagc-3′</td></tr><tr><td colspan="3">Cell markers</td></tr><tr><td> <i>CX3CR1</i></td><td>5′-gagtatgacgattctgctgagg-3′</td><td>5′-cagaccgaacgtgaagacgag-3′</td></tr><tr><td> <i>CCR2</i></td><td>5′-ctatctgctcaacttggccatct-3′</td><td>5′-tgagcccagaatggtaatgtga-3′</td></tr><tr><td> <i>Ly6C</i></td><td>5′-gcagtgctacgagtgctatgg-3′</td><td>5′-actgacgggtctttagtttcctt-3′</td></tr><tr><td> <i>F4</i>/<i>80</i></td><td>5′-aatcctgtgaagatgtgg-3′</td><td>5′-gagtgttgatgcaaatgaag-3′</td></tr><tr><td colspan="3">Adhesion molecules</td></tr><tr><td> <i>LFA1</i></td><td>5′-gaatgtatgaagggcaaagtc-3′</td><td>5′-gcagcaaactggtaggaag-3′</td></tr><tr><td> <i>VCAM</i></td><td>5′-ccaagtctctccaaaagatatacagctt-3′</td><td>5′-atgacggtgtctccctct-3′</td></tr><tr><td> <i>L</i>-<i>selectin</i></td><td>5′-actgctctgttgtgacttcc-3′</td><td>5′-tgtatggcgactaaatctgtg-3′</td></tr><tr><td> <i>PECAM1</i></td><td>5′-tccctgggaggtcgtccat-3′</td><td>5′-gaacaaggcagcggggttta-3′</td></tr><tr><td> <i>VE</i>-<i>cadherin</i></td><td>5′-tcctcttgcatcctcactatcaca-3′</td><td>5′-gtaagtgaccaactgctcgtgaat-3′</td></tr></table> |
47ca4a7e287d83e14b96fbc06f13d25ff326c482c4c0df5d473e460519816657.png | simple | <table><tr><td>locus</td><td>primer</td><td>source</td><td>sequence</td></tr><tr><td>COI</td><td>LCO_Hym (C1-J-1514)</td><td>[75]</td><td>5'-TATCAACCAATCATAAAGATATTGG-3'</td></tr><tr><td></td><td>C1-J-1580</td><td>new</td><td>5'-ACATCTTTAAGAATAATTATTCG-3'</td></tr><tr><td></td><td>Nancy-short (C1-N-2194)</td><td>[76]</td><td>5'-CCCGGTAAAATTAAAATATAAAC-3'</td></tr><tr><td></td><td>Pat (TL2-N-3014)</td><td>[76]</td><td>5'-TCCAATGCACTAATCTGCCATATTA-3'</td></tr><tr><td>28S</td><td>28S for (D2-3665F)</td><td>[82]</td><td>5'-AAGAGAGAGTTCAAGAGTACGTG-3'</td></tr><tr><td></td><td>28Srev (D3-4283R)</td><td>[82]</td><td>5'-TAGTTCACCATCTTTCGGGTCCC-3'</td></tr><tr><td>TPI</td><td>L1F</td><td>[83]</td><td>5'-CTKCGTBGGNGGNAACTGGAAGATGA-3'</td></tr><tr><td></td><td>L1R</td><td>[83]</td><td>5'-CCRATRGCCCANACNGGYTCRTA-3'</td></tr></table> |
3b4585e6b32cc96750f8df54ebbcc6df7eda8a4cab446261c28fbd72f521e735.png | simple | <table><tr><td>Range(mA)</td><td>Heaterresistance (Ω)</td><td>Thermocoupleresistance (Ω)</td><td>Output emf(mV)</td><td>Reversalerror (μA/A)</td><td>Timeconstant (s)</td></tr><tr><td>5</td><td>50 to 60</td><td>8 to 13</td><td>11</td><td>50</td><td><2</td></tr><tr><td>10</td><td>30 to 40</td><td>7 to 8</td><td>9</td><td>220</td><td><2</td></tr><tr><td>20</td><td>20 to 25</td><td>3 to 5</td><td>9</td><td>250</td><td><2</td></tr><tr><td>30</td><td>6 to 7</td><td>3 to 5</td><td>9</td><td>240</td><td><2</td></tr><tr><td>50</td><td>3 to 4</td><td>3 to 5</td><td>9</td><td>100</td><td><2</td></tr><tr><td>100</td><td>1 to 2</td><td>3 to 5</td><td>10</td><td>140</td><td><2</td></tr><tr><td>250</td><td>0.5 to 1.0</td><td>2 to 4</td><td>11</td><td>130</td><td><3</td></tr></table> |
d084e53f75596a767d2240869be497c950ea40b291e91045d35e3fd10ec30995.png | simple | <table><tr><td></td><td>PEF (L/s)</td><td>PEF:PIF</td></tr><tr><td>Control</td><td>0.68 ± 0.28</td><td>0.85 ± 0.14</td></tr><tr><td>Treadmill</td><td>1.68* ± 0.51</td><td>0.90 ± 0.10</td></tr><tr><td>Flutter®</td><td>1.53* ± 0.25</td><td>1.13* ± 0.37</td></tr></table> |
da80827142404f1cfb4f34caebb0c0e3527988451046ec605f3e265403357da0.png | complex | <table><tr><td> </td><td>0 additional risk</td><td>1 additional risk</td><td>2 additional risk</td><td>3 additional risk</td><td>4 additional risk</td></tr><tr><td colspan="6">Physical Activity Risk</td></tr><tr><td>No</td><td>88</td><td>223</td><td>211</td><td>114</td><td>30</td></tr><tr><td>Yes</td><td>168</td><td>591</td><td>815</td><td>481</td><td>157</td></tr></table> |
8252bb11ce4711bd6991e5f19ce3f2e187d7e9997ec92c6392b47a369fb802f6.png | complex | <table><tr><td rowspan="2">Age(y)</td><td rowspan="2">n</td><td colspan="2">Males</td><td colspan="2">Females</td></tr><tr><td>Mean ± SEM *</td><td>% Anemic</td><td>Mean ± SEM *</td><td>% Anemic</td></tr><tr><td>0–4.9</td><td>252</td><td>123.9 ± 1.6</td><td>15.6</td><td>122.8 ± 2.0</td><td>15.7</td></tr><tr><td>5–11</td><td>181</td><td>131.7 ± 0.9</td><td>9.9</td><td>130.6 ± 1.1</td><td>12.4</td></tr><tr><td>12–14</td><td>182</td><td>140.9 ± 2.2</td><td>8.8</td><td>132.5 ± 1.8</td><td>5.7</td></tr><tr><td>15–19</td><td>194</td><td>152.8 ± 1.7</td><td>2.4</td><td>131.0 ± 1.4</td><td>10.2</td></tr><tr><td>20–49</td><td>663</td><td>156.6 ± 1.1</td><td>2.5</td><td>127.2 ± 1.0</td><td>17.1</td></tr><tr><td>≥50</td><td>358</td><td>149.1 ± 1.4</td><td>5.5</td><td>128.0 ± 0.9</td><td>18.0</td></tr></table> |
027d3b1b1406b1830744c3f58a0781697b9af591555584c16372f022c23af2a0.png | simple | <table><tr><td>Code</td><td>Value</td><td>%age<sup>a</sup></td><td>Description</td></tr><tr><td>J</td><td>140</td><td>7.28</td><td>Translation</td></tr><tr><td>A</td><td>0</td><td>0</td><td>RNA processing and modification</td></tr><tr><td>K</td><td>101</td><td>5.25</td><td>Transcription</td></tr><tr><td>L</td><td>128</td><td>6.66</td><td>Replication, recombination and repair</td></tr><tr><td>B</td><td>1</td><td>0.05</td><td>Chromatin structure and dynamics</td></tr><tr><td>D</td><td>24</td><td>1.25</td><td>Cell cycle control, mitosis and meiosis</td></tr><tr><td>Y</td><td>0</td><td>0</td><td>Nuclear structure</td></tr><tr><td>V</td><td>47</td><td>2.45</td><td>Defense mechanisms</td></tr><tr><td>T</td><td>62</td><td>3.23</td><td>Signal transduction mechanisms</td></tr><tr><td>M</td><td>66</td><td>3.43</td><td>Cell wall/membrane biogenesis</td></tr><tr><td>N</td><td>5</td><td>0.26</td><td>Cell motility</td></tr><tr><td>Z</td><td>0</td><td>0</td><td>Cytoskeleton</td></tr><tr><td>W</td><td>0</td><td>0</td><td>Extracellular structures</td></tr><tr><td>U</td><td>26</td><td>1.35</td><td>Intracellular trafficking and secretion</td></tr><tr><td>O</td><td>56</td><td>2.91</td><td>Posttranslational modification, protein turnover, chaperones</td></tr><tr><td>C</td><td>79</td><td>4.11</td><td>Energy production and conversion</td></tr><tr><td>G</td><td>40</td><td>2.08</td><td>Carbohydrate transport and metabolism</td></tr><tr><td>E</td><td>137</td><td>7.13</td><td>Amino acid transport and metabolism</td></tr><tr><td>F</td><td>61</td><td>3.17</td><td>Nucleotide transport and metabolism</td></tr><tr><td>H</td><td>58</td><td>3.02</td><td>Coenzyme transport and metabolism</td></tr><tr><td>I</td><td>41</td><td>2.13</td><td>Lipid transport and metabolism</td></tr><tr><td>P</td><td>77</td><td>4.01</td><td>Inorganic ion transport and metabolism</td></tr><tr><td>Q</td><td>15</td><td>0.78</td><td>Secondary metabolites biosynthesis, transport and catabolism</td></tr><tr><td>R</td><td>179</td><td>9.31</td><td>General function prediction only</td></tr><tr><td>S</td><td>133</td><td>6.92</td><td>Function unknown</td></tr><tr><td>-</td><td>554</td><td>28.82</td><td>Not in COGs</td></tr></table> |
52113749f23d779f6fb70b74da9b15c33ea277f0b79479d3513fc3d3e4ed97ab.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Mean (SD) Larsen score</td><td rowspan="2"><i>p</i> value</td></tr><tr><td>No BMD loss</td><td>Moderate BMD loss</td><td>Severe BMD loss</td></tr><tr><td>Baseline (SD)</td><td>3.2 (4,23)</td><td>4.3 (4.81)</td><td>6.0 (6.28)</td><td>0.039</td></tr><tr><td>1 year (SD)</td><td>4.0 (4.68)</td><td>5.3 (5.45)</td><td>7.3 (6.38)</td><td>0.024</td></tr><tr><td>2 years (SD)</td><td>5.4 (5.1)</td><td>6.9 (5.6)</td><td>8.8 (6.04)</td><td>0.056</td></tr></table> |
29f5446a0b9e408bf8b8af95de475b2a36c8638dc5484c336c01ed9b69b6d7a6.png | simple | <table><tr><td></td><td>GT1M</td><td>GT3X</td><td>Actitrainer</td></tr><tr><td>Belgium (n = 109)</td><td>0%</td><td>96%</td><td>4%</td></tr><tr><td>Greece (n = 142)</td><td>0%</td><td>0%</td><td>100%</td></tr><tr><td>Hungary (n = 140)</td><td>67%</td><td>0%</td><td>33%</td></tr><tr><td>The Netherlands (n = 104)</td><td>0%</td><td>0%</td><td>100%</td></tr><tr><td>Switzerland (n = 192)</td><td>37%</td><td>63%</td><td>0%</td></tr><tr><td>Total sample (n = 687)</td><td>33%</td><td>43%</td><td>24%</td></tr></table> |
d72884635a29d5d5d79fee614c2345f8f04813a1b96c6aee99f9ea3d5afefeb8.png | simple | <table><tr><td>Response</td><td>N</td><td>%</td></tr><tr><td>Nothing would happen</td><td>34</td><td>30.1</td></tr><tr><td>My Doctor (the researcher) would not be happy with me</td><td>10</td><td>8.8</td></tr><tr><td>I don't know</td><td>8</td><td>7.1</td></tr><tr><td>Could be a bad decision for me clinically</td><td>38</td><td>33.6</td></tr><tr><td>Others</td><td>23</td><td>20.4</td></tr><tr><td><i>"I might regret not utilizing the opportunity for the free treatment"</i></td><td></td><td></td></tr><tr><td><i>"How can I stop participation when I have come to seek medical help?"</i></td><td></td><td></td></tr><tr><td><i>"I would discourage others who want to join"</i></td><td></td><td></td></tr><tr><td><i>"I would spoil their work."</i></td><td></td><td></td></tr><tr><td><i>"It is compulsory"</i></td><td></td><td></td></tr><tr><td><i>"It shows that there is no reason for my coming"</i></td><td></td><td></td></tr><tr><td><i>"It is a research work, I can't stop"</i></td><td></td><td></td></tr><tr><td><i>"I would be insulting the Doctors by stopping"</i></td><td></td><td></td></tr><tr><td><i>"I would have cheated myself"</i></td><td></td><td></td></tr><tr><td><i>"It shows that I'm not serious"</i></td><td></td><td></td></tr><tr><td><i>"I can't stop because Doctor is doing something good"</i></td><td></td><td></td></tr><tr><td><i>"I would go back with the problem I came with"</i></td><td></td><td></td></tr><tr><td><i>"Doctor would go away"</i></td><td></td><td></td></tr><tr><td><i>"I can't say I would stop participation since I chose to come for my health sake"</i></td><td></td><td></td></tr><tr><td><i>"My conscience would not allow me because it is helpful"</i></td><td></td><td></td></tr><tr><td><i>"I want to know what they are doing" etc</i></td><td></td><td></td></tr></table> |
eff25d9e778f5e928d04e5ba2b8a7a3a61468c7cea5102cdafcc0274205c686f.png | complex | <table><tr><td></td><td>H-SLI</td><td>TD</td><td><i>F</i></td><td><i>p</i></td></tr><tr><td colspan="5">Non-word repetition</td></tr><tr><td> 1 syllable</td><td>96.9 (1.3)</td><td>98.7 (0.7)</td><td>1.385</td><td>0.249</td></tr><tr><td> 2 syllable</td><td>94.2 (1.0)</td><td>97.6 (0.8)</td><td>7.53</td><td>0.009</td></tr><tr><td> 3 syllable</td><td>86.6 (2.7)</td><td>97.6 (0.7)</td><td>15.601</td><td>0.001</td></tr><tr><td> 4 syllable</td><td>64.7 (3.3)</td><td>85.7 (2.1)</td><td>27.967</td><td><0.001</td></tr><tr><td colspan="5">TAPS-3 number memory</td></tr><tr><td> Forward</td><td>7.3 (0.5)</td><td>10.9 (0.5)</td><td>23.069</td><td><0.001</td></tr><tr><td> Reversed</td><td>8.9 (0.4)</td><td>11.9 (0.6)</td><td>16.04</td><td><0.001</td></tr><tr><td>Conners’ ADHD Index</td><td>54.9 (2.4)</td><td>47.9 (1.3)</td><td>6.629</td><td>0.016</td></tr></table> |
4905872faf3b6e0cee01045adf675a27c9b8e5ab11a0d29ffe6e075aeeaeaaf0.png | simple | <table><tr><td>Group</td><td>Surgery time* (mean ± SD)</td><td>Extubation time* (mean ± SD)</td></tr><tr><td>TRA</td><td>95.3 ± 17.4</td><td>6.6 ± 2.4</td></tr><tr><td>MET 0.5</td><td>98.2 ± 15.2</td><td>7.2 ± 1.6</td></tr><tr><td>MET 0.7</td><td>98.5 ± 12.8</td><td>7.3 ± 2.2</td></tr></table> |
ecd54844dcd25884c55733478d035d1cb305b8dbd3d91ff93008932acdfcba00.png | complex | <table><tr><td rowspan="2"></td><td></td><td colspan="2">Median ± SD of PRB expression (2^-∆Ct)</td></tr><tr><td>PRB status at day 1</td><td>Day 1</td><td>Day 15</td></tr><tr><td rowspan="2">Control group</td><td>PRB+</td><td>0.014 ± 0.01</td><td>0.010 ± 0.02</td></tr><tr><td>PRB-</td><td>0.007 ± 0.00</td><td>0.007 ± 0.001</td></tr><tr><td rowspan="2">Treated group</td><td>PRB+</td><td>0.014 ± 0.01</td><td>0.011 ± 0.01</td></tr><tr><td>PRB-</td><td>0.006 ± 0.002</td><td>0.006 ± 0.003</td></tr></table> |
32b3aefd5c6d939cc7de4c4da176a32fee2e41b844168f1bc4896885fc61760d.png | simple | <table><tr><td>Drug</td><td>Brain disease</td><td>Mechanism</td><td>Reference</td></tr><tr><td><i>ω</i>-3 PUFA</td><td>ADHD</td><td>Nonspecific antioxidant effect</td><td>[151, 152]</td></tr><tr><td>Vitamin C</td><td>Vascular dementia</td><td>Free radical scavenger</td><td>[153]</td></tr><tr><td>Hyperbaric O<sub>2</sub></td><td>Autism</td><td>Anti-inflammatory and reduces oxidative stress</td><td>[157]</td></tr><tr><td>H<sub>2</sub>S</td><td>Focal cerebral ischemia/reperfusion</td><td>Inhibits oxidative phosphorylation, inflammation, and apoptosis</td><td>[159]</td></tr><tr><td>H<sub>2</sub>-rich saline</td><td>Focal or global cerebral ischemia/reperfusion</td><td>Reduces oxidative stress and inflammation</td><td>[160, 161]</td></tr><tr><td>Lithium</td><td>Healthy volunteers</td><td>Prevents/or reverses DNA damage, lipid peroxidation, and free radical formation</td><td>[164]</td></tr><tr><td>Pifithrin-<i>μ</i></td><td>Perinatal hypoxic-ischemic brain damage</td><td>Inhibition of the apoptotic pathways and reduction of the oxidative stress</td><td>[166]</td></tr><tr><td>Telmisartan</td><td>Vascular dementia</td><td>Anti-inflammatory and antioxidant effects</td><td>[174–176]</td></tr><tr><td>Nanodrugs</td><td> </td><td>ROS scavengers</td><td>[177]</td></tr><tr><td>Triterpenoids</td><td>Parkinson</td><td>Antioxidants via Nrf2/ARE pathway</td><td>[146]</td></tr><tr><td>PPARgamma agonists</td><td>Neurodegenerative diseases</td><td>Anti-inflammatory</td><td>[162–164]</td></tr></table> |
e2613a0bd195f9dfe7bf0f00a58ad94ebfb9b9295a6b37a54dcdb1e4ad946177.png | complex | <table><tr><td rowspan="2"></td><td colspan="4">eGFR (mL/min/1.73 m<sup>2</sup>)</td><td colspan="3">Albuminuria</td></tr><tr><td colspan="4">N = 966,436</td><td colspan="3">N = 966,436</td></tr><tr><td></td><td>≥60</td><td>45-59</td><td>30-44</td><td>15-29</td><td>None</td><td>Mild</td><td>Heavy</td></tr><tr><td></td><td>N = 892,350</td><td>N = 52,237</td><td>N = 16,926</td><td>N = 4,923</td><td>N = 877,076</td><td>N = 75,421</td><td>N = 13,939</td></tr><tr><td>Female</td><td>53</td><td>58</td><td>61</td><td>59</td><td>60</td><td>51</td><td>42</td></tr><tr><td>Aboriginal</td><td>1</td><td>1</td><td>1</td><td>2</td><td>2</td><td>3</td><td>4</td></tr><tr><td>Diabetes,</td><td>12</td><td>21</td><td>29</td><td>35</td><td>9</td><td>18</td><td>34</td></tr><tr><td>Hypertension</td><td>38</td><td>65</td><td>81</td><td>84</td><td>29</td><td>41</td><td>56</td></tr><tr><td>Cerebrovascular dis</td><td>3</td><td>7</td><td>11</td><td>12</td><td>2</td><td>4</td><td>7</td></tr><tr><td>Congestive heart failure</td><td>2</td><td>8</td><td>15</td><td>25</td><td>2</td><td>5</td><td>9</td></tr><tr><td>Myocardial infarction</td><td>3</td><td>6</td><td>11</td><td>15</td><td>2</td><td>4</td><td>6</td></tr><tr><td>Socioeconomic status</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Pensioner</td><td>33</td><td>73</td><td>84</td><td>78</td><td>22</td><td>31</td><td>35</td></tr><tr><td>Low</td><td>18</td><td>12</td><td>7</td><td>8</td><td>15</td><td>14</td><td>14</td></tr><tr><td>Low with subsidy</td><td>2</td><td>2</td><td>2</td><td>3</td><td>3</td><td>5</td><td>6</td></tr></table> |
d262585dc2997025542d53ec07b2711c6e66c36a9cf7fb1484621c12fa3c52d7.png | simple | <table><tr><td></td><td>CRP (mg/L)</td><td><i>P</i> value</td></tr><tr><td>SDNN < 20 ms (<i>n</i> = 256)</td><td>8.06 ± 9.06</td><td>0.031</td></tr><tr><td>SDNN ≥20 ms (<i>n</i> = 126)</td><td>5.92 ± 9.10</td><td></td></tr></table> |
4a7384aa52c7fedc57cd162ffbee08eef3048cc51727453deaf3bc817a9084e6.png | simple | <table><tr><td>Main Reason for Being Here</td><td>Frequency</td><td>Percent</td></tr><tr><td>Fracture</td><td>6</td><td>12.8</td></tr><tr><td>Strain, sprain, dislocation</td><td>7</td><td>14.9</td></tr><tr><td>Cut, bite, penetrating injury, open wound</td><td>19</td><td>40.4</td></tr><tr><td>Bruise, scrape, superficial wound</td><td>9</td><td>19.1</td></tr><tr><td>Concussion, closed head injury</td><td>2</td><td>4.3</td></tr><tr><td>Organ system injury/multiple organ injury</td><td>2</td><td>4.3</td></tr><tr><td>Other</td><td>1</td><td>2.1</td></tr><tr><td>Unknown</td><td>1</td><td>2.1</td></tr><tr><td>Total</td><td>47</td><td>100.0</td></tr></table> |
9ec78b9e9eb18928b7150929d3362f1ca90185e61a8e876a1e632eff98c7bd91.png | complex | <table><tr><td>Parameter</td><td> </td><td colspan="2">HCC in NCL; n = 93</td><td colspan="2">HCC in LC; n = 571</td><td>p</td></tr><tr><td> </td><td> </td><td>n/median</td><td>%/range</td><td>n/median</td><td>%/range</td><td> </td></tr><tr><td>Gender</td><td>Male</td><td>68</td><td>73</td><td>468</td><td>82</td><td rowspan="2">0.045</td></tr><tr><td> </td><td>Female</td><td>25</td><td>27</td><td>103</td><td>18</td></tr><tr><td>Age</td><td> </td><td>69</td><td>32-85</td><td>66</td><td>31-85</td><td>0.004</td></tr><tr><td>BMI</td><td> </td><td>24.68</td><td>19.18-38.5</td><td>27.1</td><td>18.07-46.30</td><td><0.001</td></tr><tr><td>ECOG status</td><td> </td><td>n = 79</td><td> </td><td>n = 428</td><td> </td><td rowspan="5">0.432</td></tr><tr><td> </td><td>0</td><td>37</td><td>46.84</td><td>195</td><td>45.56</td></tr><tr><td> </td><td>1</td><td>30</td><td>37.97</td><td>148</td><td>34.58</td></tr><tr><td> </td><td>2</td><td>12</td><td>15.19</td><td>72</td><td>16.82</td></tr><tr><td> </td><td>3 or 4</td><td>0</td><td>0</td><td>13</td><td>3.04</td></tr><tr><td>Diabetes mellitus</td><td>Yes</td><td>42 (n = 59)</td><td>71.2</td><td>308 (n = 368)</td><td>83.7</td><td>0.020</td></tr><tr><td>History of nicotine abuse</td><td>Yes</td><td>22 (n = 55)</td><td>40.0</td><td>110 (n = 231)</td><td>47.6</td><td>0.308</td></tr><tr><td>Etiology</td><td>Alcohol</td><td>14</td><td>15.05</td><td>285</td><td>49.91</td><td rowspan="4">0.008</td></tr><tr><td> </td><td>Viral</td><td>7</td><td>7.53</td><td>91</td><td>15.94</td></tr><tr><td> </td><td>NAFLD</td><td>6</td><td>6.45</td><td>37</td><td>6.48</td></tr><tr><td> </td><td>Other</td><td>13</td><td>13.98</td><td>93</td><td>16.29</td></tr><tr><td> </td><td>Unknown</td><td>53</td><td>56.99</td><td>65</td><td>11.38</td><td> </td></tr></table> |
ab467dfaeb5e56772dd77f76aa2501461a4fd8d41f02c2ad146cb3991d5ffb1f.png | simple | <table><tr><td>Sample number</td><td>Biofilm formation (OD) at 660 nm</td><td>Biofilm inhibition by biosurfactant (OD) at 660 nm</td><td>% inhibition of biofilm</td></tr><tr><td>1</td><td>0.316</td><td>0.183</td><td>41.38 ± 1.09</td></tr><tr><td>2</td><td>0.239</td><td>0.152</td><td>36.62 ± 1.13</td></tr><tr><td>3</td><td>0.388</td><td>0.173</td><td>54.71 ± 1.27</td></tr><tr><td>4</td><td>0.281</td><td>0.147</td><td>47.68 ± 0.54</td></tr><tr><td>5</td><td>0.226</td><td>0.139</td><td>38.49 ± 0.68s</td></tr></table> |
d9150285cd91bb9f3af27fb2156076cd0acf7befaa48a04bfa8869c507b81ffd.png | complex | <table><tr><td colspan="9">Comparison of number of knots along the sessions between loop & winding method</td></tr><tr><td> </td><td>S1</td><td>S2</td><td>S3</td><td>S4</td><td>S5</td><td>S6</td><td>S7</td><td>S8</td></tr><tr><td>Loop</td><td>3</td><td>4</td><td>5</td><td>5</td><td>6</td><td>7</td><td>7</td><td>7</td></tr><tr><td>Wind</td><td>3</td><td>6</td><td>8</td><td>9</td><td>11</td><td>12</td><td>14</td><td>15</td></tr><tr><td><i>Z</i>-value</td><td>0.24</td><td>3.14</td><td>3.77</td><td>3.58</td><td>3.78</td><td>3.81</td><td>3.83</td><td>3.87</td></tr><tr><td><i>P</i> value</td><td>0.853<sup>#</sup></td><td>0.0001<sup><i>∗∗</i></sup></td><td>0.0001<sup><i>∗∗</i></sup></td><td>0.0001<sup><i>∗∗</i></sup></td><td>0.0001<sup><i>∗∗</i></sup></td><td>0.0001<sup><i>∗∗</i></sup></td><td>0.0001<sup><i>∗∗</i></sup></td><td>0.0001<sup><i>∗∗</i></sup></td></tr></table> |
976abaa4aab26b09be03a07ea3d6bc52bd90e52bb44d8ca922d447649ee81374.png | complex | <table><tr><td rowspan="2">Weeks of Treatment</td><td colspan="3">Group</td><td rowspan="2">Overall Mean</td></tr><tr><td>A (Control)</td><td>B (Treatment 1)</td><td>C (Treatment 2)</td></tr><tr><td>0</td><td>5.25 ± 0.95d-h</td><td>4.50 ± 0.29fgh</td><td>3.75 ± 0.48 h</td><td>4.50 ± 0.38D</td></tr><tr><td>5</td><td>3.38 ± 0.24 h</td><td>5.00 ± 0.41d-h</td><td>4.50 ± 0.29fgh</td><td>4.29 ± 0.26D</td></tr><tr><td>6</td><td>3.75 ± 0.48 h</td><td>5.75 ± 0.14c-g</td><td>4.75 ± 0.25e-h</td><td>4.75 ± 0.30CD</td></tr><tr><td>7</td><td>4.00 ± 0.41gh</td><td>6.50 ± 0.20a-e</td><td>6.00 ± 0.41b-f</td><td>5.50 ± 0.37BC</td></tr><tr><td>8</td><td>3.63 ± 0.38 h</td><td>6.50 ± 0.20a-e</td><td>6.75 ± 0.32a-d</td><td>5.63 ± 0.46ABC</td></tr><tr><td>9</td><td>3.63 ± 0.38 h</td><td>7.38 ± 0.24abc</td><td>7.38 ± 0.24abc</td><td>6.13 ± 0.55AB</td></tr><tr><td>10</td><td>3.75 ± 0.48 h</td><td>7.63 ± 0.24abc</td><td>7.88 ± 0.13ab</td><td>6.42 ± 0.59AB</td></tr><tr><td>11</td><td>3.63 ± 0.38 h</td><td>7.88 ± 0.31ab</td><td>8.00 ± 0.20a</td><td>6.50 ± 0.63A</td></tr><tr><td>12</td><td>3.63 ± 0.24 h</td><td>7.88 ± 0.13ab</td><td>8.13 ± 0.13a</td><td>6.54 ± 0.63A</td></tr><tr><td>Mean</td><td>3.85 ± 0.17B</td><td>6.56 ± 0.21A</td><td>6.35 ± 0.28A</td><td></td></tr></table> |
d5fa1de48b022614b22b761e138e030372bf9d2b54112264e3921f26960ef28c.png | complex | <table><tr><td></td><td colspan="6">Percent Correct</td><td colspan="6">F-Measure</td></tr><tr><td>Activity</td><td>C4.5</td><td>SMO</td><td>VP</td><td>DT</td><td>RF</td><td>Best</td><td>C4.5</td><td>SMO</td><td>VP</td><td>DT</td><td>RF</td><td>Best</td></tr><tr><td>Get drink</td><td>96.86</td><td>99.32</td><td>95.37</td><td>96.87</td><td>100.00</td><td>100.00</td><td>0.83</td><td>0.96</td><td>0.57</td><td>0.80</td><td>1.00</td><td>1.00</td></tr><tr><td>Go to bed</td><td>89.26</td><td>89.54</td><td>90.36</td><td>90.23</td><td>91.43</td><td>91.43</td><td>0.00</td><td>0.00</td><td>0.03</td><td>0.00</td><td>0.30</td><td>0.30</td></tr><tr><td>Leave the house</td><td>97.96</td><td>97.96</td><td>94.56</td><td>97.02</td><td>97.42</td><td>97.96</td><td>0.94</td><td>0.94</td><td>0.74</td><td>0.91</td><td>0.92</td><td>0.94</td></tr><tr><td>Prepare breakfast</td><td>96.19</td><td>95.91</td><td>94.82</td><td>91.02</td><td>97.82</td><td>97.82</td><td>0.75</td><td>0.71</td><td>0.56</td><td>0.29</td><td>0.83</td><td>0.83</td></tr><tr><td>Prepare dinner</td><td>95.51</td><td>96.18</td><td>96.06</td><td>94.39</td><td>97.82</td><td>97.82</td><td>0.42</td><td>0.51</td><td>0.30</td><td>0.33</td><td>0.64</td><td>0.64</td></tr><tr><td>Take a shower</td><td>98.36</td><td>98.23</td><td>94.04</td><td>90.63</td><td>98.63</td><td>98.63</td><td>0.90</td><td>0.89</td><td>0.44</td><td>0.00</td><td>0.91</td><td>0.91</td></tr><tr><td>Use the toilet</td><td>89.26</td><td>88.19</td><td>84.91</td><td>87.08</td><td>91.44</td><td>91.44</td><td>0.89</td><td>0.87</td><td>0.84</td><td>0.88</td><td>0.91</td><td>0.91</td></tr></table> |
0691211aa130546c66ce3d407f8f3638933abce158cbe6e9e5255bf21b50af6e.png | simple | <table><tr><td>No of isolates</td><td>Locus</td><td>Fragment length (bp)</td><td>No. of alleles</td><td>Gene diversity ± SD</td><td>No. of polymorphic sites</td><td>Avg. number of nucleotide differences</td><td>Nucleotide diversity ± SD</td></tr><tr><td>56</td><td><i>acsA</i></td><td>390</td><td>20</td><td>0.904 ± 0.027</td><td>23</td><td>5.15325</td><td>0.01321 ± 0.00095</td></tr><tr><td>56</td><td><i>aroE</i></td><td>498</td><td>10</td><td>0.827 ± 0.025</td><td>69</td><td>9.10909</td><td>0.01829 ± 0.00507</td></tr><tr><td>56</td><td><i>guaA</i></td><td>373</td><td>15</td><td>0.868 ± 0.034</td><td>14</td><td>2.62013</td><td>0.00702 ± 0.00062</td></tr><tr><td>54</td><td><i>mutL</i></td><td>442</td><td>14</td><td>0.764 ± 0.055</td><td>28</td><td>3.16702</td><td>0.00717 ± 0.00169</td></tr><tr><td>56</td><td><i>nuoD</i></td><td>366</td><td>6</td><td>0.642 ± 0.048</td><td>11</td><td>1.52922</td><td>0.00418 ± 0.00081</td></tr><tr><td>56</td><td><i>ppsA</i></td><td>370</td><td>14</td><td>0.879 ± 0.024</td><td>39</td><td>4.61364</td><td>0.01247 ± 0.00347</td></tr><tr><td>56</td><td><i>trpE</i></td><td>443</td><td>15</td><td>0.876 ± 0.023</td><td>19</td><td>4.50260</td><td>0.01016 ± 0.00076</td></tr></table> |
bdc5f89a8e68f984deccd77153ffe9005e7a4e17d26df91c4cfa3d84bc0bfa44.png | simple | <table><tr><td>Predictors</td><td>Regression coefficient</td><td>Odds ratio</td><td>95% CI</td><td>Risk score = Regression coefficient × 25</td></tr><tr><td>Pre-existing diseases (CCI >3)</td><td>2.02</td><td>7.52</td><td>2.01 to 28.1</td><td>50.5</td></tr><tr><td>Parent to children <18 years</td><td>1.26</td><td>3.51</td><td>1.39 to 8.89</td><td>31.5</td></tr><tr><td>Previous psychological problems</td><td>1.14</td><td>3.13</td><td>1.12 to 8.76</td><td>28.5</td></tr><tr><td>In-ICU agitation</td><td>0.8</td><td>2.23</td><td>-0.80 to 6.22</td><td>20</td></tr><tr><td>Unemployed/sick-leave at ICU admission</td><td>0.48</td><td>1.62</td><td>-0.54 to 4.88</td><td>12</td></tr><tr><td>Appeared depressed in ICU</td><td>0.30</td><td>1.35</td><td>-0.55 to 3.31</td><td>7.5</td></tr></table> |
9db678d5023cf207b99b900b4be71ab56fa6ed01d7e55042911bcea6d12fbe17.png | complex | <table><tr><td rowspan="3">Items</td><td rowspan="3"><i>n</i></td><td colspan="2">Visited physician during past 12 months?</td><td rowspan="3"><i>P</i></td></tr><tr><td>Yes</td><td>No</td></tr><tr><td>Self-medication during past 12 months</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>242 (52.0)</td><td>71 (29.3)</td><td>171 (70.7)</td><td rowspan="2"><0.001</td></tr><tr><td> No</td><td>223 (48.0)</td><td>134 (60.1)</td><td>89 (39.9)</td></tr><tr><td>Have periodic physical examinations</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>255 (54.8)</td><td>145 (56.9)</td><td>110 (43.1)</td><td rowspan="2"><0.001</td></tr><tr><td> No</td><td>210 (45.2)</td><td>60 (28.6)</td><td>150 (71.4)</td></tr><tr><td colspan="2">Been a patient in hospital in previous 3 years(respondent or family member)</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>275 (59.1)</td><td>146 (53.1)</td><td>129 (46.9)</td><td rowspan="2"><0.001</td></tr><tr><td> No</td><td>190 (40.9)</td><td>59 (31.1)</td><td>131 (68.9)</td></tr><tr><td>Have medical insurance</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>288 (61.9)</td><td>145 (50.4)</td><td>143 (49.6)</td><td rowspan="2">0.001</td></tr><tr><td> No</td><td>177 (38.1)</td><td>60 (33.9)</td><td>117 (66.1)</td></tr><tr><td>Pay attention to health examinations</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>88 (18.9)</td><td>55 (62.5)</td><td>33 (37.5)</td><td rowspan="2">0.001</td></tr><tr><td> No</td><td>377 (81.1)</td><td>150 (39.8)</td><td>227 (60.2)</td></tr><tr><td colspan="2">Volunteered to help others during past 12 months</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>45 (9.7)</td><td>29 (64.4)</td><td>16 (35.6)</td><td rowspan="2">0.004</td></tr><tr><td> No</td><td>420 (90.3)</td><td>176 (41.9)</td><td>244 (58.1)</td></tr><tr><td>Smoking habit</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Smoker</td><td>138 (29.7)</td><td>48 (34.8)</td><td>90 (65.2)</td><td rowspan="2">0.009</td></tr><tr><td> Nonsmoker</td><td>327 (70.3)</td><td>157 (48.0)</td><td>170 (52.0)</td></tr><tr><td colspan="3">Visited friend or loved one in hospital during past 12 months</td><td> </td><td> </td></tr><tr><td> Yes</td><td>257 (55.3)</td><td>127 (49.4)</td><td>130 (50.6)</td><td rowspan="2">0.01</td></tr><tr><td> No</td><td>208 (44.7)</td><td>78 (37.5)</td><td>130 (62.5)</td></tr><tr><td colspan="2">Want to participate in group support activities</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>44 (9.5)</td><td>27 (61.4)</td><td>17 (38.6)</td><td rowspan="2">0.015</td></tr><tr><td> No</td><td>421 (90.5)</td><td>178 (42.3)</td><td>243 (57.7)</td></tr><tr><td>Radio use</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>239 (51.4)</td><td>93 (38.9)</td><td>146 (61.1)</td><td rowspan="2">0.021</td></tr><tr><td> No</td><td>226 (48.6)</td><td>112 (49.6)</td><td>114 (50.4)</td></tr><tr><td colspan="3">Lack of legal documents as reason for not visiting health facility</td><td> </td><td> </td></tr><tr><td> Yes</td><td>122 (26.2)</td><td>43 (35.3)</td><td>79 (64.7)</td><td rowspan="2">0.022</td></tr><tr><td> No</td><td>343 (73.8)</td><td>162 (47.2)</td><td>181 (52.8)</td></tr><tr><td>Have periodic dental examination</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>256 (55.0)</td><td>125 (48.8)</td><td>131 (51.2)</td><td rowspan="2">0.023</td></tr><tr><td> No</td><td>209 (45.0)</td><td>80 (38.3)</td><td>129 (61.7)</td></tr><tr><td>Internet use</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>221 (47.5)</td><td>86 (38.9)</td><td>135 (61.1)</td><td rowspan="2">0.033</td></tr><tr><td> No</td><td>244 (52.5)</td><td>119 (48.8)</td><td>125 (51.2)</td></tr><tr><td colspan="3">Get health-related instruction from religious people</td><td> </td><td> </td></tr><tr><td> Yes</td><td>144 (31.0)</td><td>74 (51.4)</td><td>70 (48.6)</td><td rowspan="2">0.034</td></tr><tr><td> No</td><td>321 (69.0)</td><td>131 (40.8)</td><td>190 (59.2)</td></tr><tr><td>Want information on child health care</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>44 (9.5)</td><td>13 (29.5)</td><td>31 (70.5)</td><td rowspan="2">0.041</td></tr><tr><td> No</td><td>421 (90.5)</td><td>192 (45.6)</td><td>229 (54.4)</td></tr><tr><td>Pay attention to weight</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>62 (13.3)</td><td>20 (32.3)</td><td>42 (67.7)</td><td rowspan="2">0.044</td></tr><tr><td> No</td><td>403 (86.7)</td><td>185 (45.9)</td><td>218 (54.1)</td></tr><tr><td>Pay attention to food and nutrition</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>343 (73.8)</td><td>142 (41.4)</td><td>201 (58.6)</td><td rowspan="2">0.05</td></tr><tr><td> No</td><td>122 (26.2)</td><td>63 (51.6)</td><td>59 (48.4)</td></tr><tr><td colspan="2">Want information on food and nutrition</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>191 (41.1)</td><td>74 (38.7)</td><td>117 (61.3)</td><td rowspan="2">0.053</td></tr><tr><td> No</td><td>274 (58.9)</td><td>131 (47.8)</td><td>143 (52.2)</td></tr></table> |
6190058b7a5413c8b91d1c78b735a576321460d32528c6ef2333dc5ae3861268.png | simple | <table><tr><td>Cisplatin concentration</td><td>Apoptosis level</td></tr><tr><td>0.0</td><td>0.0</td></tr><tr><td>0.0001</td><td>0.0</td></tr><tr><td>0.001</td><td>5E-6</td></tr><tr><td>0.01</td><td>4.67E-4</td></tr><tr><td>0.1</td><td>2.96E-2</td></tr><tr><td>0.5</td><td>0.16</td></tr><tr><td>1.0</td><td>0.23</td></tr></table> |
9b31b60004a6b2adfd2f9f0ff86fab5549d9ad52ee5b6d5f4f25dfb92f75a4b0.png | complex | <table><tr><td>Measure</td><td>Outcome results</td></tr><tr><td colspan="2">Maternal</td></tr><tr><td> Dams’ daily mean fluid consumption (mL/day)</td></tr><tr><td>For 14 days before mating</td><td>14.7 ± 0.8</td></tr><tr><td>During gestation</td><td>29.5 ± 1.8</td></tr><tr><td>PND1–PND10</td><td>46.8 ± 3.7</td></tr><tr><td> Dams’ weight (g)</td></tr><tr><td>14 days before mating</td><td>223 ± 6</td></tr><tr><td>At mating</td><td>247 ± 7</td></tr><tr><td>Total weight gain during pregnancy</td><td>127 ± 6</td></tr><tr><td> Mating success rate (%)</td><td>93.8 ± 1.2</td></tr><tr><td colspan="2">Litter and physical milestones</td></tr><tr><td> Length of gestation (days)</td><td>20.5 ± 0.2</td></tr><tr><td> Mean litter size (pups)</td><td>11.9 ± 0.4</td></tr><tr><td> Sex distribution at birth [male/female (%)]</td><td>54/46</td></tr><tr><td> Litter mortality (dead newborn pups/litter)</td><td>0.2 ± 0.1</td></tr><tr><td> Pup mortality during lactation (%)</td><td>1.9 ± 0.1</td></tr><tr><td> Eye opening [male/female (%)]</td></tr><tr><td>At PND14, one or both eyes</td><td>78 ± 5/75 ± 6</td></tr><tr><td>At PND16, both eyes</td><td>100/100</td></tr><tr><td colspan="2">Female offspring body weight (g)</td></tr><tr><td> At birth (PND0)</td><td>6.12 ± 0.14</td></tr><tr><td> PND10</td><td>20.3 ± 1.2</td></tr><tr><td> PND21</td><td>50.1 ± 2.1</td></tr><tr><td> PND90</td><td>254.6 ± 4.8</td></tr></table> |
363fec7c92077b4ac1334458b59c93d4e456a2227b01d41674992bcdfc0064b0.png | complex | <table><tr><td rowspan="2">Number</td><td rowspan="2">Compound</td><td rowspan="2"><i>t</i><sub><i>R</i></sub> (min)</td><td>HR-L</td><td>HR-D</td><td>SR</td></tr><tr><td>mg g<sup>−1</sup> DW</td><td>mg g<sup>−1</sup> DW</td><td>mg g<sup>−1</sup> DW</td></tr><tr><td>1</td><td>3-<i>O</i>-Caffeoylquinic acid</td><td>4.0</td><td>0.06 (4.80)<sup>a</sup></td><td>—</td><td>0.70 (0.34)<sup>b</sup></td></tr><tr><td>2</td><td>5-<i>O</i>-Caffeoylquinic acid </td><td>7.4</td><td>5.12 (2.24)<sup>b</sup></td><td>1.96 (2.92)<sup>a</sup></td><td>18.26 (0.46)<sup>c</sup></td></tr><tr><td>3</td><td>4-<i>O</i>-Caffeoylquinic acid</td><td>8.1</td><td>0.12 (5.03)<sup>b</sup></td><td>0.06 (2.35)<sup>a</sup></td><td>0.42 (0.95)<sup>c</sup></td></tr><tr><td>4</td><td>1,3-Di-<i>O</i>-caffeoylquinic acid</td><td>10.2</td><td>0.22 (3.90)<sup>b</sup></td><td>0.12 (2.68)<sup>a</sup></td><td>1.21 (1.88)<sup>c</sup></td></tr><tr><td>5</td><td>Quercetagetin hexoside</td><td>10.7</td><td>0.96 (1.65)</td><td>—</td><td>—</td></tr><tr><td>6</td><td>Quercetin hexoside</td><td>11.4</td><td>0.93 (1.71)</td><td>—</td><td>—</td></tr><tr><td>7</td><td>Quercetin hexoside</td><td>11.9</td><td>0.52 (0.61)</td><td>—</td><td>—</td></tr><tr><td>8</td><td>20-Hydroxyecdysone</td><td>12.0</td><td>—</td><td>—</td><td>5.60 (1.36)</td></tr><tr><td>9</td><td>Luteolin hexoside</td><td>12.1</td><td>0.27 (1.43)</td><td>—</td><td>—</td></tr><tr><td>10</td><td>Patuletin hexoside</td><td>12.2</td><td>0.25 (1.24)</td><td>—</td><td>—</td></tr><tr><td>11</td><td>3,4-Di-<i>O</i>-caffeoylquinic acid</td><td>13.1</td><td>0.22 (0.95)<sup>b</sup></td><td>0.15 (3.67)<sup>a</sup></td><td>0.52 (2.62)<sup>c</sup></td></tr><tr><td>12</td><td>3,5-Di-<i>O</i>-caffeoylquinic acid</td><td>13.4</td><td>3.08 (3.32)<sup>b</sup></td><td>1.92 (2.75)<sup>a</sup></td><td>8.47 (0.51)<sup>c</sup></td></tr><tr><td>13</td><td>1,5-Di-<i>O</i>-caffeoylquinic acid</td><td>13.9</td><td>0.28 (3.28)<sup>b</sup></td><td>0.12 (3.01)<sup>a</sup></td><td>1.44 (2.75)<sup>c</sup></td></tr><tr><td>14</td><td>4,5-Di-<i>O</i>-caffeoylquinic acid</td><td>14.1</td><td>1.97 (3.39)<sup>c</sup></td><td>1.23 (1.77)<sup>b</sup></td><td>1.04 (2.05)<sup>a</sup></td></tr><tr><td>15</td><td>1,4,5-Tri-<i>O</i>-caffeoylquinic acid</td><td>15.3</td><td>1.38 (4.67)<sup>b</sup></td><td>1.08 (2.86)<sup>a</sup></td><td>—</td></tr><tr><td>16</td><td>Tricaffeoylquinic acid derivative</td><td>15.6</td><td>5.97 (4.88)<sup>c</sup></td><td>4.34 (2.09)<sup>b</sup></td><td>0.26 (2.18)<sup>a</sup></td></tr><tr><td>17</td><td>Tricaffeoylquinic acid derivative</td><td>16.4</td><td>0.66 (0.24)<sup>b</sup></td><td>0.47 (4.58)<sup>a</sup></td><td>2.88 (1.38)<sup>c</sup></td></tr></table> |
362e708fac6d2334d7247b53e8d54fc8ba9b4e58e655fecbb7faaf1cac4312ec.png | simple | <table><tr><td>Group</td><td>First dose (μg/kg) 30–60 min before surgery</td><td>Second dose (μg/kg) 24 h after surgery</td><td>Total dose (μg/kg)</td></tr><tr><td>1</td><td>0.25</td><td>0.25</td><td>0.5</td></tr><tr><td>2</td><td>0.5</td><td>0.5</td><td>1.0</td></tr><tr><td>3</td><td>0.75</td><td>0.5</td><td>1.25</td></tr><tr><td>4</td><td>1.0</td><td>0.5</td><td>1.5</td></tr><tr><td>5</td><td>1.0</td><td>1.0</td><td>2.0</td></tr></table> |
c6d488f602d6a2787ac271bbb654302c0a0239d8f4d1d92d34669b715e7501f3.png | complex | <table><tr><td colspan="3">Number of patients tested and pathological findings (<i>N</i> = 33)</td></tr><tr><td> </td><td>Number (%)</td><td>Pathology (%)</td></tr><tr><td>Gluten antibodies</td><td>21 (63.6)</td><td>0 (0.0)</td></tr><tr><td>Anti-nucleus antibodies</td><td>14 (42.4)</td><td>0 (0.0)</td></tr><tr><td>Cobalamin</td><td>23 (69.7)</td><td>3 (9.1)</td></tr><tr><td>Folate</td><td>23 (69.7)</td><td>0 (0.0)</td></tr><tr><td>TSH/FT4</td><td>30 (91.0)</td><td>2 (15.2)</td></tr><tr><td>Cortisol</td><td>10 (30.3)</td><td>1 (3.0)</td></tr><tr><td>ACTH</td><td> 5 (15.2)</td><td>0 (0.0)</td></tr><tr><td>CK</td><td>24 (72.7)</td><td>1 (3.0)</td></tr><tr><td>ASAT</td><td>24 (72.7)</td><td>0 (0.0)</td></tr><tr><td>Creatine</td><td>31 (93.9)</td><td>0 (0.0)</td></tr><tr><td>CRP</td><td>30 (90.9)</td><td>0 (0.0)</td></tr><tr><td>Haemoglobin</td><td>33 (100)</td><td>1 (3.0)</td></tr><tr><td>SR</td><td>29 (87.8)</td><td>1 (3.0)</td></tr><tr><td>Urine dip sticks </td><td>19 (57.5)</td><td>0 (0.0)</td></tr></table> |
87046b95fed7c58b9bc68369826790474f105d1d46067e784af451808fa421e9.png | complex | <table><tr><td rowspan="3">Scaffold Designation</td><td colspan="4">Composition</td></tr><tr><td>Chitosan (Ch) 1%</td><td>Gelatin (Gel) 1%</td><td>nHAp 0.25%</td><td>nCuZn Alloy 0.01%</td></tr><tr><td colspan="4">Final Concentrations in Blend (%)</td></tr><tr><td>Ch/Gel</td><td>0.5</td><td>0.25</td><td>-</td><td>-</td></tr><tr><td>Ch/Gel/nHAp</td><td>0.5</td><td>0.25</td><td>0.0625</td><td>-</td></tr><tr><td>Ch/Gel/nHAp/nCuZn</td><td>0.5</td><td>0.25</td><td>0.0625</td><td>0.00025</td></tr></table> |
7eb76fe1d91bbb639551087f415cedcf229f2d33a69821ed548df593c404f28e.png | complex | <table><tr><td colspan="2"></td><td>Absence of protective haplotypes</td><td>At least one protective haplotypes</td></tr><tr><td rowspan="2">Anti-MAP2694 Abs</td><td>Negative</td><td>258 (71 %)</td><td>103 (29 %)</td></tr><tr><td>Positive</td><td>122 (80 %)</td><td>31 (20 %)</td></tr></table> |
0197fe2ab1f368bfd650fa7b2d8559147303d9286e910a7830859c4238f50453.png | complex | <table><tr><td rowspan="3">Variable </td><td colspan="2">Place of delivery</td><td rowspan="3"><i>P</i> value</td></tr><tr><td>Home</td><td>Facility</td></tr><tr><td><i>N</i> = 906 (100%)</td><td><i>N</i> = 1372 (100%)</td></tr><tr><td><i>Maternal age</i></td><td> </td><td> </td><td>0.107</td></tr><tr><td>15–19</td><td>23 (38.0%)</td><td>38 (62.0%)</td><td> </td></tr><tr><td>20–24</td><td>153 (40.0%)</td><td>228 (60.0%)</td><td> </td></tr><tr><td>25–29</td><td>206 (36.4%)</td><td>360 (63.6%)</td><td> </td></tr><tr><td>30–34</td><td>223 (45.5%)</td><td>267 (54.5%)</td><td> </td></tr><tr><td>35–39</td><td>165 (38.4%)</td><td>288 (63.6%)</td><td> </td></tr><tr><td>40–44</td><td>93 (38.6%)</td><td>148 (61.4%)</td><td> </td></tr><tr><td>45–49</td><td>45 (51.2%)</td><td>43 (48.8%)</td><td> </td></tr><tr><td><i>Wealth index</i></td><td> </td><td> </td><td>0.000</td></tr><tr><td>Poorest</td><td>452 (53.7%)</td><td>389 (46.3%)</td><td> </td></tr><tr><td>Poorer</td><td>301 (41.9%)</td><td>418 (58.1%)</td><td> </td></tr><tr><td>Middle</td><td>138 (29.7%)</td><td>327 (70.3%)</td><td> </td></tr><tr><td>Richer</td><td>13 (5.9%)</td><td>207 (94.1%)</td><td> </td></tr><tr><td>Richest</td><td>3 (8.4%)</td><td>31 (91.6%)</td><td> </td></tr><tr><td><i>Educational level</i></td><td> </td><td> </td><td>0.000</td></tr><tr><td>No education</td><td>468 (53.4%)</td><td>409 (46.6%)</td><td> </td></tr><tr><td>Primary</td><td>213 (41.1%)</td><td>305 (58.9%)</td><td> </td></tr><tr><td>Secondary</td><td>223 (26.4%)</td><td>620 (73.6%)</td><td> </td></tr><tr><td>Higher</td><td>3 (6.9%)</td><td>38 (93.1%)</td><td> </td></tr><tr><td><i>Ecological zone </i></td><td> </td><td> </td><td>0.000</td></tr><tr><td>Coastal zone</td><td>302 (34.7%)</td><td>569 (65.3%)</td><td> </td></tr><tr><td>Forest zone</td><td>256 (34.4%)</td><td>490 (65.6%)</td><td> </td></tr><tr><td>Savannah zone</td><td>348 (52.7%)</td><td>313 (47.3%)</td><td> </td></tr><tr><td><i>Getting money needed for treatment</i></td><td> </td><td> </td><td>0.000</td></tr><tr><td>Big problem</td><td>531 (46.0%)</td><td>623 (54.0%)</td><td> </td></tr><tr><td>Not a big problem</td><td>375 (33.4%)</td><td>749 (66.6%)</td><td> </td></tr><tr><td><i>Ethnicity </i></td><td> </td><td> </td><td>0.000</td></tr><tr><td>Akan</td><td>296 (31.0%)</td><td>659 (69.0%)</td><td> </td></tr><tr><td>Ga/Dangme</td><td>38 (43.0%)</td><td>52 (57.0%)</td><td> </td></tr><tr><td>Ewe</td><td>104 (37.6%)</td><td>172 (62.4%)</td><td> </td></tr><tr><td>Guan</td><td>16 (34.3%)</td><td>30 (65.7%)</td><td> </td></tr><tr><td>Mole–Dagbani</td><td>181 (37.8%)</td><td>297 (62.2%)</td><td> </td></tr><tr><td>Grusi</td><td>28 (37.9%)</td><td>46 (62.1%)</td><td> </td></tr><tr><td>Gurma</td><td>217 (73.9%)</td><td>77 (26.1%)</td><td> </td></tr><tr><td>Mande</td><td>5 (15.9%)</td><td>27 (84.1%)</td><td> </td></tr><tr><td>Other</td><td>21 (66.8%)</td><td>10 (33.2%)</td><td> </td></tr><tr><td><i>Parity </i></td><td> </td><td> </td><td>0.000</td></tr><tr><td>One birth</td><td>90 (27.5%)</td><td>238 (72.5%)</td><td> </td></tr><tr><td>Two births</td><td>139 (36.6%)</td><td>240 (63.4%)</td><td> </td></tr><tr><td>Three births</td><td>146 (34.9%)</td><td>273 (65.1%)</td><td> </td></tr><tr><td>Four births or more</td><td>531 (46.1%)</td><td>621 (53.9%)</td><td> </td></tr><tr><td><i>Partner's education </i></td><td> </td><td> </td><td>0.000</td></tr><tr><td>No education</td><td>396 (56.0%)</td><td>311 (44.0%)</td><td> </td></tr><tr><td>Primary</td><td>129 (40.9%)</td><td>187 (59.1%)</td><td> </td></tr><tr><td>Secondary</td><td>361 (32.0%)</td><td>767 (68.0%)</td><td> </td></tr><tr><td>Higher</td><td>20 (15.8%)</td><td>106 (84.3%)</td><td> </td></tr><tr><td><i>Distance to health facility</i></td><td> </td><td> </td><td>0.000</td></tr><tr><td>Big problem</td><td>422 (51.8%)</td><td>392 (48.2%)</td><td> </td></tr><tr><td>Not a big problem</td><td>485 (33.1%)</td><td>979 (66.9%)</td><td> </td></tr></table> |
6a3d63878697e1730d30680a9f8ec875afb72c18830fce48e444ada820f86fe8.png | simple | <table><tr><td>Household characteristics</td><td>Value</td></tr><tr><td>% of houses with</td><td></td></tr><tr><td> Land ownership</td><td>42.2</td></tr><tr><td> Head of household with agriculture related occupation</td><td>18.1</td></tr><tr><td> Ground water as main source of drinking water</td><td>61.8</td></tr><tr><td> Piped water in own house</td><td>26.2</td></tr><tr><td> Access to water seal latrine</td><td>74.7</td></tr><tr><td> Wood/cow dung as main Fuel used for cooking</td><td>69.1</td></tr><tr><td> Tobacco smoker in the HH</td><td>60.5</td></tr><tr><td>Mean (Standard Deviation) number of</td><td></td></tr><tr><td> Persons per household</td><td>5.97 (2.61)</td></tr><tr><td> Children ≤ 10 years per household</td><td>1.75 (1.54)</td></tr><tr><td> Sleeping rooms per household</td><td>1.89 (0.98)</td></tr></table> |
d77c9b78ba935bcc1766f82f4e7718b3a04ac5e4d7ce045a2ce5d403708aff75.png | simple | <table><tr><td>No.</td><td>Age/sex</td><td>Etiology</td><td>Defect location</td><td>Flap dimensions (cm)</td><td>Complications</td></tr><tr><td>1</td><td>45/f</td><td>Trauma</td><td>Heel avulsion </td><td>24×11</td><td>Partial graft loss at lower donor site</td></tr><tr><td>2</td><td>45/m</td><td>Verrucous carcinoma of heel</td><td>Heel</td><td>23×10</td><td>None</td></tr><tr><td>3</td><td>42/m</td><td>Trauma</td><td>Avulsion of heel and sole of midfoot</td><td>28×14</td><td>Patchy graft loss, healed within 20 days with dressings.</td></tr><tr><td>4</td><td>38/f</td><td>Squamous cell carcinoma of heel</td><td>Heel region</td><td>26×12</td><td>None</td></tr><tr><td>5</td><td>42/m</td><td>Verrucous carcinoma </td><td>Heel region</td><td>23×10</td><td>None</td></tr><tr><td>6</td><td>60/m</td><td>Squamous cell carcinoma of heel</td><td>Heel region extending in to the sole</td><td>26×11</td><td>Partial graft loss at lower donor site</td></tr><tr><td>7</td><td>43/f</td><td>Trauma</td><td>Medial malleolus with dorsal foot region</td><td>25×10</td><td>None</td></tr><tr><td>8</td><td>48/m</td><td>Verrucous carcinoma</td><td>Heel region</td><td>22×10</td><td>Exposed fibula – 5 cm fibula excised and covered with left flap during final inset </td></tr><tr><td>9</td><td>49/f</td><td>Trauma</td><td>Medial malleolus region</td><td>21×10</td><td>None</td></tr><tr><td>10</td><td>38/m</td><td>Trauma</td><td>Heel with tendoachillis region</td><td>24×11</td><td>Partial graft loss at lower donor site</td></tr></table> |
546e77720ffa6aff07ef83f873a7414d8174a06618289f791d477547023c8a67.png | complex | <table><tr><td></td><td>Group S (<i>n</i> = 29)</td><td>Group SD (<i>n</i> = 29)</td></tr><tr><td colspan="3">Coughing episode</td></tr><tr><td>1–5</td><td>12 (41.4)</td><td>22 (75.9)</td></tr><tr><td>6–10</td><td>10 (34.5)</td><td>7 (24.1)</td></tr><tr><td>>10</td><td>7 (24.1)</td><td>2 (6.9)</td></tr><tr><td>Sleeping disturbance</td><td>20 (69.0)</td><td>11 (37.9)</td></tr><tr><td colspan="3">Satisfaction</td></tr><tr><td> Favorable</td><td>19 (65.5)</td><td>27 (93.1)</td></tr><tr><td> A little</td><td>9 (31.0)</td><td>2 (6.9)</td></tr><tr><td> Not favorable</td><td>1 (3.4)</td><td>0</td></tr></table> |
fd8aa8d8c75780e11e13e155aeaffd061b71c0051b9b20f2c0491abd5c10f3c3.png | complex | <table><tr><td colspan="2">(1) Events were classified as related to knowledge-acquisition goals if their content fulfilled any of the following criteria and did not conflict</td></tr><tr><td colspan="2">with the criteria for emotional goals.</td></tr><tr><td>(a) Knowledge-acquisition goals related to the future (if an event referred to words related to time, such as 6 months later, or in the future; the event was classified as related to knowledge-acquisition goals. There was also a wide range of non-future events which were coded as present-focused events).</td><td>e.g., “The problems in middle school math competitions became increasingly difficult in today’s classes, which stumped a number of my classmates. Only three questions were covered in the two classes, and I did still not understand the problem-solving process. I was very concerned about my future studies.”</td></tr><tr><td>(b) Knowledge acquisition</td><td>e.g., “This morning, I attended a project in which student volunteers taught us how to use computers face-to-face at the University of Posts and Telecommunications. The two problems that I didn’t understand before were solved. Thus, I was very happy.”</td></tr><tr><td>(c) An individual’s observation, understanding; learning of social survival skills through interaction with others; and inspiration for knowledge acquisition from the people around them, events, and their own life experiences.</td><td>e.g., “Today, I went to the Aging Lab at Beijing Normal University to take part in tests. It was a very happy thing and I acquired much knowledge constantly. It’s never too late to learn.”</td></tr><tr><td>(d) Realization of one’s own shortcomings through interaction with others and engagement in periodic self-assessment.</td><td>e.g., “The lesson on the Study on New Venture’s Creation was boring. The teacher suddenly asked, ‘What are you interested in? What do you care about?’ Then, I realized that I did not know how to answer these questions. I have spent days and months without doing anything meaningful. While listening to classmates’ answers, I was lost in thought.”</td></tr><tr><td>(e) Use of activities and events to provide information (reading books, etc.)</td><td>e.g., “On Friday evening, I turned on the computer and watched <i>Tian tian Xiang shang</i>, a famous, entertaining talk-show in China. The hosts sounded very happy. I should imitate their speech to improve my public-speaking skills.”</td></tr><tr><td colspan="2">(2) Events were classified as related to emotional goals if their content fulfilled any of the following criteria and did not conflict</td></tr><tr><td colspan="2">with the criteria for knowledge-acquisition goals.</td></tr><tr><td>(a) Emotional goals related to the present (if the event referred to words related to time, such as now, the present, and were within 6 months; the event was classified as related to emotional goals).</td><td>e.g., “On Sunday, my husband’s colleague, whom we had not seen for many years, was coming. We were all happy. They were very excited when they chatted about their time at the company.”</td></tr><tr><td>(b) Mood control rather than pursuit of new knowledge (emotion can be affected by tourism, scenery, environment, weather, prices, or physical conditions, and individuals can acquire emotional experience and become inspired by events and the people around them).</td><td>e.g., “This morning, when I pulled back the curtain, a silver world appeared outside the window! Snow was everywhere, just lying on the trees. An unseasonable snowfall gave a surprise to spring. Particularly in these days of the hazy weather, the snow scene was a rare and beautiful thing.”</td></tr><tr><td>(c) Preference for spending time with family and close friends, rather than going to a party to obtain emotional satisfaction (sometimes, individuals need to feel needed and supported by others, and people acquire positive emotional experience by helping others).</td><td>e.g., “On the way to the library, a man asked me how to get to the classroom. I explained the way to him clearly and patiently. I had a strong feeling of presence and being needed as soon as he thanked me, which made me very happy.”</td></tr><tr><td>(d) A focus on the meaning of life and emotional intimacy (individual’s might seek to control their own moods or to engender a positive emotional experience).</td><td>e.g., “Although it was late, I still went for a walk with my friend. After I poured out my problems to her, I felt quite relaxed. She calmed me down and let me think about some things objectively. I thanked her a lot.”</td></tr><tr><td>(e) A focus on emotional rewards achieved through various activities or participation in social activities for the sake of an emotional experience.</td><td>e.g., “I had a good time with my friends at the beginning of this morning’s exercise. The teacher who taught us to make fans came to the classroom at 9:00. Some of her behaviors made us feel uncomfortable. I attended this class for pleasure, but I was unhappy. So I left the classroom and looked for pleasure elsewhere.”</td></tr><tr><td>(3) If an event could be classified as related to either an emotional or a knowledge-acquisition goal; it was classified as a mixed event.</td><td>e.g., “Today, in art class, the teacher taught us how to draw a peony. It was good to understand new things; it put us in a good mood and we gained something.”</td></tr><tr><td colspan="2">(4) Descriptions of some events were too simple and did not contain distinguishing information. These events were considered non-specific.</td></tr><tr><td colspan="2">Examples of these events include “Let the robot clean the house” or “Cooking meat for dinner.”</td></tr></table> |
081d5ba088d6a73cc54c4f0dbcf0a166f55210e31411c0d50f7791bd401f28ef.png | simple | <table><tr><td>Method</td><td>P</td><td>R</td><td>F</td><td>Sn</td><td>PPV</td><td>Acc</td></tr><tr><td>MCODE</td><td>0.576</td><td>0.096</td><td>0.164</td><td>0.282</td><td>0.328</td><td>0.304</td></tr><tr><td>CFinder</td><td>0.396</td><td>0.257</td><td>0.312</td><td>0.612</td><td>0.297</td><td>0.437</td></tr><tr><td>CMC</td><td>0.283</td><td>0.505</td><td>0.363</td><td>0.523</td><td>0.526</td><td>0.525</td></tr><tr><td>RRW</td><td>0.541</td><td>0.365</td><td>0.436</td><td>0.378</td><td>0.557</td><td>0.459</td></tr><tr><td>COACH</td><td>0.418</td><td>0.529</td><td>0.467</td><td>0.545</td><td>0.481</td><td>0.512</td></tr><tr><td>CORE</td><td>0.16</td><td>0.662</td><td>0.258</td><td>0.569</td><td>0.567</td><td>0.568</td></tr><tr><td>Ours</td><td>0.537</td><td>0.699</td><td>0.607</td><td>0.583</td><td>0.578</td><td>0.581</td></tr></table> |
772d73909d37683e4a7acad20067c54cfdc67c64f4a8505a3ea47ee4080152de.png | simple | <table><tr><td></td><td>OR (95% CI)</td><td><i>β</i></td><td>P</td><td>OR</td></tr><tr><td>UA</td><td>0.994-0.999</td><td>-0.003</td><td>0.006</td><td>0.997</td></tr><tr><td>PLT</td><td>0.993-0.999</td><td>-0.004</td><td>0.020</td><td>0.996</td></tr><tr><td>Fibrillation</td><td>1.691-11.389</td><td>1.479</td><td>0.002</td><td>4.389</td></tr><tr><td>Diabetes</td><td>1.193-3.674</td><td>0.739</td><td>0.010</td><td>2.094</td></tr><tr><td>Leukocyte</td><td>1.078-1.257</td><td>0.152</td><td>0.000</td><td>1.164</td></tr></table> |
f6bd50553fcb79a41bb855481c7eac448cb6d45347c22866dce5c8344c3a235a.png | simple | <table><tr><td>Trait</td><td>Total cases</td><td>Pathologically confirmed cases</td></tr><tr><td>DLB</td><td>788</td><td>667</td></tr><tr><td>AD</td><td>959</td><td>113</td></tr><tr><td>PD</td><td>804</td><td>0</td></tr></table> |
6f3e34f867bb5fc1444c96898c19df5459aae92fa5d5f9a82645c414c266b9be.png | simple | <table><tr><td>Pathway name</td><td>No. of genes</td><td><i>p</i>-Value</td></tr><tr><td>Antigen processing and presentation</td><td>9</td><td>0</td></tr><tr><td>Chemokine signaling pathway</td><td>13</td><td>0</td></tr><tr><td>Complement and coagulation cascades</td><td>7</td><td>0</td></tr><tr><td>Cytokine-cytokine receptor interaction</td><td>23</td><td>0</td></tr><tr><td>Natural killer cell mediated cytotoxicity</td><td>9</td><td>0</td></tr><tr><td>Classical Complement Pathway</td><td>3</td><td>1.00E-04</td></tr><tr><td>Complement Pathway</td><td>3</td><td>4.00E-04</td></tr><tr><td>Alternative Complement Pathway</td><td>2</td><td>0.0021</td></tr><tr><td>Granzyme A mediated Apoptosis Pathway</td><td>2</td><td>0.0036</td></tr><tr><td>Toll-like receptor signaling pathway</td><td>4</td><td>0.0071</td></tr><tr><td>Intestinal immune network for IgA production</td><td>3</td><td>0.009</td></tr><tr><td>CCR3 signaling in Eosinophils</td><td>2</td><td>0.0111</td></tr><tr><td>Caspase Cascade in Apoptosis</td><td>2</td><td>0.0121</td></tr><tr><td>NOD-like receptor signaling pathway</td><td>3</td><td>0.0121</td></tr><tr><td>MAPK signaling pathway</td><td>6</td><td>0.0168</td></tr><tr><td>ECM-receptor interaction</td><td>3</td><td>0.0232</td></tr><tr><td>Jak-STAT signaling pathway</td><td>4</td><td>0.0284</td></tr><tr><td>IFN gamma signaling pathway</td><td>1</td><td>0.0478</td></tr><tr><td>B Lymphocyte Cell Surface Molecules</td><td>1</td><td>0.0611</td></tr><tr><td>T cell receptor signaling pathway</td><td>3</td><td>0.069</td></tr></table> |
9221f26a1960f0ec2856e504f0aadb13e6820486e79df967027a980f7c692c14.png | simple | <table><tr><td></td><td><i>n</i></td><td>%</td><td>Median</td><td>Range</td><td>Interquartile range</td></tr><tr><td>Wait time for first visit (time 1)</td><td></td><td></td><td>6</td><td>1–24</td><td>3–9</td></tr><tr><td> 1 month</td><td>3</td><td>5.3%</td><td></td><td></td><td></td></tr><tr><td> 2 months</td><td>7</td><td>12.3%</td><td></td><td></td><td></td></tr><tr><td> 3 months</td><td>10</td><td>17.5%</td><td></td><td></td><td></td></tr><tr><td> 4 months</td><td>4</td><td>7.0%</td><td></td><td></td><td></td></tr><tr><td> 5 months</td><td>1</td><td>1.8%</td><td></td><td></td><td></td></tr><tr><td> 6 months</td><td>10</td><td>17.5%</td><td></td><td></td><td></td></tr><tr><td> 7 months</td><td>2</td><td>3.5%</td><td></td><td></td><td></td></tr><tr><td> 8–9 months</td><td>5</td><td>8.8%</td><td></td><td></td><td></td></tr><tr><td> 10–12 months</td><td>7</td><td>12.3%</td><td></td><td></td><td></td></tr><tr><td> 13–18 months</td><td>5</td><td>8.8%</td><td></td><td></td><td></td></tr><tr><td> 19–24 months</td><td>3</td><td>5.3%</td><td></td><td></td><td></td></tr><tr><td>Wait time from first visit to diagnosis (time 2)</td><td></td><td></td><td>1</td><td>0–6.5</td><td>0.5–2</td></tr><tr><td> 0 months</td><td>7</td><td>12.3%</td><td></td><td></td><td></td></tr><tr><td> 0.25 months</td><td>3</td><td>5.3%</td><td></td><td></td><td></td></tr><tr><td> 0.5 months</td><td>5</td><td>8.8%</td><td></td><td></td><td></td></tr><tr><td> 0.75 months</td><td>5</td><td>8.8%</td><td></td><td></td><td></td></tr><tr><td> 1 month</td><td>18</td><td>31.6%</td><td></td><td></td><td></td></tr><tr><td> 1.5 months</td><td>2</td><td>3.5%</td><td></td><td></td><td></td></tr><tr><td> 2 months</td><td>7</td><td>12.3%</td><td></td><td></td><td></td></tr><tr><td> 3 months</td><td>4</td><td>7.0%</td><td></td><td></td><td></td></tr><tr><td> 4.5 months</td><td>2</td><td>3.5%</td><td></td><td></td><td></td></tr><tr><td>≥ 6 months</td><td>4</td><td>7.0%</td><td></td><td></td><td></td></tr><tr><td>Total wait from referral to diagnosis</td><td></td><td></td><td>7</td><td>2–26</td><td>4–12</td></tr><tr><td>< 2 months</td><td>3</td><td>5.3%</td><td></td><td></td><td></td></tr><tr><td> 2–3 months</td><td>6</td><td>10.5%</td><td></td><td></td><td></td></tr><tr><td> 4 months</td><td>6</td><td>10.5%</td><td></td><td></td><td></td></tr><tr><td> 5–6 months</td><td>7</td><td>12.3%</td><td></td><td></td><td></td></tr><tr><td> 7–8 months</td><td>9</td><td>15.8%</td><td></td><td></td><td></td></tr><tr><td> 9–10 months</td><td>8</td><td>14.0%</td><td></td><td></td><td></td></tr><tr><td> 11–12 months</td><td>2</td><td>3.5%</td><td></td><td></td><td></td></tr><tr><td> 13–14 months</td><td>6</td><td>10.5%</td><td></td><td></td><td></td></tr><tr><td> 15–18 months</td><td>3</td><td>5.3%</td><td></td><td></td><td></td></tr><tr><td> 19–22 months</td><td>4</td><td>7.0%</td><td></td><td></td><td></td></tr><tr><td> 23–26 months</td><td>3</td><td>5.3%</td><td></td><td></td><td></td></tr></table> |
2256dbd8677f1692a93957a04e1bc977a29dc151dc57b0f2ebe99c745039d4a3.png | simple | <table><tr><td>Predisposing factor</td><td>Mechanism of action</td></tr><tr><td>Moisture [1, 3, 12]</td><td>Increased relative moisture of the skinDamage to the skin barrier</td></tr><tr><td>Friction [3, 10, 11]</td><td>Friction between diaper and damp skin increases skin damage (convex regions)</td></tr><tr><td>Urine [1, 3, 9]</td><td>Presence of urea causes irritation and is the base product for conversion to ammonia</td></tr><tr><td>Feces [1, 3, 9, 13, 20]</td><td>The presence of lipases and proteases causes skin damage with filaggrin proteolysis and increased NMF<sup>a</sup> and TWEL<sup>b</sup></td></tr><tr><td>Ammonia and increased pH [1, 3, 12, 13]</td><td>Conversion of urea to ammonium hydroxide by bacterial flora (main responsible, <i>Bacillus ammoniagenes)</i>Increase in pH from 5.5 to 6.8–7.15</td></tr><tr><td>Microorganisms [1, 3, 12, 13, 16–19, 21, 22]</td><td>Bacteria<i>Staphylococcus aureus</i> (isolated most frequently)Other: (β-hemolytic) <i>Streptococcus</i> sp.<i>, E. coli</i> and <i>Bacteroides</i> sp.More than 80 %<i>C. albicans</i> (80−90 %)Other: <i>C. tropicalis, C. parapsilosis, C. glabrata</i></td></tr><tr><td>Use of antibiotics [1, 3, 9, 21, 22]</td><td>Use of broad-spectrum antibiotics causes increased <i>Candida</i> spp.</td></tr><tr><td>Association with other conditions [1, 3, 11]</td><td>Seborrheic dermatitis, inverse psoriasis, epidermolysis bullosa, granuloma gluteale infantum and acrodermatitis enteropathica</td></tr></table> |
3ea8b7fffd0261fb80d775a1bd7ac1af574b353fea86eba24ab16de686cbb1eb.png | simple | <table><tr><td>Plastid type</td><td>Plastid size (μm)</td><td>Protein content (pg/plastid)</td></tr><tr><td>Chloroplasts (7-days-old light-grown leaves)</td><td>3.24 ± 0.23</td><td>8.13 ± 1.42</td></tr><tr><td>Leucoplasts (4-days-old dark-grown roots)</td><td>1.81 ± 0.21</td><td>1.85 ± 0.63</td></tr></table> |
9031975cb3f932c33aa3507b9b17443d9e8e773f42789140e701484f4cd6f50f.png | complex | <table><tr><td></td><td colspan="2">Before treatment</td><td colspan="2">After 1 month</td><td colspan="2">After 3 months</td><td colspan="2">After 6 months</td></tr><tr><td>Group (no. of subjects)</td><td>Mn-Cells</td><td>CBPI</td><td>Mn-Cells</td><td>CBPI</td><td>Mn-Cells</td><td>CBPI</td><td>Mn-Cells</td><td>CBPI</td></tr><tr><td>A (8)</td><td>10.00 ± 2.00</td><td>1.73</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>8.00 ± 4.73</td><td>1.73</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>5.83 ± 0.75</td><td>1.70</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>5.00 ± 0.89</td><td>1.69</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>4.00 ± 2.97</td><td>1.75</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>4.00 ± 2.00</td><td>1.73</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>3.67 ± 0.82</td><td>1.69</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>2.00 ± 0.89</td><td>1.88</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>B (9)</td><td>17.00 ± 4.69</td><td>1.82</td><td>4.00 ± 1.79</td><td>1.79</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>7.83 ± 4.12</td><td>1.70</td><td>15.00 ± 6.13</td><td>1.74</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>7.00 ± 1.55</td><td>1.74</td><td>3.00 ± 0.89</td><td>1.85</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>6.00 ± 3.58</td><td>1.92</td><td>2.50 ± 0.84</td><td>1.56</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>5.67 ± 1.21</td><td>1.63</td><td>4.67 ± 1.03</td><td>1.63</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>5.33 ± 2.07</td><td>1.78</td><td>2.17 ± 1.33</td><td>1.69</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>4.00 ± 1.29</td><td>1.77</td><td>2.67 ± 0.82</td><td>1.78</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>3.00 ± 0.89</td><td>1.58</td><td>5.33 ± 1.03</td><td>1.67</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>2.67 ± 0.82</td><td>1.77</td><td>3.67 ± 0.82</td><td>1.68</td><td></td><td></td><td></td><td></td></tr><tr><td>C (13)</td><td>16.00 ± 4.34</td><td>1.88</td><td>14.00 ± 2.37</td><td>1.81</td><td>5.00 ± 1.78</td><td>1.75</td><td></td><td></td></tr><tr><td></td><td>11.67 ± 4.08</td><td>1.70</td><td>6.67 ± 1.63</td><td>1.68</td><td>5.50 ± 1.38</td><td>1.66</td><td></td><td></td></tr><tr><td></td><td>8.83 ± 2.32</td><td>1.76</td><td>13.00 ± 2.53</td><td>1.74</td><td>7.33 ± 2.50</td><td>1.76</td><td></td><td></td></tr><tr><td></td><td>8.00 ± 0.89</td><td>1.69</td><td>8.17 ± 3.60</td><td>1.74</td><td>6.00 ± 1.67</td><td>1.70</td><td></td><td></td></tr><tr><td></td><td>7.00 ± 2.19</td><td>1.67</td><td>4.00 ± 3.03</td><td>1.75</td><td>8.00 ± 1.79</td><td>1.84</td><td></td><td></td></tr><tr><td></td><td>7.00 ± 1.41</td><td>1.79</td><td>3.00 ± 2.53</td><td>1.72</td><td>5.17 ± 2.32</td><td>1.82</td><td></td><td></td></tr><tr><td></td><td>6.00 ± 1.27</td><td>1.77</td><td>10.00 ± 2.83</td><td>1.85</td><td>1.67 ± 1.03</td><td>1.72</td><td></td><td></td></tr><tr><td></td><td>4.83 ± 2.14</td><td>1.75</td><td>7.83 ± 2.32</td><td>1.80</td><td>5.00 ± 2.10</td><td>1.78</td><td></td><td></td></tr><tr><td></td><td>4.00 ± 1.27</td><td>1.76</td><td>6.67 ± 1.03</td><td>1.85</td><td>3.67 ± 1.21</td><td>1.92</td><td></td><td></td></tr><tr><td></td><td>4.00 ± 2.00</td><td>1.73</td><td>4.33 ± 1.21</td><td>1.66</td><td>5.33 ± 1.37</td><td>1.66</td><td></td><td></td></tr><tr><td></td><td>3.00 ± 3.03</td><td>1.74</td><td>3.00 ± 1.55</td><td>1.73</td><td>3.67 ± 1.63</td><td>1.69</td><td></td><td></td></tr><tr><td></td><td>2.83 ± 2.14</td><td>1.75</td><td>3.00 ± 1.27</td><td>1.84</td><td>7.67 ± 2.94</td><td>1.73</td><td></td><td></td></tr><tr><td></td><td>2.00 ± 0.89</td><td>1.80</td><td>2.83 ± 1.47</td><td>1.85</td><td>9.67 ± 4.41</td><td>1.81</td><td></td><td></td></tr><tr><td>D (8)</td><td>21.00 ± 5.22</td><td>1.76</td><td>10.00 ± 5.37</td><td>1.74</td><td>13.67 ± 3.50</td><td>1.85</td><td>5.00 ± 0.89</td><td>1.71</td></tr><tr><td></td><td>6.17 ± 1.17</td><td>1.81</td><td>5.33 ± 1.03</td><td>1.81</td><td>6.50 ± 1.38</td><td>1.84</td><td>5.67 ± 0.82</td><td>1.78</td></tr><tr><td></td><td>4.17 ± 1.47</td><td>1.73</td><td>2.00 ± 2.28</td><td>1.77</td><td>11.50 ± 4.85</td><td>1.77</td><td>3.50 ± 1.64</td><td>1.80</td></tr><tr><td></td><td>3.17 ± 2.86</td><td>1.65</td><td>3.00 ± 1.41</td><td>1.74</td><td>1.50 ± 1.05</td><td>1.67</td><td>3.33 ± 0.52</td><td>1.67</td></tr><tr><td></td><td>3.00 ± 1.79</td><td>1.78</td><td>16.00 ± 2.19</td><td>1.85</td><td>2.00 ± 1.41</td><td>1.72</td><td>5.67 ± 1.37</td><td>1.79</td></tr><tr><td></td><td>2.67 ± 1.75</td><td>1.74</td><td>3.00 ± 1.27</td><td>1.72</td><td>4.83 ± 2.48</td><td>1.78</td><td>5.17 ± 1.17</td><td>1.74</td></tr><tr><td></td><td>2.00 ± 0.63</td><td>1.80</td><td>8.17 ± 3.76</td><td>1.78</td><td>5.50 ± 2.34</td><td>1.68</td><td>4.33 ± 1.03</td><td>1.64</td></tr><tr><td></td><td>2.00 ± 0.63</td><td>1.69</td><td>2.00 ± 1.27</td><td>1.70</td><td>27.83 ± 3.71</td><td>1.78</td><td>3.67 ± 0.82</td><td>1.70</td></tr><tr><td>Total no. of patients</td><td>38</td><td>38</td><td>30</td><td>30</td><td>21</td><td>21</td><td>8</td><td>8</td></tr><tr><td> Mean ± SD</td><td>6.06 ± 4.29</td><td>1.75 ± 0.07</td><td>5.97 ± 4.12</td><td>1.76 ± 0.08</td><td>7.00 ± 5.65</td><td>1.76 ± 0.07</td><td>4.54 ± 0.96</td><td>1.73 ± 0.06</td></tr><tr><td> <i>p</i>-Value (<i>t</i>-test/Wilcoxon)</td><td></td><td></td><td>0.75/0.75</td><td>0.53/0.41</td><td>0.60/0.96</td><td>0.61/0.78</td><td>0.67/0.55</td><td>0.54/0.81</td></tr></table> |
7473ae15f80a3873fdb66595eb77b93e8091c48172d1298daeb662f5373e1140.png | simple | <table><tr><td>Variable</td><td></td><td>Change in Mean CSA</td><td>Change in Type II CSA</td><td>Change in Type I CSA</td></tr><tr><td>Fold change AR</td><td>r</td><td>0.60</td><td>0.60</td><td>0.47</td></tr><tr><td></td><td>P</td><td>0.003</td><td>0.002</td><td>0.023</td></tr><tr><td>Free Testosterone AUC</td><td>r</td><td>0.06</td><td>0.07</td><td>0.10</td></tr><tr><td></td><td>P</td><td>0.771</td><td>0.760</td><td>0.639</td></tr><tr><td>IL-6 AUC</td><td>r</td><td>0.48</td><td>0.42</td><td>0.51</td></tr><tr><td></td><td>P</td><td>0.019</td><td>0.047</td><td>0.013</td></tr><tr><td>GH AUC</td><td>r</td><td>0.39</td><td>0.40</td><td>0.38</td></tr><tr><td></td><td>P</td><td>0.069</td><td>0.061</td><td>0.073</td></tr><tr><td>IGF-1 AUC</td><td>r</td><td>-0.30</td><td>-0.27</td><td>-0.23</td></tr><tr><td></td><td>P</td><td>0.165</td><td>0.219</td><td>0.292</td></tr><tr><td>Cortisol AUC</td><td>r</td><td>-0.02</td><td>0.00</td><td>-0.09</td></tr><tr><td></td><td>P</td><td>0.919</td><td>0.990</td><td>0.670</td></tr><tr><td>TNF-alpha AUC</td><td>r</td><td>0.02</td><td>-0.05</td><td>0.10</td></tr><tr><td></td><td>P</td><td>0.919</td><td>0.812</td><td>0.652</td></tr><tr><td>CRP AUC</td><td>r</td><td>0.18</td><td>0.13</td><td>0.06</td></tr><tr><td></td><td>P</td><td>0.420</td><td>0.567</td><td>0.784</td></tr></table> |
c9cec8ccd3bde7fe511249203a9eb408b3af875843cf027ce28c02559d28a96c.png | simple | <table><tr><td>Formula</td><td>Observations</td><td>Grade</td></tr><tr><td>F1</td><td>Rapidly forming clear emulsion</td><td>A</td></tr><tr><td>F2</td><td>Rapidly forming clear emulsion</td><td>A</td></tr><tr><td>F3</td><td>Rapidly forming clear emulsion</td><td>A</td></tr><tr><td>F4</td><td>Rapidly forming clear emulsion</td><td>A</td></tr><tr><td>F5</td><td>Rapidly forming clear emulsion</td><td>A</td></tr><tr><td>F6</td><td>Rapidly forming clear emulsion</td><td>A</td></tr><tr><td>F7</td><td>Rapidly forming clear emulsion</td><td>A</td></tr><tr><td>F8</td><td>Rapidly forming clear emulsion</td><td>A</td></tr></table> |
f8cb67e1b6edaac741bfd36ef447a4a66e3c8a6853105a8050a4d10a45cdc9c4.png | simple | <table><tr><td>Primary antibody</td><td>Manufacturer (Cat. No.)</td><td>Pretreatment</td><td>Working dilution</td></tr><tr><td>Mouse anti-CD20 monoclonal antibody</td><td>Zymed, San Diego, CA, USA (18-0155)</td><td>HP CB (pH 6.0)</td><td>1:100</td></tr><tr><td>Mouse anti-CD79A monoclonal antibody</td><td>Novocastra, New Castle, Tyne and Wear, UK (RTU-CD79α-192)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-CD3ε monoclonal antibody</td><td>Novocastra, New Castle, Tyne and Wear, UK (RTU-CD3-PS1)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-CD45RO monoclonal antibody</td><td>Zymed, San Diego, CA, USA (08-1365)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-CD5 monoclonal antibody</td><td>Zymed, San Diego, CA, USA (08-1283)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-CD10 monoclonal antibody</td><td>Novocastra, New Castle, Tyne and Wear, UK (RTU-CD10-270)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-CD23 monoclonal antibody</td><td>Novocastra, New Castle, Tyne and Wear, UK (RTU-CD23-1B12)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-CD30 monoclonal antibody</td><td>Zymed, San Diego, CA, USA (08-0155)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-CD56 monoclonal antibody</td><td>Zymed, San Diego, CA, USA (08-0152)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-Bcl-6 monoclonal antibody</td><td>Zymed, San Diego, CA, USA (08-1426)</td><td>HP EDTA (pH 9.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-ALK monoclonal antibody</td><td>Zeta, Sierra Madre, CA, USA (Z2035)</td><td>HP EDTA (pH 8.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-Ki-67 monoclonal antibody</td><td>Zymed, San Diego, CA, USA (18-0192Z)</td><td>HP CB (pH 6.0)</td><td>1:50</td></tr><tr><td>Mouse anti-TdT monoclonal antibody</td><td>Zymed, San Diego, CA, USA (18-7237)</td><td>HP EDTA (pH 9.0)</td><td>1:50</td></tr><tr><td>Mouse anti-TIA-1 monoclonal antibody</td><td>Zeta, Sierra Madre, CA, USA (Z2183)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-Perforin monoclonal antibody</td><td>Zeta, Sierra Madre, CA, USA (Z2118)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-Granzyme B monoclonal antibody</td><td>Newmarket Scientific, Newmarket, Suffolk, UK (MS-1157-s)</td><td>HP CB (pH 6.0)</td><td>Ready to use</td></tr><tr><td>Mouse anti-PD-1 monoclonal antibody</td><td>Zymed, San Diego, CA, USA (0381)</td><td>HP CB (pH 6.0)</td><td>1:100</td></tr><tr><td>Goat anti-CXCL13 polyclonal antibody</td><td>Zymed, San Diego, CA, USA (0043)</td><td>HP CB (pH 6.0)</td><td>1:100</td></tr><tr><td>Mouse anti-CD4 monoclonal antibody</td><td>Zymed, San Diego, CA, USA (0032)</td><td>HP CB (pH 6.0)</td><td>1:200</td></tr><tr><td>Rabbit anti-CD8 monoclonal antibody</td><td>Zymed, San Diego, CA, USA (0043)</td><td>HP CB (pH 6.0)</td><td>1:100</td></tr></table> |
a589333d0f4925713151e5eabd3feae3da569bfb52434ee17d1abca78c7ee192.png | complex | <table><tr><td> </td><td colspan="2">Non-PD</td><td colspan="2">PD<sup>a</sup></td></tr><tr><td>Gender</td><td>Male</td><td>Female</td><td>Male</td><td>Female</td></tr><tr><td>Number</td><td>10</td><td>11</td><td>14 </td><td>12</td></tr><tr><td>Age (years)</td><td>70 ± 3.2 </td><td>71 ± 3.2</td><td>73 ± 2.1</td><td>73 ± 2.6</td></tr><tr><td>Disease duration (years)</td><td>NA<sup>b</sup></td><td>NA</td><td>5.8 ± 0.60</td><td>4.8 ± 0.60</td></tr></table> |
308d609f009a6866ccf00fd1394190e977fc07d2bb786b091b0ce5b7b937b348.png | simple | <table><tr><td>The nursing home as my home</td><td>Interpersonal care quality</td></tr><tr><td>‘Being at home in a nursing home’</td><td>‘Care for and alleviation of medical, physical and psychological needs’</td></tr><tr><td>‘Paying the price for 24-hour care’</td><td>‘Protecting the resident’s integrity’</td></tr><tr><td>‘Personal habits and institutional routines’</td><td>‘Psychosocial well-being’</td></tr><tr><td>‘Meaningful activities for a meaningful day’</td><td></td></tr></table> |
bade988a413e50aad55c7dca647d4a54f4a98036824e06f6f82e4e59b76fb36e.png | simple | <table><tr><td>District name</td><td>Upazila Health Complex (UHC)</td><td>Samples (N)</td><td>K13 Nested PCR and sequencing N (%)</td><td>Non-synonymous Mutation N (%)</td></tr><tr><td>Bandarban</td><td>Lama UHC</td><td>14</td><td>149(100)</td><td>0(0.0)</td></tr><tr><td>Cox’s Bazar</td><td>Ramu and Ukhia UHC</td><td>74</td><td>69(93.2)</td><td>0(0.0)</td></tr><tr><td>Netrokona</td><td>Durgapur and Kalmakanda UHC</td><td>10</td><td>9(90)</td><td>0(0.0)</td></tr><tr><td>Mymensingh</td><td>Haluaghat UHC</td><td>2</td><td>2(100)</td><td>0(0.0)</td></tr><tr><td>Khagrachari</td><td>Matiranga UHC</td><td>154</td><td>144(93.5)</td><td>2*(1.29)</td></tr><tr><td>Rangamati</td><td>Rajasthali UHC</td><td>6</td><td>5(66.7)</td><td>0(0.0)</td></tr><tr><td>Moulvibazar</td><td>Sreemangal and Kamalganj UHC</td><td>11</td><td>11(100)</td><td>0(0.0)</td></tr><tr><td></td><td>Total</td><td>271</td><td>254(93.7)</td><td>2(0.78)</td></tr></table> |
cc94c8ab2ad00fb87cbfc236a1244788ef6a8e885600d7fb8a55b5b0e0556a17.png | simple | <table><tr><td>Genomic resources</td><td>Source material</td><td>Number</td></tr><tr><td>Mapping populations</td><td></td><td></td></tr><tr><td><i> </i>DH line</td><td>Chiffu-401-42 × Kenshin-402-43</td><td>78 lines (F<sub>2</sub> generation)</td></tr><tr><td><i> </i>RI line</td><td>Chiffu-401-42 × Kenshin-402-43</td><td>201 lines (F<sub>8</sub> generation)</td></tr><tr><td>BAC libraries</td><td></td><td></td></tr><tr><td><i> </i><i>Hin</i>dIII (KBrH) </td><td>Chiffu-401-42</td><td>56592 clones (115 kb<sup>(1)</sup>)</td></tr><tr><td><i> </i><i>Bam</i>HI (KBrB)</td><td>Chiffu-401-42</td><td>50688 clones (124 kb<sup>(1)</sup>)</td></tr><tr><td><i> </i><i>Sau</i>3AI (KBrS)</td><td>Chiffu-401-42</td><td>55296 clones (100 kb<sup>(1)</sup>) </td></tr><tr><td>cDNA libraries </td><td></td><td></td></tr><tr><td><i> </i>22 cDNA libraries</td><td>Different tissues of Chiffu-401-42 and Jangwon including leaves, roots, cotyledons, stems,seedlings, ovules, siliques, anthers </td><td>—</td></tr><tr><td>BAC-end sequences</td><td>KBrH, KBrB, and KBrS clones </td><td>200017 sequences</td></tr><tr><td>ESTs</td><td>22 cDNA clones </td><td>129928 sequences</td></tr><tr><td>BAC shotgun sequences</td><td>KBrH, KBrB, and KBrS clones</td><td>on-going<sup>(2)</sup></td></tr></table> |
f24fd1277093810323285dc313cd305da63d63419199a021ad624527376193ae.png | simple | <table><tr><td>Equipment contents of the emergency caesarean section tray</td><td>Equipment for neonatal resuscitation and stabilization</td></tr><tr><td>Scalpel with no. 10 blade</td><td>Overbed warmer</td></tr><tr><td>Lower end of Balfour retractor</td><td>Neonatal airway supplies</td></tr><tr><td>Pack of sponges</td><td>Umbilical access</td></tr><tr><td>2 Kelly clamps</td><td>Medications (e.g., epinephrine 1 : 10 000)</td></tr><tr><td>Needle driver</td><td> </td></tr><tr><td>Russian forceps</td><td> </td></tr><tr><td>Sutures and suture scissors</td><td> </td></tr></table> |
c8e22dd5ea94bb1092b35d45c645ca51df319d66d21f6a95fdc7423348b7b057.png | complex | <table><tr><td>Dataset</td><td>Proposed method</td><td colspan="2">Greedy</td></tr><tr><td></td><td>(<i>α</i>=0<i>.</i>5)</td><td><i>r</i>=0<i>.</i>05</td><td><i>r</i>=0<i>.</i>001</td></tr><tr><td>USA - Netherlands</td><td>25.10%</td><td>8.28%</td><td>7.60%</td></tr><tr><td>USA - Belgium</td><td>19.04%</td><td>5.22%</td><td>6.09%</td></tr><tr><td>USA - Sweden</td><td>19.71%</td><td>5.32%</td><td>5.51%</td></tr><tr><td>Netherlands - Belgium</td><td>18.11%</td><td>8.84%</td><td>10.09%</td></tr><tr><td>Netherlands - Sweden</td><td>18.85%</td><td>7.92%</td><td>7.78%</td></tr><tr><td>Belgium - Sweden</td><td>17.13%</td><td>11.57%</td><td>11.31%</td></tr></table> |
27baa739b41da2e40fb0760a5ead949eaf0f85d23f40fac3f9ce6730b2d6698b.png | simple | <table><tr><td>Age (years)</td><td>16</td><td>17</td><td>18</td><td>19</td><td>20</td><td>All</td></tr><tr><td>N</td><td>22</td><td>40</td><td>28</td><td>50</td><td>31</td><td>171</td></tr><tr><td>CAARMS positive</td><td>1(4.5%)</td><td>10 (25%)</td><td>10 (35.7%)</td><td>11 (22%)</td><td>7 (22.6%)</td><td>39(22.8%)</td></tr><tr><td>95% confidence interval</td><td>1.1 -21.9%</td><td>14.2 – 40.3%</td><td>20.7 – 54.3%</td><td>12.8 – 35.3%</td><td>11.4 – 40%</td><td>17.2 – 29.7%</td></tr></table> |
e5b2b105b4f4306a094e9988653c40e351d7cc7f524cbf6a0032831f0c9ea789.png | simple | <table><tr><td>Admitting medical diagnosis </td><td>Number of subjects (total <i>n</i> = 126)</td></tr><tr><td>Stroke (all types)</td><td>38</td></tr><tr><td>General medical (nonbrain)<sup>1</sup></td><td>23</td></tr><tr><td>Brain tumor (all types)</td><td>22</td></tr><tr><td>Neurological disease (brain)<sup>2</sup></td><td>20</td></tr><tr><td>Orthopedic<sup>3</sup></td><td>14</td></tr><tr><td>Hydrocephalus (all types)</td><td> 9</td></tr></table> |
9c3c2f9755d687edc2ad83a30bfa9665d4b6b996ffde2931490beb751ebf075e.png | simple | <table><tr><td></td><td>Female</td><td>Male</td></tr><tr><td>Succeeded in returning to workplace **</td><td>49 (48.0 %)</td><td>237 (67.3 %)</td></tr><tr><td>Relapse of psychiatric symptoms **</td><td>37 (36.3 %)</td><td>71 (20.2 %)</td></tr><tr><td>Moved to another medical facility</td><td>6 (5.9 %)</td><td>12 (3.4 %)</td></tr><tr><td>Retirement or other</td><td>10 (9.8 %)</td><td>32 (9.1 %)</td></tr><tr><td>Total</td><td>102</td><td>352</td></tr></table> |
b985087a6d290f129dd0740fac11dae934182d8df3af8c9b8b55a433a84ea1b9.png | simple | <table><tr><td>Variables</td><td>Correlation</td><td>P</td></tr><tr><td>FIQ</td><td>−0.32</td><td><0.001</td></tr><tr><td>PCS</td><td>−0.55</td><td>< 0.001</td></tr><tr><td>HADS-dep</td><td>−0.57</td><td><0.001</td></tr><tr><td>HADS-ans</td><td>−0.51</td><td><0.001</td></tr><tr><td>PVAS</td><td>−0.12</td><td>0.113</td></tr><tr><td>CPAQ</td><td>0.44</td><td><0.001</td></tr><tr><td>MAS</td><td>0.39</td><td><0.001</td></tr></table> |
a168d007734fa545c50efb95216587a0e1300353658355200b20420027f6c7c5.png | simple | <table><tr><td>Gene category</td><td>List hits</td><td>Population hits</td><td>EASE score</td></tr><tr><td>(GO biological process)</td><td>(Total = 348)</td><td>(Total = 10,937)</td><td></td></tr><tr><td>response to external stimulus</td><td>67</td><td>1263</td><td>2.52E-05</td></tr><tr><td> response to biotic stimulus</td><td>61</td><td>821</td><td>6.47E-10</td></tr><tr><td> defense response</td><td>57</td><td>756</td><td>1.62E-09</td></tr><tr><td> immune response</td><td>56</td><td>682</td><td>9.89E-11</td></tr><tr><td> response to pest/pathogen/parasite</td><td>27</td><td>444</td><td>1.92E-03</td></tr><tr><td> antigen processing, endogenous antigen via MHC class I</td><td>4</td><td>12</td><td>5.63E-03</td></tr><tr><td>response to stress</td><td>37</td><td>784</td><td>1.57E-02</td></tr><tr><td>signal transduction</td><td>97</td><td>2196</td><td>3.43E-04</td></tr><tr><td> intracellular signaling cascade</td><td>47</td><td>761</td><td>1.62E-05</td></tr><tr><td> protein kinase cascade</td><td>12</td><td>155</td><td>1.04E-02</td></tr><tr><td> activation of MAPK</td><td>4</td><td>16</td><td>1.30E-02</td></tr><tr><td>phosphate metabolism</td><td>33</td><td>662</td><td>1.13E-02</td></tr><tr><td> phosphorylation</td><td>28</td><td>524</td><td>8.90E-03</td></tr><tr><td> protein amino acid phosphorylation</td><td>26</td><td>478</td><td>9.74E-03</td></tr><tr><td>RNA splicing, via transesterification reactions</td><td>8</td><td>83</td><td>1.61E-02</td></tr></table> |
63482fa373562042e6950abd1c44262e3cf34c3aee1d5277bd91ef28ea523021.png | complex | <table><tr><td rowspan="2">Exogenous variable</td><td colspan="7">Endogenous variable</td></tr><tr><td>Arm movement speed (plate tapping)</td><td>Agility (10x5m shuttle run)</td><td>Explosive strength of the legs (standing broad jump)</td><td>Trunk strength (sit-ups)</td><td>Explosive strength of trunk and shoulder girdle (1kg medicine ball throw)</td><td>MAP</td><td>Flexibility (sit and reach)</td></tr><tr><td>Body height</td><td>−0.677</td><td>−0.635</td><td>0.638</td><td>0.581</td><td>0.702</td><td>0.309</td><td></td></tr><tr><td>Body mass</td><td></td><td>0.302</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>BMI</td><td></td><td></td><td></td><td></td><td>0.488</td><td></td><td>0.233</td></tr><tr><td>Rohrer’s index</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>∑ of skinfold thickness</td><td>0.123</td><td></td><td>−0.437</td><td>−0.220</td><td>−0.588</td><td></td><td>−0.455</td></tr><tr><td>LBM</td><td></td><td></td><td></td><td></td><td></td><td>0.605</td><td></td></tr><tr><td>Objective quality of life index</td><td></td><td>−0.177</td><td>0.216</td><td></td><td></td><td>0.114</td><td></td></tr><tr><td>Subjective quality of life index</td><td>0.110</td><td></td><td></td><td>−0.090</td><td></td><td></td><td>0.136</td></tr><tr><td>R</td><td>0.649</td><td>0.494</td><td>0.685</td><td>0.543</td><td>0.727</td><td>0.924</td><td>0.308</td></tr><tr><td>R<sup>2</sup></td><td>0.422</td><td>0.244</td><td>0.469</td><td>0.295</td><td>0.529</td><td>0.854</td><td>0.095</td></tr><tr><td>F</td><td>22.620</td><td>9.992</td><td>27.370</td><td>13.002</td><td>34.862</td><td>181.37</td><td>3.255</td></tr><tr><td>p</td><td>0.000</td><td>0.000</td><td>0.000</td><td>0.000</td><td>0.000</td><td>0.000</td><td>0.025</td></tr></table> |
a59f53717175af005ea5ad69045b9b7296b92b8ce3b703ab6b7ca76f85ec8c50.png | complex | <table><tr><td colspan="3">Mikołajskie september</td><td colspan="3">Mamry september</td></tr><tr><td colspan="2">Microscope</td><td rowspan="2">DGGE-ITS</td><td colspan="2">Microscope</td><td rowspan="2">DGGE-ITS</td></tr><tr><td>taxon</td><td>(cells/mL)</td><td>taxon</td><td>(cells/mL)</td></tr><tr><td><i>Snowella litoralis</i></td><td>3</td><td> </td><td><i>Snowella litoralis</i></td><td>118</td><td> </td></tr><tr><td><i>Snowella lacustris</i></td><td>31</td><td> </td><td><i>Snowella lacustris</i></td><td>1</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Woronichinia compacta</i></td><td>1</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Woronichinia naegeliana</i></td><td>2</td><td> </td></tr><tr><td><i>Chroococcus</i> spp.</td><td><1</td><td> </td><td><i>Chroococcus</i> spp.</td><td>13</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Aphanothece</i> spp.</td><td>779</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Microcystis aeruginosa</i></td><td>19</td><td><i>Microcystis</i></td></tr><tr><td> </td><td> </td><td> </td><td><i>Microcystis flos-aquae</i></td><td>7</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Microcystis smithii</i></td><td>5</td><td> </td></tr><tr><td><i>Aphanocapsa</i> spp.</td><td>34</td><td> </td><td><i>Aphanocapsa</i> spp.</td><td>4599</td><td> </td></tr><tr><td><i>Aphanocapsa planctonica</i></td><td>4</td><td> </td><td><i>Aphanocapsa planctonica</i></td><td>75</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Coelosphaerium kuetzingianum</i></td><td>2</td><td> </td></tr><tr><td><i>Coelosphaerium minutissimum</i></td><td>3</td><td> </td><td><i>Coelosphaerium minutissimum</i></td><td>18</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Merismopedia punctata</i></td><td>1</td><td> </td></tr><tr><td><i>Cyanodictyon reticulatum</i></td><td>2</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Cyanodictyon</i> cf. <i>planctonicum</i></td><td>7</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Lemmermanniella pallida</i></td><td>4</td><td> </td></tr><tr><td><i>Synechococcus</i>-like<i>/Cyanobium</i>-like</td><td>60042</td><td><i>Synechococcus</i></td><td><i>Synechococcus</i>-like/<i>Cyanobium</i>-like</td><td>76386</td><td><i>Synechococcus</i></td></tr><tr><td><i>Aphanizomenon gracile</i></td><td>839</td><td><i>Aphanizomenon</i> (?)</td><td><i>Aphanizomenon gracile</i></td><td>336</td><td><i>Aphanizomenon</i> (?)</td></tr><tr><td><i>Cuspidothrix issatschenkoi</i></td><td>20</td><td><i>Cuspidothrix issatschenkoi</i></td><td><i>Cuspidothrix issatschenkoi</i></td><td>25</td><td><i>Cuspidothrix issatschenkoi</i></td></tr><tr><td> </td><td> </td><td><i>Dolichospermum</i></td><td><i>Dolichospermum lemmermannii</i></td><td>1</td><td><i>Dolichospermum</i></td></tr><tr><td> </td><td> </td><td><i>Phormidium</i> (?)</td><td> </td><td> </td><td><i>Phormidium</i> (?)</td></tr><tr><td><i>Planktothrix agardhii</i></td><td>45</td><td><i>Planktothrix</i></td><td> </td><td> </td><td><i>Planktothrix</i></td></tr><tr><td><i>Planktothrix suspensa</i></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td><i>Pseudanabaenaceae</i></td><td> </td><td> </td><td><i>Pseudanabaenaceae</i></td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td><i>Leptolyngbya</i></td></tr><tr><td><i>Limnothrix lauterbornii</i></td><td>128</td><td> </td><td><i>Limnothrix lauterbornii</i></td><td>154</td><td> </td></tr><tr><td><i>Limnothrix redekei</i></td><td>692</td><td> </td><td><i>Limnothrix redekei</i></td><td>742</td><td> </td></tr><tr><td><i>Planktolyngbya limnetica</i></td><td>5455</td><td> </td><td><i>Planktolyngbya limnetica</i></td><td>3293</td><td> </td></tr><tr><td><i>Pseudanabaena catenata</i></td><td>5963</td><td> </td><td><i>Pseudanabaena catenata</i></td><td>1393</td><td> </td></tr><tr><td><i>Pseudanabaena limnetica</i></td><td>18172</td><td> </td><td><i>Pseudanabaena limnetica</i></td><td>24635</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td><i>Pseudanabaena mucicola</i></td><td>10</td><td> </td></tr><tr><td> </td><td> </td><td><i>Romeria</i> (?)</td><td><i>Romeria gracilis</i></td><td>214</td><td><i>Romeria</i> (?)</td></tr><tr><td> </td><td> </td><td>unassigned sequences</td><td> </td><td> </td><td>unassigned sequences</td></tr><tr><td> </td><td> </td><td>nonsequenced</td><td> </td><td> </td><td>nonsequenced</td></tr></table> |
cd33efa1b8623d8c19839528d4696db6dc684614183ef553561ca494b80c3175.png | simple | <table><tr><td>Variable</td><td>Cases (n = 50)</td><td>Controls (n = 44)</td><td><i>p</i>-values</td></tr><tr><td>Age (yrs)*</td><td>30.78 (19-41)</td><td>30.68 (19-40)</td><td>0.893</td></tr><tr><td>Body mass index (kg/m<sup>2</sup>)*</td><td>30.26 ± 2.21</td><td>31.07 ± 1.69</td><td>0.211</td></tr><tr><td>Duration of Infertility (yrs)*</td><td>3.93 (2.5-10)</td><td>5.0 (2-16)</td><td>0.041</td></tr><tr><td>< <i>5 years</i></td><td>26 (52 %)</td><td>31 (70.5 %)</td><td>0.068</td></tr><tr><td><i>≥5 years</i></td><td>24 (48 %)</td><td>13 (29.5 %)</td><td></td></tr><tr><td>Type of infertility</td><td></td><td></td><td></td></tr><tr><td><i>Primary</i></td><td>36 (72 %)</td><td>35 (79.5 %)</td><td>0.396</td></tr><tr><td><i>Secondary</i></td><td>14 (28 %)</td><td>9 (20.5 %)</td><td></td></tr><tr><td>Previous parity</td><td>9 (18 %)</td><td>6 (13.6 %)</td><td>0.564</td></tr><tr><td>Previous abortion</td><td>10 (20 %)</td><td>6 (13.6 %)</td><td>0.413</td></tr><tr><td>Previous ICSI/IUI</td><td>17 (34 %)</td><td>9 (20.5 %)</td><td>0.308</td></tr><tr><td>Anti C.<i>trachomatis</i> IgM + ve</td><td>3/50 (6 %)</td><td>0/44 (0 %)</td><td>0.099</td></tr><tr><td>Anti C.<i>trachomatis</i> IgG + ve</td><td>18 (36 %)</td><td>8 (18.2 %)</td><td>0.054</td></tr><tr><td>Ratio of IgM*</td><td>0.37 ± 0.26</td><td>0.59 ± 0.24</td><td><i><</i> 0.05</td></tr><tr><td>Ratio of IgG*</td><td>1.26 ± 0.99</td><td>0.87 ± 0.63</td><td>0.03</td></tr><tr><td>PCR positive</td><td>3/50 (6 %)</td><td>0/44 (0 %)</td><td>0.09</td></tr><tr><td>Antisperm Abs positive</td><td>3/50 (6 %)</td><td>1/44 (2.3 %)</td><td>0.372</td></tr></table> |
0e3310186a36f5ff52e6019bd0bdf5761e45d1b936a84fd66ec7e30fe10ae044.png | simple | <table><tr><td>Variables</td><td>Class II</td><td>Class III</td></tr><tr><td>Gender (male)</td><td>38.56 (11.78–126.19) *</td><td>57.27 (13.56–241.85) *</td></tr><tr><td>Age <sup>a</sup></td><td></td><td></td></tr><tr><td> 31–40</td><td>1.47 (0.60–3.58)</td><td>8.08 (2.03–32.18) *</td></tr><tr><td> >40</td><td>1.29 (0.48–3.49)</td><td>8.35 (2.01–34.74) *</td></tr><tr><td>Ethnicity <sup>b</sup></td><td></td><td></td></tr><tr><td> Minority</td><td>2.14 (0.74–6.23)</td><td>1.36 (0.40–4.64)</td></tr><tr><td>Educational background <sup>c</sup></td><td></td><td></td></tr><tr><td> Master</td><td>1.10 (0.51–2.38)</td><td>0.55 (0.25–1.20)</td></tr><tr><td> PhD</td><td>0.96 (0.42–2.18)</td><td>0.54 (0.24–1.19)</td></tr><tr><td>Married status <sup>d</sup></td><td></td><td></td></tr><tr><td> Married</td><td>0.98 (0.41–2.36)</td><td>1.83 (0.53–6.33)</td></tr><tr><td> Divorced or widowed</td><td>1.19 (0.17–8.27)</td><td> 3.47 (0.53–22.59)</td></tr><tr><td>Position <sup>e</sup></td><td></td><td></td></tr><tr><td> Non–HCPs</td><td>1.09 (0.56–2.12)</td><td>0.71 (0.37–1.39)</td></tr><tr><td>Knowledge <sup>f</sup></td><td></td><td></td></tr><tr><td> ≥23</td><td>1.19 (0.66–2.13)</td><td>1.35 (0.72–2.51)</td></tr><tr><td>Attitude <sup>g</sup></td><td></td><td></td></tr><tr><td> ≥9</td><td>1.22 (0.68–2.19)</td><td>1.68 (0.90–3.15)</td></tr></table> |
36c6e278da59be44c87cc05fdd215d5c786cb6b1201e5e2de52fc26ff870ce9a.png | complex | <table><tr><td colspan="3"> Causes of preterm labor</td><td rowspan="2">Spontaneous preterm labor</td><td rowspan="2">PROM</td><td rowspan="2">Preterm elective termination of pregnancy</td><td rowspan="2">Term labor</td></tr><tr><td colspan="3">Group</td></tr><tr><td colspan="2">Case (progesterone)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td colspan="2">Number</td><td>0</td><td>4</td><td>0</td><td>48</td></tr><tr><td></td><td colspan="2">Percentage</td><td>0%</td><td>7.7%</td><td>0%</td><td>92.3%</td></tr><tr><td colspan="2">Control (placebo)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td colspan="2">Number</td><td>3</td><td>2</td><td>3</td><td>39</td></tr><tr><td></td><td colspan="2">Percentage</td><td>6.4%</td><td>4.3%</td><td>6.4%</td><td>83%</td></tr></table> |
8185577ddc3a55c74333d7a43ac92b4a717bd84c03297d43bf67085d05454634.png | complex | <table><tr><td rowspan="3">Characteristics</td><td rowspan="3"><i>n</i> = 60(%)</td><td colspan="2">miR-335-5p mRNA expression</td><td rowspan="3"><i>p</i> value</td><td colspan="2">CPNE1 mRNA expression</td><td rowspan="3"><i>p</i> value</td></tr><tr><td>high</td><td>low</td><td>high</td><td>low</td></tr><tr><td>(<i>n</i> = 15)</td><td>(<i>n</i> = 45)</td><td>(<i>n</i> = 53)</td><td>(<i>n</i> = 7)</td></tr><tr><td colspan="8">Age</td></tr><tr><td> ≤65</td><td>41 (68%)</td><td>9</td><td>32</td><td rowspan="2">0.432</td><td>36</td><td>5</td><td rowspan="2">0.851</td></tr><tr><td> > 65</td><td>19 (32%)</td><td>6</td><td>13</td><td>17</td><td>2</td></tr><tr><td colspan="8">Gender</td></tr><tr><td> Male</td><td>38 (63%)</td><td>10</td><td>28</td><td rowspan="2">0.757</td><td>34</td><td>4</td><td rowspan="2">0.718</td></tr><tr><td> Female</td><td>22 (37%)</td><td>5</td><td>17</td><td>19</td><td>3</td></tr><tr><td colspan="8">Histology</td></tr><tr><td> Adenocarcinoma</td><td>33 (55%)</td><td>7</td><td>26</td><td rowspan="3">0.479</td><td>30</td><td>3</td><td rowspan="3">0.661</td></tr><tr><td> Squamous cell carcinoma</td><td>17 (28%)</td><td>4</td><td>13</td><td>14</td><td>3</td></tr><tr><td> Others</td><td>10 (17%)</td><td>4</td><td>6</td><td>9</td><td>1</td></tr><tr><td colspan="8">Smoking status</td></tr><tr><td> Yes</td><td>33 (55%)</td><td>7</td><td>26</td><td rowspan="2">0.454</td><td>30</td><td>3</td><td rowspan="2">0.492</td></tr><tr><td> No</td><td>27 (45%)</td><td>8</td><td>19</td><td>23</td><td>4</td></tr><tr><td colspan="8">Clinical stage</td></tr><tr><td> I/II</td><td>24 (40%)</td><td>4</td><td>20</td><td rowspan="2">0.224</td><td>21</td><td>3</td><td rowspan="2">0.870</td></tr><tr><td> III/IV</td><td>36 (60%)</td><td>11</td><td>25</td><td>32</td><td>4</td></tr><tr><td colspan="8">Lymph node metastasis</td></tr><tr><td> No</td><td>24 (40%)</td><td>10</td><td>14</td><td rowspan="2">0.015</td><td>18</td><td>6</td><td rowspan="2">0.009</td></tr><tr><td> Yes</td><td>36 (60%)</td><td>5</td><td>31</td><td>35</td><td>1</td></tr></table> |
06f34ce3b1058c9590a8bf96bf337ea1597b1d3a46eaa4398df3869f058e6390.png | simple | <table><tr><td>Dataset</td><td>Number</td><td>Overlap</td><td><i>P</i> Value<i><sup>a</sup></i></td><td>Odds Ratio</td></tr><tr><td>Expressed genes for Smaug-dependent decay (embryos 2–3 hr)</td><td>3956</td><td></td><td></td><td></td></tr><tr><td>Smaug-dependent decay genes (embryos 2–3 hr, 5% FDR)<i><sup>b</sup></i></td><td>418</td><td></td><td></td><td></td></tr><tr><td>Smaug-dependent-miR target genes</td><td>1507</td><td>151</td><td>4.9 × 10<sup>−6</sup></td><td>1.6</td></tr><tr><td>Expressed genes for Smaug-dependent decay (embryos 2–3 hr)</td><td>3956</td><td></td><td></td><td></td></tr><tr><td>Smaug-dependent decay genes (embryos 2–3 hr, 5% FDR)<i><sup>c</sup></i></td><td>341</td><td></td><td></td><td></td></tr><tr><td>Smaug-dependent-miR target genes</td><td>1507</td><td>128</td><td>3.1 × 10<sup>−6</sup></td><td>1.7</td></tr><tr><td>Expressed genes for Smaug-RIP (embryos 0–3 hr)</td><td>4481</td><td></td><td></td><td></td></tr><tr><td>Smaug-RIP genes (embryos 0–3 hr, 5% FDR)</td><td>339</td><td></td><td></td><td></td></tr><tr><td>Smaug-dependent-miR target genes</td><td>1200</td><td>101</td><td>0.11</td><td>1.1</td></tr></table> |
e6aa53cf1f2a4c2fcda2fef56c89895a89a04c5e4cac85f2195ce3d1f63b5215.png | complex | <table><tr><td rowspan="2">Variables</td><td>All (<i>N</i> = 663)</td><td>Depressive symptoms (<i>n</i> = 321)</td><td>Non-depressive symptoms (<i>n</i> = 338)</td><td>Statistic</td></tr><tr><td><i>N</i> (%)Mean (SD)</td><td><i>N</i> (%)Mean (SD)</td><td><i>N</i> (%)Mean (SD)</td><td><i>t</i>/<i>χ</i><sup>2</sup>, <i>p</i></td></tr><tr><td colspan="5">HIV-related variables</td></tr><tr><td colspan="5">Diagnosed with HIV in this pregnancy</td></tr><tr><td> No, before</td><td>304 (45.9%)</td><td>146 (45.2%)</td><td>158 (46.5%)</td><td>.107; .743</td></tr><tr><td> Yes</td><td>359 (54.1%)</td><td>177 (54.8%)</td><td>182 (53.5%)</td><td> </td></tr><tr><td colspan="5">Disclosure of HIV serostatus to anyone</td></tr><tr><td> No</td><td>185 (27.9%)</td><td>98 (30.3%)</td><td>87 (25.6%)</td><td>1.86; .173</td></tr><tr><td> Yes</td><td>478 (72.1%)</td><td>225 (69.7%)</td><td>253 (74.4%)</td><td> </td></tr><tr><td>Months since ART initiation</td><td>13.0 (23.9)</td><td>11.8 (22.3)</td><td>14.0 (25.3)</td><td>1.09; .277<sup>a</sup></td></tr><tr><td colspan="5">Has HIV-positive children</td></tr><tr><td> No or do not know</td><td>498 (94.9%)</td><td>252 (97.3%)</td><td>246 (92.5%)</td><td>6.23; .012</td></tr><tr><td> Yes</td><td>27 (5.1%)</td><td>7 (2.7%)</td><td>20 (7.5%)</td><td> </td></tr><tr><td colspan="5">Internalized AIDS stigma</td></tr><tr><td> Score 0</td><td>391 (59.0%)</td><td>173 (53.6%)</td><td>218 (64.1%)</td><td>7.63; .006</td></tr><tr><td> Score 1 or more</td><td>272 (41.0%)</td><td>150 (46.4%)</td><td>122 (35.9%)</td><td> </td></tr><tr><td colspan="5">Skipped medication in the past 7 days</td></tr><tr><td> Non-adherent (<100%)</td><td>218 (32.9%)</td><td>132 (40.9%)</td><td>86 (25.3%)</td><td>18.20; <.001</td></tr><tr><td> Adherent (100%)</td><td>445 (67.1%)</td><td>191 (59.1%)</td><td>254 (74.6%)</td><td> </td></tr><tr><td colspan="5">Partner variables</td></tr><tr><td colspan="5">Disclosure of HIV serostatus to partner</td></tr><tr><td> No</td><td>275 (41.5%)</td><td>145 (44.9%)</td><td>130 (38.2%)</td><td>3.02; .082</td></tr><tr><td> Yes</td><td>388 (58.5%)</td><td>178 (55.1%)</td><td>210 (61.8%)</td><td> </td></tr><tr><td colspan="5">HIV-positive partner</td></tr><tr><td> No or do not know</td><td>497 (75.0%)</td><td>253 (78.3%)</td><td>244 (71.8%)</td><td>3.80; .051</td></tr><tr><td> Yes</td><td>166 (25.0%)</td><td>70 (21.7%)</td><td>96 (28.2%)</td><td> </td></tr><tr><td colspan="5">Condom use at last sex</td></tr><tr><td> Yes</td><td>317 (47.8%)</td><td>176 (54.5%)</td><td>141 (41.5%)</td><td>11.25; <.001</td></tr><tr><td> No</td><td>346 (52.2%)</td><td>147 (45.5%)</td><td>199 (58.5%)</td><td> </td></tr><tr><td colspan="5">IPV</td></tr><tr><td> No mild or severe physical violence</td><td>533 (80.4%)</td><td>239 (74.0%)</td><td>294 (86.5%)</td><td>16.36; <.001</td></tr><tr><td> Mild or severe physical violence</td><td>130 (19.6%)</td><td>84 (26.0%)</td><td>46 (13.5%)</td><td> </td></tr><tr><td>Male involvement index</td><td>7.15 (3.0)</td><td>6.7 (3.2)</td><td>7.6 (2.8)</td><td>3.58; <.001</td></tr></table> |
5292f1b79d0d7588c4ccdc51d976244e81b434249aac038a8ec16fa647c1d903.png | simple | <table><tr><td>Suspected VOC</td><td>Healthy <i>vs.</i> Benign + Cancer</td><td>Healthy + Benign <i>vs.</i> Cancer</td><td>Cancer <i>vs.</i> DCIS</td><td>Triple Negative <i>vs.</i> Other</td><td>HER2+ <i>vs.</i> Other</td><td>HER2 + status*<i>vs.</i> Other</td><td>HER2+ status (Non Luminal) <i>vs.</i> Other</td><td>HER2+ status (Luminal) <i>vs.</i> Other</td></tr><tr><td>Ethanol</td><td>X</td><td>X</td><td>X</td><td></td><td></td><td>X</td><td></td><td></td></tr><tr><td>Acetone</td><td></td><td></td><td></td><td></td><td>X</td><td></td><td>X</td><td></td></tr><tr><td>Cyclopentane</td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>Carbonic acid, dimethyl ester (DMC)</td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td></td><td>X</td></tr><tr><td>Pentane, 2, 3-dimethyl-</td><td></td><td></td><td>X</td><td></td><td></td><td></td><td>X</td><td></td></tr><tr><td>Heptane</td><td></td><td>X</td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Toluene</td><td></td><td></td><td></td><td></td><td></td><td>X</td><td></td><td></td></tr><tr><td>Cyclohexane, 1, 4-dimethyl-</td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td>X</td></tr><tr><td>Acetic acid, butyl ester</td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>Benzene, 1, 3-dimethyl-</td><td></td><td></td><td></td><td></td><td>X</td><td>X</td><td></td><td></td></tr><tr><td>2-Propenoic acid, butyl ester</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>alpha.-Pinene</td><td>X</td><td></td><td></td><td></td><td>X</td><td></td><td></td><td></td></tr><tr><td>5-Hepten-2-one, 6-methyl-</td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1-Hexanol, 2-ethyl-</td><td></td><td></td><td>X</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Sensitivity</td><td>86</td><td>78</td><td>70</td><td>40</td><td>67</td><td>68</td><td>100</td><td>73</td></tr><tr><td>Specificity</td><td>70</td><td>61</td><td>83</td><td>95</td><td>76</td><td>72</td><td>57</td><td>70</td></tr><tr><td>Accuracy</td><td>83</td><td>72</td><td>81</td><td>87</td><td>74</td><td>70</td><td>82</td><td>72</td></tr><tr><td><i>p</i>-value</td><td>< 0.0001</td><td>< 0.0001</td><td>0.0001</td><td>0.006</td><td>0.0001</td><td>< 0.0001</td><td>0.0047</td><td>0.0018</td></tr><tr><td>AUC</td><td>0.93</td><td>0.79</td><td>0.88</td><td>0.78</td><td>0.83</td><td>0.82</td><td>0.91</td><td>0.87</td></tr></table> |
6a8f1b16a75c9e09095b85ae2cf1ab47ea6704de5576b1061e1528d092e82f0e.png | complex | <table><tr><td colspan="2">Clinical manifestations/Hospitalization</td><td>Number of events</td><td>Number of doses per event</td><td>Rate per 10,000 dosesb</td></tr><tr><td colspan="5">Local</td></tr><tr><td></td><td>Pain</td><td>189</td><td>4,040</td><td>2.5</td></tr><tr><td></td><td>Nodule</td><td>163</td><td>4,684</td><td>2.1</td></tr><tr><td></td><td>Abscess</td><td>33</td><td>23,138</td><td>0.4</td></tr><tr><td></td><td>Lymphadenitis</td><td>33</td><td>23,138</td><td>0.4</td></tr><tr><td></td><td>Ulcer</td><td>1</td><td>763,548</td><td>0.1</td></tr><tr><td colspan="5">Systemic</td></tr><tr><td></td><td>Headache</td><td>1</td><td>763,548</td><td>0.1</td></tr><tr><td></td><td>Nausea</td><td>10</td><td>76,355</td><td>0.1</td></tr><tr><td></td><td>Diarrhea</td><td>23</td><td>33,198</td><td>0.3</td></tr><tr><td></td><td>Vomiting</td><td>54</td><td>14,140</td><td>0.7</td></tr><tr><td></td><td>Cyanosis</td><td>27</td><td>28,280</td><td>0.4</td></tr><tr><td></td><td>Malaise</td><td>23</td><td>33,198</td><td>0.3</td></tr><tr><td></td><td>Irritability</td><td>102</td><td>7,486</td><td>1.3</td></tr><tr><td></td><td>Sleepiness</td><td>44</td><td>17,353</td><td>0.6</td></tr><tr><td></td><td>Myalgia</td><td>7</td><td>109,078</td><td>0.1</td></tr><tr><td></td><td>Exanthema</td><td>46</td><td>16,599</td><td>0.6</td></tr><tr><td></td><td>Jaundice</td><td>1</td><td>763,548</td><td>0.1</td></tr><tr><td></td><td>Parotitis</td><td>20</td><td>38,177</td><td>0.3</td></tr><tr><td></td><td>Fever</td><td>344</td><td>2,220</td><td>4.5</td></tr><tr><td></td><td>< 38°C</td><td>51</td><td>14,971</td><td>0.7</td></tr><tr><td></td><td>38|-|39,4°C</td><td>196</td><td>3,896</td><td>2,6</td></tr><tr><td></td><td>≥ 39.5°C</td><td>68</td><td>11,229</td><td>0.9</td></tr><tr><td></td><td>Hypotonic-hyporesponsive episode</td><td>67</td><td>11,396</td><td>0.9</td></tr><tr><td></td><td>Adenoiditis</td><td>18</td><td>42,419</td><td>0.2</td></tr><tr><td></td><td>Arthralgia</td><td>1</td><td>763,548</td><td>0.1</td></tr><tr><td></td><td>Hypersensitivity</td><td>11</td><td>69,413</td><td>0.1</td></tr><tr><td></td><td>Seizure</td><td>25</td><td>30,542</td><td>0.3</td></tr><tr><td></td><td>Loss of consciousness</td><td>6</td><td>127,258</td><td>0.1</td></tr><tr><td></td><td>Myelitis</td><td>1</td><td>763,548</td><td>0.1</td></tr><tr><td></td><td>Paresis</td><td>1</td><td>763,548</td><td>0.1</td></tr><tr><td colspan="2">Hospitalization</td><td>16</td><td>47,722</td><td>0.2</td></tr></table> |
53514c429800b8185ecdb61be3644352aae115447afb9ec692f434f82a660c39.png | simple | <table><tr><td>Criterion</td><td>ALARM (n,%)</td><td>Control (n,%)</td><td>p-value</td></tr><tr><td> </td><td>N = 68</td><td>N = 70</td><td> </td></tr><tr><td>Anticonvulsant administered</td><td> </td><td> </td><td> </td></tr><tr><td> Magnesium sulphate</td><td>26, 38.2%</td><td>20, 28.6%</td><td> </td></tr><tr><td> Valium</td><td>7, 10.3%</td><td>7, 10.0%</td><td> </td></tr><tr><td> None</td><td>35, 51.5%</td><td>43, 61.4%</td><td>0.455</td></tr><tr><td>Blood pressure recorded every four hours after birth</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>15, 22.1%</td><td>13, 18.6%</td><td> </td></tr><tr><td> No</td><td>53, 77.9%</td><td>57, 81.4%</td><td>0.675</td></tr><tr><td>Urinary output measured at least once in 24 hours</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>22, 32.4%</td><td>22, 31.4%</td><td> </td></tr><tr><td> No</td><td>46, 67.6%</td><td>48, 68.6%</td><td>1.000</td></tr><tr><td>Test of bleeding time</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>5, 7.4%</td><td>10, 14.3%</td><td> </td></tr><tr><td> No</td><td>63, 92.6%</td><td>60, 85.7%</td><td>0.275</td></tr><tr><td>Test of coagulation rate</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>5, 7.4%</td><td>9, 12.9%</td><td> </td></tr><tr><td> No</td><td>63, 92.6%</td><td>61, 87.1%</td><td>0.346</td></tr><tr><td>Platelet count</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>22, 32.4%</td><td>17, 24.3%</td><td> </td></tr><tr><td> No</td><td>46, 67.6%</td><td>53, 75.7%</td><td>0.346</td></tr><tr><td>Albumin test</td><td> </td><td> </td><td> </td></tr><tr><td> Yes</td><td>18, 26.5%</td><td>18, 26.1%</td><td> </td></tr><tr><td> No</td><td>50, 73.5%</td><td>51, 73.9%</td><td>1.00</td></tr><tr><td>Total severe (pre-) eclampsia score</td><td>25.2%</td><td>23.2%</td><td>0.621</td></tr></table> |
bacaea365173e147afe336135b8532ebd976107d2ae4cc14481966a3d6cc36d0.png | simple | <table><tr><td></td><td></td><td>Strain</td><td>NRRL2338</td><td>Px</td></tr><tr><td>COG</td><td>Functional categories</td><td>% COG probesets</td><td>% Probesets with q-value < = 0.001</td><td>% Probesets with q-value < = 0.001</td></tr><tr><td>I</td><td>Cellular processes and signaling</td><td></td><td></td><td></td></tr><tr><td>I.1</td><td>Cell cycle control, cell division, chromosome partitioning</td><td>0,35</td><td>0,99</td><td>0,69</td></tr><tr><td>I.2</td><td>Cell motility</td><td>0,01</td><td>0</td><td>0</td></tr><tr><td>I.3</td><td>Cell wall/membrane/envelope biogenesis</td><td>2,05</td><td>3,22</td><td>3,81</td></tr><tr><td>I.4</td><td>Defense mechanisms</td><td>0,89</td><td>0,00</td><td>0,87</td></tr><tr><td>I.5</td><td>Intracellular trafficking, secretion, and vesicular transport</td><td>0,24</td><td>0,25</td><td>0,69</td></tr><tr><td>I.6</td><td>Posttranslational modification, protein turnover, chaperones</td><td>1,90</td><td>5,94</td><td>3,99</td></tr><tr><td>I.7</td><td>Signal transduction mechanisms</td><td>1,91</td><td>0,99</td><td>1,91</td></tr><tr><td>II</td><td>Information storage and processing</td><td></td><td></td><td></td></tr><tr><td>II.1</td><td>Amino acid transport and metabolism</td><td>0,01</td><td>0</td><td>0</td></tr><tr><td>II.2</td><td>Cell wall/membrane/envelope biogenesis</td><td>0,01</td><td>0</td><td>0</td></tr><tr><td>II.3</td><td>Chromatin structure and dynamics</td><td>0,01</td><td>0</td><td>0</td></tr><tr><td>II.4</td><td>General function prediction only</td><td>0,30</td><td>0,50</td><td>0,35</td></tr><tr><td>II.5</td><td>Nucleotide transport and metabolism</td><td>0,07</td><td>0</td><td>0</td></tr><tr><td>II.6</td><td>Posttranslational modification, protein turnover, chaperone</td><td>0,04</td><td>0</td><td>0</td></tr><tr><td>II.7</td><td>Replication, recombination and repair</td><td>2,44</td><td><i>0,74</i></td><td>2,43</td></tr><tr><td>II.8</td><td>RNA processing and modification</td><td>0,01</td><td>0</td><td></td></tr><tr><td>II.9</td><td>Secondary metabolites biosynthesis, transport catabolism</td><td>0,04</td><td>0</td><td></td></tr><tr><td>II.10</td><td>Signal transduction mechanisms</td><td>0,71</td><td>0,50</td><td>0,69</td></tr><tr><td>II.11</td><td>Transcription</td><td>7,20</td><td><i>2,23</i></td><td><i>3,29</i></td></tr><tr><td>II.12</td><td>Translation, ribosomal structure and biogenesis</td><td>2,48</td><td>4,21</td><td>10,75</td></tr><tr><td>III</td><td>Metabolism</td><td></td><td></td><td></td></tr><tr><td>III.l</td><td>Amino acid transport and metabolism</td><td>6,60</td><td>0</td><td>8,15</td></tr><tr><td>III.2</td><td>Carbohydrate transport and metabolism</td><td>6,08</td><td>7,67</td><td>6,59</td></tr><tr><td>III.3</td><td>Cell wall/membrane/envelope biogenesis</td><td>0,38</td><td>0</td><td><i>0,17</i></td></tr><tr><td>III.4</td><td>Coenzyme transport and metabolism</td><td>2,63</td><td>5,20</td><td>4,33</td></tr><tr><td>III.5</td><td>Energy production and conversion</td><td>4,79</td><td>9,90</td><td>8,15</td></tr><tr><td>III.6</td><td>Inorganic ion transport and metabolism</td><td>2,68</td><td>4,21</td><td>2,25</td></tr><tr><td>III.7</td><td>Lipid transport and metabolism</td><td>4,24</td><td>2,72</td><td>5,03</td></tr><tr><td>III.8</td><td>Nucleotide transport and metabolism</td><td>1,27</td><td>2,97</td><td>3,64</td></tr><tr><td>III.9</td><td>Posttranslational modification, protein turnover, chaperones</td><td>0,08</td><td>0</td><td>0,17</td></tr><tr><td>III.10</td><td>Secondary metabolites biosynthesis, transport catabolism</td><td>2,90</td><td>2,48</td><td>2,77</td></tr><tr><td>III. 11</td><td>Signal transduction mechanisms</td><td>0,16</td><td>0</td><td>0</td></tr><tr><td>IV</td><td>Poorly characterized</td><td></td><td></td><td></td></tr><tr><td>IV.1</td><td>Function unknown</td><td>32,11</td><td>27,23</td><td>22,70</td></tr><tr><td>IV.2</td><td>General function prediction only</td><td>7,37</td><td>8,17</td><td>6,59</td></tr><tr><td></td><td>Total probesets</td><td>7060</td><td>404</td><td>577</td></tr></table> |
0a24e7c96fd8bed5f4a6305d46b2487e9a65ca325dbe5a850f83657feb82861b.png | simple | <table><tr><td>No.</td><td>Name</td><td>Concentration of β-asarone (mg/kg)</td><td>Concentration of α-asarone (mg/kg)</td><td>Source</td></tr><tr><td>1</td><td>Product 1</td><td>Not detected</td><td>Not detected</td><td>–</td></tr><tr><td>2</td><td>Product 2</td><td>Not detected</td><td>Not detected</td><td>–</td></tr><tr><td>3</td><td>Product 3</td><td>273.6 ± 21.6</td><td>40 ± 1.2</td><td><i>Acori tatarinowii</i> Rhizoma</td></tr><tr><td>4</td><td>Product 4</td><td>Not detected</td><td>Not detected</td><td>–</td></tr><tr><td>5</td><td>Product 5</td><td>230.9 ± 21.3</td><td>34.7 ± 1.2</td><td><i>Acori tatarinowii</i> Rhizoma</td></tr><tr><td>6</td><td>Product 6</td><td>4.8 ± 0.2</td><td>5.0 ± 0.2</td><td><i>Acori tatarinowii</i> Rhizoma</td></tr><tr><td>7</td><td>Product 7</td><td>11.2 ± 0.1</td><td>47.7 ± 3.0</td><td><i>Acori graminei</i> Rhizoma</td></tr><tr><td>8</td><td>Product 8</td><td>181.6 ± 5.4</td><td>106.1 ± 1.0</td><td>–</td></tr><tr><td>9</td><td>Product 9</td><td>Not detected</td><td>Not detected</td><td>–</td></tr><tr><td>10</td><td>Product 10</td><td>Not detected</td><td>Not detected</td><td>–</td></tr><tr><td>11</td><td>Product 11</td><td>181.6 ± 5.4</td><td>106.1 ± 1.0</td><td>unknown source</td></tr><tr><td>12</td><td>Product 12</td><td>4.3 ± 0.3</td><td>13.3 ± 0.1</td><td>unknown source</td></tr><tr><td>13</td><td>Product 13</td><td>3.2 ± 0.2</td><td>10.9 ± 3.3</td><td><i>Asari radix et</i> Rhizoma</td></tr><tr><td>14</td><td>Product 14</td><td>241.5 ± 10.5</td><td>53.2 ± 1.2</td><td>unknown source</td></tr><tr><td>15</td><td>Product 15</td><td>Not detected</td><td>Not detected</td><td>–</td></tr><tr><td>16</td><td>Product 16</td><td>Not detected</td><td>Not detected</td><td>–</td></tr><tr><td>17</td><td>Product 17</td><td>Not detected</td><td>Not detected</td><td>–</td></tr><tr><td>18</td><td>Product 18</td><td>243.5 ± 18.2</td><td>144.3 ± 7.1</td><td>unknown source</td></tr><tr><td>19</td><td>Product 19</td><td>Not detected</td><td>Not detected</td><td>–</td></tr><tr><td>20</td><td>Product 20</td><td>425.7 ± 28.2</td><td>62.8 ± 3.1</td><td><i>Acori tatarinowii</i> Rhizoma</td></tr><tr><td>21</td><td>Authentic herb A<i>cori tatarinowii</i></td><td>7679.8 ± 85.7</td><td>679.1 ± 20.3</td><td><i>Acori tatarinowii</i> Rhizoma</td></tr></table> |
57941a547579ca8ec3959b961239eacc729f78c3b7cf0646a40094b0f9db70ee.png | complex | <table><tr><td rowspan="2">Clinical symptom</td><td rowspan="2">Symptom frequency level</td><td rowspan="2">Level definition</td><td rowspan="2">% per level</td><td>Mean utility (±SD)<sup>a</sup></td><td>Mean utility (±SD)<sup>a</sup></td><td rowspan="2">Difference between utilities, adjusted mean (±SD)<sup>a</sup></td><td rowspan="2">P value<sup>b</sup></td></tr><tr><td>EQ-5D</td><td>OAB-5D</td></tr><tr><td rowspan="5">Micturitions/24 h</td><td>1</td><td>< 8</td><td>21.2</td><td>0.85 (±0.21)</td><td>0.90 (±0.08)</td><td>0.046 (±0.396)</td><td><.0001</td></tr><tr><td>2</td><td>8 - < =10</td><td>30.7</td><td>0.84 (±0.20)</td><td>0.87 (±0.09)</td><td>0.025 (±0.458)</td><td><.0001</td></tr><tr><td>3</td><td>10 - < =12</td><td>22.7</td><td>0.82 (±0.21)</td><td>0.85 (±0.09)</td><td>0.015 (±0.401)</td><td>0.0205</td></tr><tr><td>4</td><td>12 - < = 14</td><td>13.2</td><td>0.80 (±0.22)</td><td>0.82 (±0.09)</td><td>0.007 (±0.325)</td><td>0.3073</td></tr><tr><td>5</td><td>> 14</td><td>12.3</td><td>0.78 (±0.23)</td><td>0.80 (±0.09)</td><td>0.007 (±0.331)</td><td>0.3477</td></tr><tr><td rowspan="5">Incontinence episodes/24 h</td><td>1</td><td>0</td><td>50.3</td><td>0.85 (±0.19)</td><td>0.89 (±0.08)</td><td>0.032 (±0.470)</td><td><.0001</td></tr><tr><td>2</td><td>> 0 - < = 1</td><td>19.7</td><td>0.82 (±0.20)</td><td>0.85 (±0.09)</td><td>0.019 (±0.320)</td><td>0.0006</td></tr><tr><td>3</td><td>1 - < =2</td><td>11.0</td><td>0.80 (±0.22)</td><td>0.83 (±0.09)</td><td>0.009 (±0.262)</td><td>0.1529</td></tr><tr><td>4</td><td>2 - < =3</td><td>6.9</td><td>0.78 (±0.23)</td><td>0.81 (±0.09)</td><td>0.006 (±0.229)</td><td>0.4157</td></tr><tr><td>5</td><td>> 3</td><td>12.2</td><td>0.76 (±0.26)</td><td>0.79 (±0.09)</td><td>0.004 (±0.290)</td><td>0.5353</td></tr></table> |
51522087880ff63769afc751981731ffd1c5eebe462d33b30ffe8783b4fe86fe.png | simple | <table><tr><td>Characteristic</td><td>Patients with asthma</td><td>Patients without asthma</td><td><i>P-</i>Value<sup>*</sup></td></tr><tr><td> </td><td>No. (%) (n = 137)</td><td>No. (%) (n = 336)</td><td> </td></tr><tr><td>Tachypnea</td><td>60/137 (44)</td><td>110/336 (33)</td><td>0.07</td></tr><tr><td>Tachycardia</td><td>88/137 (64)</td><td>213/336 (63)</td><td>0.86</td></tr><tr><td>Intensive care unit admission</td><td>37/133 (28)</td><td>108/321 (34)</td><td>0.31</td></tr><tr><td>Mechanical ventilation</td><td>16/127 (13)</td><td>69/301 (23)</td><td>0.02</td></tr><tr><td>Acute respiratory distress syndrome</td><td>9/129 (7)</td><td>38/292 (13)</td><td>0.10</td></tr><tr><td>Sepsis syndrome</td><td>7/128 (6)</td><td>31/291 (11)</td><td>0.12</td></tr><tr><td>Death</td><td>5/137 (4)</td><td>32/332 (10)</td><td>0.04</td></tr><tr><td>Influenza antiviral agent receipt</td><td> </td><td> </td><td> </td></tr><tr><td> Any during hospitalization</td><td>101/137 (74)</td><td>270/336 (80)</td><td>0.15</td></tr><tr><td> ≤ 2 days of illness onset</td><td>49/99 (50)</td><td>106/269 (39)</td><td>0.10</td></tr><tr><td> ≤ 2 days of admission</td><td>79/92 (86)</td><td>219/253 (87)</td><td>0.87</td></tr><tr><td> Median days from illness onset to antiviral initiation (range)</td><td>3 (0 – 18)</td><td>3 (0 – 32)</td><td>0.06</td></tr><tr><td>Other treatment</td><td> </td><td> </td><td> </td></tr><tr><td> Antibiotics</td><td>101/137 (74)</td><td>260/336 (77)</td><td>0.40</td></tr><tr><td> Steroids</td><td>83/137 (61)</td><td>96/336 (29)</td><td><0.01</td></tr></table> |
a8a53376ee360bdbe433773391f468260806deb9b21ae38fce19e8b478b5a6f0.png | complex | <table><tr><td rowspan="2">Films with Agarose Mass Concentrations (%)</td><td colspan="2">Areas of the Antibacterial Zone (A, mm<sup>2</sup>)</td></tr><tr><td><i>S. aureus</i></td><td><i>E. coli</i></td></tr><tr><td>0</td><td>89.29 ± 1.23</td><td>83.83 ± 0.95</td></tr><tr><td>20</td><td>78.89 ± 0.89</td><td>51.52 ± 2.11</td></tr><tr><td>40</td><td>71.64 ± 2.06</td><td>37.38 ± 1.58</td></tr><tr><td>60</td><td>70.56 ± 1.55</td><td>30.43 ± 0.73</td></tr><tr><td>80</td><td>22.09 ± 1.17</td><td>13.91 ± 1.35</td></tr></table> |
786ccd195fe00daf897097ccba89f66c0c3813940dd63c6bf1004ad2f57abc9f.png | simple | <table><tr><td>Treatment priority</td><td>Probability</td></tr><tr><td>0</td><td>0.1</td></tr><tr><td>1</td><td>0.2</td></tr><tr><td>2</td><td>0.3</td></tr><tr><td>3</td><td>0.4</td></tr></table> |
db0c71e8d308394f75e76a952c0b1d5812f0d0d0e0656a1b4bd9adbc4b4f8221.png | simple | <table><tr><td> </td><td> </td><td> </td><td>Areca nut chewers</td><td> </td></tr><tr><td> </td><td>Non chewers</td><td>Raw areca chewers</td><td>Areca with tobacco additives</td><td><i>P-value for trend</i></td></tr><tr><td>Total participants</td><td>722</td><td>231</td><td>117</td><td> </td></tr><tr><td>Central Obesity</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Obese, n(%)</td><td>231 (32.0)</td><td>94 (40.7)</td><td>57 (48.7)</td><td> </td></tr><tr><td>Odds Ratio (95% CI)<sup>a</sup></td><td>reference</td><td>1.46 (1.07-1.98)</td><td>2.02 (1.36-3.00)</td><td><0.001</td></tr><tr><td>Odds Ratio (95% CI)<sup>b</sup></td><td>reference</td><td>1.42 (0.97-2.06)</td><td>1.65 (1.03-2.63)</td><td>0.015</td></tr><tr><td>Raised blood pressure</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Raised BP cases, n(%)</td><td>234 (32.4)</td><td>89 (38.5)</td><td>58 (49.6)</td><td> </td></tr><tr><td>Odds Ratio (95% CI)<sup>a</sup></td><td>reference</td><td>1.31 (0.96-1.78)</td><td>2.05 (1.38-3.04)</td><td><0.001</td></tr><tr><td>Odds Ratio (95% CI)<sup>b</sup></td><td>reference</td><td>1.23 (0.89-1.70)</td><td>1.87 (1.25-2.81)</td><td>0.003</td></tr><tr><td>Reduced HDL</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Reduced HDL cases, n(%)</td><td>233 (32.8)</td><td>104 (45.0)</td><td>58 (50.0)</td><td> </td></tr><tr><td>Odds Ratio (95% CI)<sup>a</sup></td><td>reference</td><td>1.72 (1.27-2.33)</td><td>2.06 (1.39-3.06)</td><td><0.001</td></tr><tr><td>Odds Ratio (95% CI)<sup>b</sup></td><td>reference</td><td>1.55 (1.11-2.17)</td><td>1.66 (1.09-2.54)</td><td>0.003</td></tr><tr><td>Hypertrigylceridemia</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Hypertriglyceridemia cases, n(%)</td><td>150 (20.8)</td><td>72 (31.2)</td><td>41 (35.0)</td><td> </td></tr><tr><td>Odds Ratio (95% CI)<sup>a</sup></td><td>reference</td><td>1.73 (1.24-2.41)</td><td>2.06 (1.35-3.13)</td><td><0.001</td></tr><tr><td>Odds Ratio (95% CI)<sup>b</sup></td><td>reference</td><td>1.82 (1.28-2.59)</td><td>2.04 (1.32-3.16)</td><td><0.001</td></tr><tr><td>Hyperglycemia</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Hyperglycemia cases, n(%)</td><td>88 (12.2)</td><td>43 (18.6)</td><td>26 (22.2)</td><td> </td></tr><tr><td>Odds Ratio (95% CI)<sup>a</sup></td><td>reference</td><td>1.65 (1.11-2.46)</td><td>2.06 (1.26-3.36)</td><td>0.001</td></tr><tr><td>Odds Ratio (95% CI)<sup>b</sup></td><td>reference</td><td>1.48 (0.97-2.27)</td><td>1.80 (1.08-3.00)</td><td>0.011</td></tr></table> |
de442edeafce2ade21e8d4e0f48321b901f7c13a487b8ed3af6e0b0b71b2ced2.png | complex | <table><tr><td rowspan="2">Item</td><td rowspan="2">PTV location</td><td colspan="3">Median (range, min–max)</td><td colspan="3">p value<sup>*</sup></td></tr><tr><td>IMRT</td><td>PSPT</td><td>SSPT</td><td>IMRT vs PSPT</td><td>IMRT vs SSPT</td><td>PSPT vs SSPT</td></tr><tr><td rowspan="4">PTV CI</td><td>WV</td><td>0.85 (0.72–0.88)</td><td>0.70 (0.69–0.71)</td><td>0.91 (0.89–0.92)</td><td><0.05</td><td><0.05</td><td><0.05</td></tr><tr><td>PG</td><td>0.92 (0.87–0.92)</td><td>0.83 (0.62–0.87)</td><td>0.94 (0.90–0.90)</td><td><0.05</td><td><0.05</td><td><0.05</td></tr><tr><td>SS</td><td>0.89 (0.88–0.92)</td><td>0.74 (0.72–0.83)</td><td>0.92 (0.90–0.94)</td><td><0.05</td><td><0.05</td><td><0.05</td></tr><tr><td>BG</td><td>0.88 (0.86–0.91)</td><td>0.80 (0.74–0.82)</td><td>0.94 (0.93–0.95)</td><td><0.05</td><td><0.05</td><td><0.05</td></tr><tr><td rowspan="4">PTV GI</td><td>WV</td><td>3.30 (3.08–3.75)</td><td>1.90 (1.85–2.04)</td><td>2.12 (1.99–2.19)</td><td><0.05</td><td><0.05</td><td><0.05</td></tr><tr><td>PG</td><td>3.89 (3.47–4.62)</td><td>2.90 (2.50–3.25)</td><td>2.50 (2.36–3.34)</td><td><0.05</td><td><0.05</td><td>NS</td></tr><tr><td>SS</td><td>3.82 (3.71–4.14)</td><td>2.78 (2.64–3.27)</td><td>2.59 (2.48–2.87)</td><td><0.05</td><td><0.05</td><td>NS</td></tr><tr><td>BG</td><td>3.77 (3.46–4.23)</td><td>2.35 (2.18–2.57)</td><td>2.30 (2.23–2.60)</td><td><0.05</td><td><0.05</td><td>NS</td></tr><tr><td rowspan="4">PTV HI</td><td>WV</td><td>0.97 (0.96–0.98)</td><td>0.95 (0.94–0.95)</td><td>0.98 (0.98–0.98)</td><td><0.05</td><td><0.05</td><td><0.05</td></tr><tr><td>PG</td><td>0.96 (0.95–0.97)</td><td>0.97 (0.96–0.98)</td><td>0.98 (0.97–0.98)</td><td>NS</td><td><0.05</td><td>NS</td></tr><tr><td>SS</td><td>0.96 (0.95–0.97)</td><td>0.97 (0.96–0.98)</td><td>0.97 (0.95–0.98)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>BG</td><td>0.97 (0.97–0.98)</td><td>0.97 (0.97–0.98)</td><td>0.97 (0.97–0.98)</td><td>NS</td><td>NS</td><td><0.05</td></tr><tr><td rowspan="4">PTV PQI</td><td>WV</td><td>4.06 (3.82–4.73)</td><td>2.89 (2.75–3.11)</td><td>2.37 (2.23–2.46)</td><td>0.043</td><td>0.043</td><td>0.043</td></tr><tr><td>PG</td><td>4.39 (3.92–5.55)</td><td>3.38 (3.12–5.47)</td><td>2.70 (2.54–3.83)</td><td>0.043</td><td>0.043</td><td>0.043</td></tr><tr><td>SS</td><td>4.46 (4.26–4.88)</td><td>3.92 (3.62–4.05)</td><td>2.95 (2.88–3.12)</td><td>0.043</td><td>0.043</td><td>0.043</td></tr><tr><td>BG</td><td>4.45 (4.00–4.93)</td><td>3.01 (2.81–3.59)</td><td>2.49 (2.44–2.86)</td><td>0.043</td><td>0.043</td><td>0.043</td></tr></table> |
05f541c7bf6b72ccf440c906ae50f8c4f3a6d9f61f297eddcd32be944037302c.png | complex | <table><tr><td rowspan="2">Investigators</td><td rowspan="2">Year</td><td rowspan="2"><i>n</i></td><td rowspan="2">Study design</td><td rowspan="2">Stent type</td><td rowspan="2">AVF or AVG</td><td colspan="3">Primary patency (%)</td><td>(months)</td></tr><tr><td>3 M</td><td>6 M</td><td>12 M</td><td></td></tr><tr><td>Vogel and Parise [12]</td><td>2004</td><td>53</td><td>Retrospective</td><td>SMART</td><td>AVG</td><td>77 (61–93)</td><td>51 (34–67)</td><td>20 (12–27)</td><td>mean 8.9</td></tr><tr><td>Vogel and Parise [14]</td><td>2005</td><td>25</td><td>Prospective, Non-randomized</td><td>SMART</td><td>AVG</td><td>88 (75–100)</td><td>67 (48–86)</td><td>41 (21–61)</td><td>mean 8.2</td></tr><tr><td>Pan et al. [21]</td><td>2005</td><td>12</td><td>Retrospective</td><td>Wallstent, Jostent</td><td>AVF</td><td>92 ± 8</td><td>81 ± 12</td><td>31 ± 17</td><td>n/a</td></tr><tr><td>Liang et al. [22]</td><td>2006</td><td>23</td><td>Observational</td><td>Wallstent, nitinol</td><td>AVG</td><td>69 ± 9</td><td>41 ± 10</td><td>30 ± 10</td><td>n/a</td></tr><tr><td>Maya and Allon [23]</td><td>2006</td><td>14</td><td>Prospective, Non-randomized</td><td>Wallstent, SMART, Protégé, Fluency</td><td>AVG</td><td>48</td><td>19</td><td>n/a</td><td>median 2.8</td></tr><tr><td>Chan, M.R. et al. [24]</td><td>2008</td><td>211</td><td>Retrospective</td><td>SMART</td><td>AVG</td><td>69</td><td>25</td><td>n/a</td><td>median 4.4</td></tr><tr><td>Current study</td><td>2011</td><td>50</td><td>Prospective, Observational</td><td>SMART</td><td>Both</td><td>79 ± 9</td><td>51 ± 15</td><td>27 ± 16</td><td>median 3.8</td></tr><tr><td></td><td></td><td>25</td><td></td><td></td><td>AVF</td><td>80 ± 10</td><td>65 ± 16</td><td>32 ± 21</td><td>median 5.2</td></tr><tr><td></td><td></td><td>25</td><td></td><td></td><td>AVG</td><td>76 ± 15</td><td>28 ± 22</td><td>19 ± 17</td><td>median 2.9</td></tr></table> |
95ce0fe0534deaa8df2d31f782d20d2d7a785a20a32d7006d2dd29c117c92a90.png | complex | <table><tr><td rowspan="2">Component (g/kg)</td><td colspan="5">Group</td></tr><tr><td>NFD</td><td>HFD</td><td>GR</td><td>SV0.5</td><td>SV2</td></tr><tr><td> </td><td colspan="5"> </td></tr><tr><td>Casein</td><td>210</td><td>265</td><td>265</td><td>265</td><td>265</td></tr><tr><td>L-cystine</td><td>3</td><td>4</td><td>4</td><td>4</td><td>4</td></tr><tr><td>Corn starch</td><td>280</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td>Maltodextrin</td><td>50</td><td>160</td><td>150</td><td>155</td><td>140</td></tr><tr><td>Sucrose</td><td>325</td><td>90</td><td>90</td><td>90</td><td>90</td></tr><tr><td>Lard</td><td>20</td><td>310</td><td>310</td><td>310</td><td>310</td></tr><tr><td>Soybean oil</td><td>20</td><td>30</td><td>30</td><td>30</td><td>30</td></tr><tr><td>Cellulose</td><td>37.15</td><td>65.5</td><td>65.5</td><td>65.5</td><td>65.5</td></tr><tr><td>Mineral mixture<sup>1</sup></td><td>35</td><td>48</td><td>48</td><td>48</td><td>48</td></tr><tr><td>Vitamin mixture<sup>2</sup></td><td>15</td><td>21</td><td>21</td><td>21</td><td>21</td></tr><tr><td>Calcium phosphate, dibasic</td><td>2</td><td>3.4</td><td>3.4</td><td>3.4</td><td>3.4</td></tr><tr><td>Choline bitartrate</td><td>2.75</td><td>3</td><td>3</td><td>3</td><td>3</td></tr><tr><td>Yellow food color</td><td>0.1</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td>Blue food color</td><td>–</td><td>0.1</td><td>0.1</td><td>0.1</td><td>0.1</td></tr><tr><td><i>Garcinia cambogia</i> extract of 60% (–)-hydroxycitric acid</td><td>–</td><td>–</td><td>10</td><td>–</td><td>–</td></tr><tr><td><i>Solidago virgaurea</i> var. <i>g</i><i>igantea</i> 10% ethanol extract</td><td>–</td><td>–</td><td>–</td><td>5</td><td>20</td></tr><tr><td>Total (g)</td><td>1000</td><td>1000</td><td>1000</td><td>1000</td><td>1000</td></tr><tr><td>Energy (kcal/g)</td><td>3.7</td><td>5.1</td><td>5.1</td><td>5.1</td><td>5.1</td></tr><tr><td>Protein (% of kcal)</td><td>20.1</td><td>18.3</td><td>18.3</td><td>18.3</td><td>18.3</td></tr><tr><td>Carbohydrate (% of kcal)</td><td>69.8</td><td>21.4</td><td>21.4</td><td>21.4</td><td>21.4</td></tr><tr><td>Fat (% of kcal)</td><td>10.2</td><td>60.3</td><td>60.3</td><td>60.3</td><td>60.3</td></tr></table> |
653f30fde185a3d8fcb38684803ad41feb8b39c19c0bfd49e8267209eb3624e0.png | simple | <table><tr><td>Well</td><td>Biochemical test</td><td>Result</td></tr><tr><td>2</td><td>D-amygdalin (AMY)</td><td>−</td></tr><tr><td>4</td><td>Phosphatidylinositol phospholipase C (PIPLC)</td><td>−</td></tr><tr><td>5</td><td>D-xylose (dXYL)</td><td>−</td></tr><tr><td>8</td><td>Arginine dihydrolase 1 (ADH1)</td><td>+</td></tr><tr><td>9</td><td>Beta-galactosidase (BGAL)</td><td>−</td></tr><tr><td>11</td><td>Alpha-glucosidase (AGLU)</td><td>−</td></tr><tr><td>13</td><td>Ala-Phe-Pro arylamidase (APPA)</td><td>−</td></tr><tr><td>14</td><td>Cyclodextrin (CDEX)</td><td>−</td></tr><tr><td>15</td><td>L-aspartate arylamidase (AspA)</td><td>−</td></tr><tr><td>16</td><td>Beta galactopyranosidase (BGAR)</td><td>−</td></tr><tr><td>17</td><td>Alha-mannosidase (AMAN)</td><td>−</td></tr><tr><td>19</td><td>Phosphatase (PHOS)</td><td>+</td></tr><tr><td>20</td><td>Leucine arylamidase (LeuA)</td><td>+</td></tr><tr><td>23</td><td>L-proline arylamidase (ProA)</td><td>−</td></tr><tr><td>24</td><td>Beta glucuronidase (BGURr)</td><td>−</td></tr><tr><td>25</td><td>Alpha-galactosidase (AGAL)</td><td>−</td></tr><tr><td>26</td><td>L-pyrrolidonyl-arylamidase (PyrA)</td><td>−</td></tr><tr><td>27</td><td>Betaglucuronidase (BGUR)</td><td>−</td></tr><tr><td>28</td><td>Alanine arylamidase (AlaA)</td><td>−</td></tr><tr><td>29</td><td>Tyrosine arylamidase (TyrA)</td><td>−</td></tr><tr><td>30</td><td>D-sorbitol (dSOR)</td><td>−</td></tr><tr><td>31</td><td>Urease (URE)</td><td>−</td></tr><tr><td>32</td><td>Polymixin b resistance (POLYB)</td><td>+</td></tr><tr><td>37</td><td>D-galactose (dGAL)</td><td>+</td></tr><tr><td>38</td><td>D-ribose (dRIB)</td><td>+</td></tr><tr><td>39</td><td>L-lactate alkalinization (ILATk)</td><td>−</td></tr><tr><td>42</td><td>L-actose (LAC)</td><td>−</td></tr><tr><td>44</td><td>N-acetyl-d-glucosamine (NAG)</td><td>+</td></tr><tr><td>45</td><td>D-maltose (dMAL)</td><td>+</td></tr><tr><td>46</td><td>Bacitracin resistance (BACI)</td><td>+</td></tr><tr><td>47</td><td>Novobiocin resistance (NOVO)</td><td>+</td></tr><tr><td>50</td><td>Growth in 6.5% NaCl (NC 6.5)</td><td>+</td></tr><tr><td>52</td><td>D-mannitol (dMAN)</td><td>−</td></tr><tr><td>53</td><td>D-mannose (dMNE)</td><td>+</td></tr><tr><td>54</td><td>Methyl-B-D-glucopyranoside (MBdG)</td><td>+</td></tr><tr><td>56</td><td>Pullulan (PUL)</td><td>−</td></tr><tr><td>57</td><td>D-raffinose (dRAF)</td><td>−</td></tr><tr><td>58</td><td>O/129 resistance (comp. vibrio) (O129R)</td><td>−</td></tr><tr><td>59</td><td>Salicin (SAL)</td><td>−</td></tr><tr><td>60</td><td>Saccharose/sucrose (SAC)</td><td>+</td></tr><tr><td>62</td><td>D-trehalose (dTRE)</td><td>+</td></tr><tr><td>63</td><td>Arginine dihydrolase 2 (ADH2s)</td><td>+</td></tr><tr><td>64</td><td>Optochin resistance (OPTO)</td><td>+</td></tr></table> |
28f560057a2861f78f1a8b79025c678ae7d3fa3c58607e297f5fbb9e680df1c4.png | simple | <table><tr><td>Treatment</td><td>Number of pregnant females</td><td>Number of implantation sites</td><td>Number of viable fetuses</td><td>Total number of resorption sites</td></tr><tr><td>Group A</td><td>19/20</td><td>9.96 ± 1.83<sup>∗</sup></td><td>9.85 ± 1.67<sup>∗∗</sup></td><td>4<sup>∗</sup></td></tr><tr><td>Group B</td><td>18/20</td><td>9.19 ± 1.05<sup>∗</sup></td><td>8.73 ± 1.12<sup>∗∗</sup></td><td>5</td></tr><tr><td>Group C (control)</td><td>17/10</td><td>7.17 ± 0.60</td><td>6.23 ± 1.05</td><td>6</td></tr></table> |
5b34c90ff5aa4b6b2956a62677b323979a93676b54501641a95a15518a04efcd.png | complex | <table><tr><td rowspan="2">Characteristic</td><td rowspan="2">No. patients %</td><td colspan="2">Direction of PHB</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>CON, <i>n</i> = 112 (%)</td><td>ECC, <i>n</i> = 160 (%)</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td>0.812</td></tr><tr><td> Male</td><td>165 (60.7)</td><td>67 (59.8)</td><td>98 (61.3)</td><td></td></tr><tr><td> Female</td><td>107 (39.3)</td><td>45 (40.2)</td><td>62 (38.7)</td><td></td></tr><tr><td>Age(yrs)</td><td></td><td></td><td></td><td>0.965</td></tr><tr><td> ≤ 60</td><td>121 (44.5)</td><td>50 (44.6)</td><td>71 (44.4)</td><td></td></tr><tr><td> > 60</td><td>151 (55.5)</td><td>62 (55.4)</td><td>89 (55.6)</td><td></td></tr><tr><td>Location</td><td></td><td></td><td></td><td>0.816</td></tr><tr><td> Colon</td><td>141 (51.8)</td><td>59 (52.7)</td><td>82 (51.3)</td><td></td></tr><tr><td> Rectum</td><td>131 (48.2)</td><td>53 (47.3)</td><td>78 (48.7)</td><td></td></tr><tr><td>Differentiation</td><td></td><td></td><td></td><td>0.009</td></tr><tr><td> Well</td><td>120 (44.1)</td><td>60 (53.6)</td><td>60 (37.5)</td><td></td></tr><tr><td> Moderate</td><td>152 (55.9)</td><td>52 (46.4)</td><td>100 (62.5)</td><td></td></tr><tr><td>TNM tumor stage</td><td></td><td></td><td></td><td>0.000</td></tr><tr><td> I</td><td>32 (11.8)</td><td>22 (19.6)</td><td>10 (6.3)</td><td></td></tr><tr><td> II</td><td>125 (45.9)</td><td>56 (50.0)</td><td>69 (43.1)</td><td></td></tr><tr><td> III</td><td>109 (40.1)</td><td>33 (29.5)</td><td>76 (47.5)</td><td></td></tr><tr><td> IV</td><td>6 (2.2)</td><td>1 (0.9)</td><td>5 (3.1)</td><td></td></tr><tr><td>LN metastasis</td><td></td><td></td><td></td><td>0.024</td></tr><tr><td> Negative</td><td>191 (70.2)</td><td>87 (77.7)</td><td>104 (65.0)</td><td></td></tr><tr><td> Positive</td><td>81 (29.8)</td><td>25 (22.3)</td><td>56 (35.0)</td><td></td></tr><tr><td>Dis. Metastasis</td><td></td><td></td><td></td><td>0.000</td></tr><tr><td> Negative</td><td>167 (61.4)</td><td>101 (90.2)</td><td>66 (41.2)</td><td></td></tr><tr><td> Positive</td><td>105 (38.6)</td><td>11 (9.8)</td><td>94 (58.8)</td><td></td></tr><tr><td>Status</td><td></td><td></td><td></td><td>0.000</td></tr><tr><td> Censored</td><td>180 (66.2)</td><td>102 (91.1)</td><td>78 (48.7)</td><td></td></tr><tr><td> Death</td><td>92 (33.8)</td><td>10 (8.9)</td><td>82(51.3)</td><td></td></tr><tr><td>Survival time</td><td></td><td></td><td></td><td>0.000</td></tr><tr><td> ≤ 60 months</td><td>131 (48.2)</td><td>34 (30.4)</td><td>97 (60.6)</td><td></td></tr><tr><td> > 60 months</td><td>141 (51.8)</td><td>78 (69.6)</td><td>63 (39.4)</td><td></td></tr></table> |
f91a08b21b34cf6edbdbc038a6cab64d8eea43d43c3aec8a8c239c7969e3be68.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2">Unit</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>OR</td><td>95 % CI</td><td>P value</td><td>aOR</td><td>95 % CI</td><td>P value</td></tr><tr><td>Age</td><td>/5 years</td><td>1.01</td><td>0.99–1.03</td><td><i>0.14</i></td><td>–</td><td>–</td><td>–</td></tr><tr><td>Employed</td><td>Yes/no</td><td>1.45</td><td>0.99–2.12</td><td><i>0.05</i></td><td>–</td><td>–</td><td>–</td></tr><tr><td>Nationality</td><td>Ivoirian/non-ivoirian</td><td>1.33</td><td>0.75–2.36</td><td>0.32</td><td>–</td><td>–</td><td>–</td></tr><tr><td rowspan="2">Marital status</td><td>Married/single</td><td>1.64</td><td>1.10–2.42</td><td><i>0.03</i></td><td>–</td><td>–</td><td>–</td></tr><tr><td>Divorced/single</td><td>1.47</td><td>0.87–2.46</td><td></td><td>–</td><td>–</td><td></td></tr><tr><td rowspan="2">Living conditions</td><td>Moderate vs bad</td><td>1.74</td><td>0.98–3.11</td><td><i>0.002</i></td><td>1.91</td><td>1.04–3.51</td><td><i>0.003</i></td></tr><tr><td>Best vs bad</td><td>2.61</td><td>1.47–4.65</td><td></td><td>2.74</td><td>1.50–5.01</td><td></td></tr><tr><td>Smoker</td><td>Yes/no</td><td>1.65</td><td>0.46–5.94</td><td>0.43</td><td>–</td><td>–</td><td>–</td></tr><tr><td>Alcohol use</td><td>Yes/no</td><td>1.09</td><td>0.75–1.58</td><td>0.63</td><td>–</td><td>–</td><td>–</td></tr><tr><td>Contraceptive</td><td>Yes/no</td><td>0.93</td><td>0.46–1.86</td><td>0.86</td><td>–</td><td>–</td><td>–</td></tr><tr><td rowspan="2">WHO stage</td><td>2 vs 1</td><td>0.69</td><td>0.45–1.06</td><td><i>0.007</i></td><td>0.76</td><td>0.49–1.20</td><td><i>0.03</i></td></tr><tr><td>3 vs 1</td><td>0.32</td><td>0.14–0.70</td><td></td><td>0.37</td><td>0.17–0.82</td><td></td></tr><tr><td>HBP(≥140/90 mmHg)</td><td>Yes/no</td><td>8.62</td><td>3.38–22.00</td><td><i>0.0001</i></td><td>9.06</td><td>3.42–24.02</td><td><i>0.0001</i></td></tr><tr><td rowspan="2">CD4 count</td><td>350–500 vs ≤350</td><td>1.17</td><td>0.74-1.85</td><td>0.41</td><td>–</td><td>–</td><td>–</td></tr><tr><td>>500 vs ≤350/mm<sup>3</sup></td><td>1.37</td><td>0.85–2.20</td><td></td><td>–</td><td>–</td><td>–</td></tr><tr><td>Viral load</td><td>/1 log10 copies/ml</td><td>0.90</td><td>0.77–1.04</td><td><i>0.16</i></td><td>–</td><td>–</td><td>–</td></tr><tr><td>Hemoglobin ≥95 g/dL</td><td>Yes/no</td><td>3.12</td><td>1.65–5.90</td><td><i>0.0004</i></td><td>3.20</td><td>1.63–6.28</td><td><i>0.0007</i></td></tr><tr><td>HyperTG</td><td>Yes/no</td><td>3.32</td><td>0.73–15.00</td><td><i>0.11</i></td><td>–</td><td>–</td><td>–</td></tr><tr><td>LDL >4.13 mmol/L</td><td>Yes/no</td><td>1.67</td><td>1.00–2.79</td><td><i>0.04</i></td><td>–</td><td>–</td><td>–</td></tr><tr><td>Hyperglycemia</td><td>Yes/no</td><td>1.22</td><td>0.11–13.64</td><td>0.86</td><td>–</td><td>–</td><td>–</td></tr></table> |
72c7f6b6ac32e878f69a8a50dc6e9c7bf802d479c4c5d10d307c32910aa78e6a.png | simple | <table><tr><td>Gene</td><td>Nucleotide (%) <sup>a</sup></td><td>Amino acid (%) <sup>b</sup></td></tr><tr><td>Pol 1a</td><td>92.5</td><td>93.2</td></tr><tr><td>Pol 1ab</td><td>92.9</td><td>95.0</td></tr><tr><td>Spike</td><td>94.2</td><td>94.2</td></tr><tr><td>Envelope</td><td>87.2</td><td>91.0</td></tr><tr><td>Membrane</td><td>89.0</td><td>91.2</td></tr><tr><td>Nucleocapsid</td><td>86.7</td><td>87.1</td></tr></table> |
25e3c4fd49ab0dee174a7c6e6a0c715d87c2590dcf9f3919157724bdb70e4614.png | complex | <table><tr><td>Gene</td><td colspan="2">ORFs</td></tr><tr><td></td><td><i>A. nidulans</i></td><td><i>A. niger</i></td></tr><tr><td><i>palA</i></td><td>AN4351</td><td>119792</td></tr><tr><td><i>palB</i></td><td>AN0256</td><td>171058</td></tr><tr><td><i>palC</i></td><td>AN7560</td><td>48740</td></tr><tr><td><i>palF</i></td><td>AN1844</td><td>Not found*</td></tr><tr><td><i>palH</i></td><td>AN6886</td><td>120044</td></tr><tr><td><i>palI</i></td><td>AN4853</td><td>52449</td></tr><tr><td><i>vps32/snf7</i></td><td>AN4240</td><td>136905</td></tr><tr><td><i>pacC</i></td><td>AN2855</td><td>47049</td></tr></table> |
8615fa63829fdeeebffea6863d186df513926866db252804cc1ea4812cb1bd33.png | complex | <table><tr><td>Variable</td><td>Category</td><td>Frequency</td><td>Percent</td></tr><tr><td rowspan="2">Distance of health institution</td><td>< 1 h</td><td>100</td><td>13.9</td></tr><tr><td>≥ 1 h</td><td>622</td><td>86.2</td></tr><tr><td rowspan="2">Accessibility of pharmacy</td><td>Yes</td><td>198</td><td>27.4</td></tr><tr><td>No</td><td>524</td><td>72.6</td></tr><tr><td rowspan="2">Presence of health profession in the family</td><td>Yes</td><td>56</td><td>7.2</td></tr><tr><td>No</td><td>666</td><td>92.8</td></tr><tr><td rowspan="2">Presence of medication at home</td><td>Yes</td><td>105</td><td>14.5</td></tr><tr><td>No</td><td>617</td><td>85.5</td></tr><tr><td rowspan="2">Previous experience of SMP</td><td>Yes</td><td>402</td><td>55.7</td></tr><tr><td>No</td><td>320</td><td>44.3</td></tr><tr><td rowspan="2">Peer/family pressure</td><td>Yes</td><td>226</td><td>31.3</td></tr><tr><td>No</td><td>496</td><td>68.7</td></tr><tr><td rowspan="2">Member of health insurance</td><td>Yes</td><td>448</td><td>62.0</td></tr><tr><td>No</td><td>274</td><td>38.0</td></tr></table> |
03c299495a90bed54115414e0542c39453cf45612ec14c44eee15b9be1fda124.png | simple | <table><tr><td>Group</td><td>Dose (mg/kg)</td><td>Malondialdehyde (MDA, nmol/mg pro)</td><td>Superoxidase Dismutase (SOD, U/mg pro)</td><td>Total Antioxidant Capacity (T-AOC, U/mg pro)</td><td>Glutathione Peroxidase (GSH-PX, U/mg pro)</td><td>Catalase (CAT, U/mg pro)</td></tr><tr><td>NC</td><td></td><td>1.40 ± 0.18</td><td>383.26 ± 15.34</td><td>4.30 ± 0.23</td><td>213.22 ± 15.56</td><td>51.07 ± 3.78</td></tr><tr><td>MC</td><td></td><td>3.09 ± 0.18 **</td><td>280.17 ± 33.59 **</td><td>2.46 ± 0.22 **</td><td>147.68 ± 19.88 **</td><td>23.79 ± 3.91 **</td></tr><tr><td>LNT</td><td>1</td><td>2.06 ± 0.14 **<sup>##</sup></td><td>368.63 ± 27.40 <sup>##</sup></td><td>4.11 ± 0.14 <sup>##</sup></td><td>211.75 ± 22.31 <sup>##</sup></td><td>34.72 ± 3.13 **<sup>##</sup></td></tr><tr><td>AHG</td><td>1</td><td>2.81 ± 0.17 **<sup>#</sup></td><td>283.71 ± 13.60 **</td><td>2.89 ± 0.26 **</td><td>156.36 ± 25.89 **</td><td>24.60 ± 1.81 **</td></tr><tr><td></td><td>5</td><td>2.17 ± 0.13 **<sup>##</sup></td><td>322.16 ± 27.94 **</td><td>3.58 ± 0.25 <sup>##</sup></td><td>191.47 ± 18.69 *<sup>#</sup></td><td>43.43 ± 2.39 *<sup>##</sup></td></tr><tr><td></td><td>10</td><td>1.60 ± 0.10 <sup>##</sup></td><td>385.12 ± 25.21 <sup>##</sup></td><td>4.31 ± 0.15 <sup>##</sup></td><td>220.12 ± 30.57 <sup>##</sup></td><td>53.19 ± 2.73 <sup>##</sup></td></tr></table> |
9d9e0826f576bf5ba5c9748e209c71d6cc1e99400e4aa8633d844781b82cb060.png | complex | <table><tr><td></td><td>Total<i>N</i> = 171</td><td>Nonoperative treatment<i>N</i> = 102</td><td>Surgical treatment<i>N</i> = 69</td></tr><tr><td>Age (years)</td><td>49.7 ± 16.8 (52.0, 18–100)</td><td>48.3 ± 16.0 (52.0, 18–85)</td><td>51.7 ± 17.6 (52.0, 18–100)</td></tr><tr><td> 18–64</td><td>142 (83.0)</td><td>89 (87.3)</td><td>53 (76.8)</td></tr><tr><td> 65–74</td><td>22 (12.9)</td><td>10 (9.8)</td><td>12 (17.4)</td></tr><tr><td> 75–84</td><td>3 (1.8)</td><td>2 (2.0)</td><td>1 (1.4)</td></tr><tr><td> 85–94</td><td>3 (1.8)</td><td>1 (1.0)</td><td>2 (2.9)</td></tr><tr><td> ≥95</td><td>1 (0.6)</td><td>0 (0.0)</td><td>1 (1.4)</td></tr><tr><td colspan="4">Sex</td></tr><tr><td> Male</td><td>74 (43.3)</td><td>42 (41.2)</td><td>32 (46.4)</td></tr><tr><td> Female</td><td>97 (56.7)</td><td>60 (58.8)</td><td>37 (53.6)</td></tr><tr><td colspan="4">Marital status</td></tr><tr><td> Partner</td><td>129 (75.4)</td><td>77 (75.5)</td><td>52 (75.4)</td></tr><tr><td> No partner</td><td>30 (17.5)</td><td>19 (18.6)</td><td>11 (15.9)</td></tr><tr><td> Missing</td><td>12 (7.0)</td><td>6 (5.9)</td><td>6 (8.7)</td></tr><tr><td colspan="4">Educational level</td></tr><tr><td> Low education: high school or less</td><td>58 (33.9)</td><td>38 (37.3)</td><td>20 (29.0)</td></tr><tr><td> High education: additional education after high school</td><td>96 (56.1)</td><td>54 (52.9)</td><td>42 (60.9)</td></tr><tr><td> Missing</td><td>17 (9.9)</td><td>10 (9.8)</td><td>7 (10.1)</td></tr><tr><td colspan="4">Anatomical location of fracture</td></tr><tr><td> Toe</td><td>25 (14.6)</td><td>25 (24.5)</td><td>0 (0.0)</td></tr><tr><td> Ankle/foot</td><td>98 (57.3)</td><td>69 (67.6)</td><td>29 (42.0)</td></tr><tr><td> Lower leg/knee</td><td>20 (11.7)</td><td>7 (6.9)</td><td>13 (18.8)</td></tr><tr><td> Upper leg/hip</td><td>28 (16.4)</td><td>1 (1.0)</td><td>27 (39.1)</td></tr></table> |
248dba44029a1ef4d1324943741a5d0b02e173004bb575bf69ef79111dc6d9ad.png | simple | <table><tr><td>Name</td><td>Oligonucleotide (5′ to 3′)</td></tr><tr><td>C286A Forward</td><td>GCT TTG ATT CTT GCA GTT GCC ATT GCA GTC AAC AGT CG</td></tr><tr><td>C286A Reverse</td><td>CGA CTG TTG ACT GCA ATG GCA ACT GCA AGA ATC AAA GC</td></tr><tr><td>C286S Forward</td><td>GCT TTG ATT CTT GCA GTT TCC ATT GCA GTC AAC AGT CG</td></tr><tr><td>C286S Reverse</td><td>CGA CTG TTG ACT GCA ATG GAA ACT GCA AGA ATC AAA GC</td></tr><tr><td>C295A Forward</td><td>CAG TCG AAG AAG GGC TGG GCA GAA GAA AAA GC</td></tr><tr><td>C295A Reverse</td><td>GCT TTT TCT TCT GCC CAG CCC TTC TTC GAC TG</td></tr></table> |
520239de5e5c89054c779a6718794e8cbe7ecf573580402d5db8d4636ba9d434.png | simple | <table><tr><td> </td><td>Control</td><td>Low P</td><td>Moderate P</td><td>High P</td><td><i>P</i>-values</td></tr><tr><td>N resorption proficiency (mg g<sup>−1</sup>)</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>D. angustifolia</i></td><td>3.70(0.09)b</td><td>5.58(0.26)a</td><td>5.69(0.23)a</td><td>5.87(0.41)a</td><td>0.002</td></tr><tr><td><i>G. spiculosa</i></td><td>4.38(0.24)c</td><td>5.11(0.22)bc</td><td>6.00(0.23)ab</td><td>6.14(0.16)a</td><td>0.001</td></tr><tr><td>P resorption proficiency (mg g<sup>−1</sup>)</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>D. angustifolia</i></td><td>0.70(0.04)c</td><td>1.25(0.01)b</td><td>1.27(0.03)b</td><td>1.45(0.02)a</td><td><0.001</td></tr><tr><td><i>G. spiculosa</i></td><td>0.72(0.03)b</td><td>1.45(0.03)a</td><td>1.51(0.03)a</td><td>1.53(0.03)a</td><td><0.001</td></tr><tr><td>N resorption efficiency (%)</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>D. angustifolia</i></td><td>48.8(1.9)</td><td>47.0(1.1)</td><td>44.1(1.1)</td><td>48.1(1.7)</td><td>0.210</td></tr><tr><td><i>G. spiculosa</i></td><td>58.6(1.5)</td><td>58.6(1.4)</td><td>57.0(1.8)</td><td>58.0(2.6)</td><td>0.921</td></tr><tr><td>P resorption efficiency (%)</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>D. angustifolia</i></td><td>57.9(1.6)a</td><td>48.0(2.7)b</td><td>46.3(0.6)b</td><td>50.7(0.6)ab</td><td>0.004</td></tr><tr><td><i>G. spiculosa</i></td><td>65.6(1.5)a</td><td>49.5(1.8)b</td><td>48.5(0.6)b</td><td>48.8(1.0)b</td><td><0.001</td></tr></table> |
16bfe9444a927620dd680b9f6cdb17bdd38880373827044e5f088496525fa5c1.png | complex | <table><tr><td rowspan="3">Race/ethnicity</td><td colspan="5">All ages</td><td colspan="5">Age ≥ 18 years</td></tr><tr><td colspan="2">Prevalence</td><td colspan="3">Adjusted odds ratio<sup>1</sup></td><td colspan="2">Prevalence</td><td colspan="3">Adjusted odds ratio<sup>2</sup></td></tr><tr><td>%</td><td>SE</td><td>OR</td><td colspan="2">95% CI</td><td>%</td><td>SE</td><td>OR</td><td colspan="2">95% CI</td></tr><tr><td>Non-Hispanic White</td><td>8.22</td><td>0.03</td><td>1.00</td><td colspan="2">Reference</td><td>8.45</td><td>0.03</td><td>1.00</td><td colspan="2">Reference</td></tr><tr><td>Mexican</td><td>22.69</td><td>0.16</td><td>1.70</td><td>1.66</td><td>1.75</td><td>24.69</td><td>0.17</td><td>1.64</td><td>1.60</td><td>1.69</td></tr><tr><td>Puerto Rican</td><td>10.14</td><td>0.24</td><td>0.78</td><td>0.73</td><td>0.82</td><td>11.32</td><td>0.27</td><td>0.76</td><td>0.72</td><td>0.81</td></tr><tr><td>Cuban</td><td>12.61</td><td>0.39</td><td>1.16</td><td>1.06</td><td>1.27</td><td>12.90</td><td>0.41</td><td>1.17</td><td>1.06</td><td>1.28</td></tr><tr><td>Central/South American</td><td>21.98</td><td>0.34</td><td>1.42</td><td>1.35</td><td>1.50</td><td>23.62</td><td>0.37</td><td>1.33</td><td>1.26</td><td>1.40</td></tr><tr><td>Other Hispanics</td><td>12.75</td><td>0.33</td><td>1.11</td><td>1.04</td><td>1.20</td><td>13.80</td><td>0.36</td><td>1.11</td><td>1.03</td><td>1.19</td></tr><tr><td>Non-Hispanic Black</td><td>13.11</td><td>0.08</td><td>1.07</td><td>1.05</td><td>1.09</td><td>14.01</td><td>0.09</td><td>1.05</td><td>1.03</td><td>1.07</td></tr><tr><td>American Indian/AN</td><td>20.01</td><td>0.34</td><td>1.84</td><td>1.75</td><td>1.93</td><td>20.84</td><td>0.36</td><td>1.84</td><td>1.75</td><td>1.94</td></tr><tr><td>Asian Indian</td><td>13.14</td><td>0.57</td><td>1.23</td><td>1.09</td><td>1.38</td><td>13.84</td><td>0.61</td><td>1.39</td><td>1.24</td><td>1.57</td></tr><tr><td>Chinese</td><td>7.56</td><td>0.32</td><td>0.78</td><td>0.69</td><td>0.87</td><td>7.83</td><td>0.34</td><td>0.83</td><td>0.74</td><td>0.94</td></tr><tr><td>Filipino</td><td>7.81</td><td>0.34</td><td>0.80</td><td>0.72</td><td>0.89</td><td>7.95</td><td>0.35</td><td>0.86</td><td>0.77</td><td>0.97</td></tr><tr><td>Japanese</td><td>2.28</td><td>0.26</td><td>0.47</td><td>0.35</td><td>0.63</td><td>2.26</td><td>0.26</td><td>0.50</td><td>0.37</td><td>0.66</td></tr><tr><td>Korean</td><td>13.31</td><td>0.67</td><td>1.12</td><td>0.96</td><td>1.29</td><td>13.73</td><td>0.70</td><td>1.23</td><td>1.06</td><td>1.42</td></tr><tr><td>Vietnamese</td><td>10.47</td><td>0.51</td><td>0.63</td><td>0.56</td><td>0.72</td><td>10.59</td><td>0.53</td><td>0.65</td><td>0.57</td><td>0.73</td></tr><tr><td>Cambodian</td><td>13.97</td><td>1.33</td><td>0.63</td><td>0.49</td><td>0.82</td><td>14.64</td><td>1.44</td><td>0.63</td><td>0.49</td><td>0.82</td></tr><tr><td>Bangladeshi</td><td>20.09</td><td>3.37</td><td>0.98</td><td>0.60</td><td>1.60</td><td>20.92</td><td>3.68</td><td>1.05</td><td>0.63</td><td>1.76</td></tr><tr><td>Pakistani</td><td>25.13</td><td>1.98</td><td>1.60</td><td>1.23</td><td>2.08</td><td>27.30</td><td>2.17</td><td>1.98</td><td>1.51</td><td>2.59</td></tr><tr><td>Hmong</td><td>10.43</td><td>1.59</td><td>0.35</td><td>0.24</td><td>0.51</td><td>10.06</td><td>1.68</td><td>0.36</td><td>0.25</td><td>0.53</td></tr><tr><td>Laotian</td><td>13.45</td><td>1.60</td><td>0.65</td><td>0.48</td><td>0.88</td><td>14.41</td><td>1.71</td><td>0.65</td><td>0.48</td><td>0.89</td></tr><tr><td>Thai</td><td>8.95</td><td>1.62</td><td>0.46</td><td>0.28</td><td>0.74</td><td>9.47</td><td>1.72</td><td>0.47</td><td>0.29</td><td>0.77</td></tr><tr><td>Other Asians</td><td>12.45</td><td>0.92</td><td>0.80</td><td>0.66</td><td>0.96</td><td>13.40</td><td>1.01</td><td>0.80</td><td>0.66</td><td>0.96</td></tr><tr><td>Native Hawaiian</td><td>9.96</td><td>1.13</td><td>0.91</td><td>0.67</td><td>1.24</td><td>10.55</td><td>1.20</td><td>0.86</td><td>0.62</td><td>1.17</td></tr><tr><td>Samoan</td><td>14.36</td><td>2.48</td><td>1.12</td><td>0.76</td><td>1.64</td><td>14.79</td><td>2.61</td><td>1.08</td><td>0.72</td><td>1.63</td></tr><tr><td>Guamanian</td><td>8.82</td><td>2.37</td><td>1.00</td><td>0.58</td><td>1.73</td><td>8.99</td><td>2.46</td><td>0.84</td><td>0.47</td><td>1.48</td></tr><tr><td>Other Pacific Islanders</td><td>25.86</td><td>3.50</td><td>1.47</td><td>0.92</td><td>2.35</td><td>25.94</td><td>3.64</td><td>1.33</td><td>0.82</td><td>2.16</td></tr><tr><td>All other groups</td><td>14.29</td><td>0.22</td><td>1.19</td><td>1.14</td><td>1.24</td><td>16.61</td><td>0.26</td><td>1.20</td><td>1.15</td><td>1.25</td></tr></table> |
45f2206c23f88470caf964c5ab8f90a529a8ded9be65d0b6c638ae7913991304.png | simple | <table><tr><td>Domain 1: Skills for Chronic Condition Self-Management</td><td>Domain 2: Skills for Self-Advocacy and Health Care Utilization</td></tr><tr><td>Do you fill a prescription if you need to?</td><td>Do you fill out the medical history form, including a list of your allergies?</td></tr><tr><td>Do you know what to do if you are having a bad reaction to your medications?</td><td>Do you keep a calendar or list of medical and other appointments?</td></tr><tr><td>Do you pay or arrange payments for your medications?</td><td>Do you tell the doctor or nurse what you are feeling?</td></tr><tr><td>Do you take medications correctly and on your own?</td><td>Do you ask questions of the doctor, nurse or clinic staff?</td></tr><tr><td>Do you reorder medications before they run out?</td><td>Do you make a list of questions before the doctor’s visit?</td></tr><tr><td>Do you call the suppliers when there is a problem with the equipment?</td><td>Do you request the accommodations & support you need at school or work?</td></tr><tr><td>Do you order medical equipment before they run out?</td><td>Do you apply for a job or work or vocational services?</td></tr><tr><td>Do you arrange payment for the medical equipment and supplies?</td><td>Do you get financial help with school or work?</td></tr><tr><td>Do you call the doctor’s office to make an appointment?</td><td>Do you help plan or prepare meals/food?</td></tr><tr><td>Do you call the doctor about unusual changes in your health?</td><td>Do you help keep home/room clean or clean up after meals?</td></tr><tr><td>Do you apply for health insurance if you lose your current coverage?</td><td>Do you use neighborhood stores and services?</td></tr><tr><td>Do you know what your health insurance covers?</td><td>Do you use community support services or advocacy services when you need them?</td></tr><tr><td>Do you manage your money and budget household expenses?</td><td></td></tr><tr><td>Do you reorder medications before they run out?</td><td></td></tr></table> |
123277ffb8f49456e8c3d8b88a4129ef38aa88f911bd883425bea1407ec8b441.png | simple | <table><tr><td>Bachaur</td><td>Gangatiri</td><td>Kherigarh</td><td>Kenkatha</td><td>Ponwar</td><td>Shahabadi</td><td>Purnea</td><td>Mewati</td><td>Gaolao</td><td>Hariana</td><td>Ongole</td><td></td></tr><tr><td>0.000</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Bachaur</td></tr><tr><td>0.008</td><td>0.000</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Gangatiri</td></tr><tr><td>0.009</td><td>0.010</td><td>0.000</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Kherigarh</td></tr><tr><td>0.008</td><td>0.009</td><td>0.009</td><td>0.000</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Kenkatha</td></tr><tr><td>0.010</td><td>0.012</td><td>0.009</td><td>0.007</td><td>0.000</td><td></td><td></td><td></td><td></td><td></td><td></td><td>Ponwar</td></tr><tr><td>0.032</td><td>0.031</td><td>0.032</td><td>0.034</td><td>0.032</td><td>0.000</td><td></td><td></td><td></td><td></td><td></td><td>Shahabadi</td></tr><tr><td>0.032</td><td>0.033</td><td>0.032</td><td>0.032</td><td>0.031</td><td>0.033</td><td>0.000</td><td></td><td></td><td></td><td></td><td>Purnea</td></tr><tr><td>0.101</td><td>0.101</td><td>0.101</td><td>0.091</td><td>0.097</td><td>0.081</td><td>0.094</td><td>0.000</td><td></td><td></td><td></td><td>Mewati</td></tr><tr><td>0.052</td><td>0.057</td><td>0.054</td><td>0.050</td><td>0.051</td><td>0.042</td><td>0.050</td><td>0.062</td><td>0.000</td><td></td><td></td><td>Gaolao</td></tr><tr><td>0.105</td><td>0.106</td><td>0.106</td><td>0.102</td><td>0.106</td><td>0.091</td><td>0.102</td><td>0.087</td><td>0.068</td><td>0.000</td><td></td><td>Hariana</td></tr><tr><td>0.212</td><td>0.210</td><td>0.213</td><td>0.213</td><td>0.212</td><td>0.203</td><td>0.206</td><td>0.257</td><td>0.201</td><td>0.261</td><td>0.000</td><td>Ongole</td></tr></table> |
fdb4d528ec4a2981331f92932d96daf8f417077f29d2a0e9f9f3d570a8070b95.png | complex | <table><tr><td>Cytokines</td><td>Cellular type</td><td>Production type</td><td>Median</td><td>Minimum</td><td>Maximum</td><td>1th quartile</td><td>3th quartile</td></tr><tr><td rowspan="4">TNF-α</td><td rowspan="2">Monocyte</td><td>Basal</td><td>0.0</td><td>0.0</td><td>24.4</td><td>0.0</td><td>0.0</td></tr><tr><td>LPS</td><td>246.6</td><td>34.5</td><td>1486.5</td><td>182.8</td><td>97.6</td></tr><tr><td rowspan="2">PBMC</td><td>Basal</td><td>2.5</td><td>0.0</td><td>19.0</td><td>0.0</td><td>10.4</td></tr><tr><td>LPS</td><td>341.6</td><td>70.8</td><td>1165.8</td><td>270.3</td><td>728.7</td></tr><tr><td rowspan="4">IL-6</td><td rowspan="2">Monocyte</td><td>Basal</td><td>2.6</td><td>0.0</td><td>68.1</td><td>0.0</td><td>8.9</td></tr><tr><td>LPS</td><td>175.8</td><td>50.5</td><td>282.0</td><td>138.3</td><td>186.1</td></tr><tr><td rowspan="2">PBMC</td><td>Basal</td><td>0.0</td><td>0.0</td><td>123.2</td><td>0.0</td><td>6.4</td></tr><tr><td>LPS</td><td>139.6</td><td>0.0</td><td>266.6</td><td>116.7</td><td>218.2</td></tr><tr><td rowspan="4">IL-1β</td><td rowspan="2">Monocyte</td><td>Basal</td><td>0.0</td><td>0.0</td><td>0.1</td><td>0.0</td><td>0.0</td></tr><tr><td>LPS</td><td>69.6</td><td>15.3</td><td>173.7</td><td>37.5</td><td>173.7</td></tr><tr><td rowspan="2">PBMC</td><td>Basal</td><td>0.0</td><td>0.0</td><td>1.0</td><td>0.0</td><td>0.0</td></tr><tr><td>LPS</td><td>17.9</td><td>0.0</td><td>113.8</td><td>0.0</td><td>31.5</td></tr><tr><td rowspan="4">CXCL-8</td><td rowspan="2">Monocyte</td><td>Basal</td><td>173.1</td><td>48.7</td><td>288.8</td><td>130</td><td>240.1</td></tr><tr><td>LPS</td><td>279.5</td><td>177.3</td><td>297.7</td><td>252.3</td><td>290.9</td></tr><tr><td rowspan="2">PBMC</td><td>Basal</td><td>144.8</td><td>64.0</td><td>215.1</td><td>118.6</td><td>185.4</td></tr><tr><td>LPS</td><td>229.8</td><td>218.4</td><td>305.4</td><td>219.8</td><td>303.0</td></tr><tr><td rowspan="4">MCP-1</td><td rowspan="2">Monocyte</td><td>Basal</td><td>6.4</td><td>0.0</td><td>190.5</td><td>0.0</td><td>39.8</td></tr><tr><td>LPS</td><td>48.2</td><td>0.0</td><td>241.2</td><td>0.0</td><td>148.4</td></tr><tr><td rowspan="2">PBMC</td><td>Basal</td><td>25.9</td><td>5.9</td><td>412.4</td><td>12.2</td><td>97.5</td></tr><tr><td>LPS</td><td>85.0</td><td>0.0</td><td>415.3</td><td>29.1</td><td>172.7</td></tr><tr><td rowspan="4">TGF-β</td><td rowspan="2">Monocyte</td><td>Basal</td><td>621.2</td><td>621.1</td><td>621.4</td><td>621.1</td><td>621.3</td></tr><tr><td>LPS</td><td>621.2</td><td>621.0</td><td>621.6</td><td>621.1</td><td>621.2</td></tr><tr><td rowspan="2">PBMC</td><td>Basal</td><td>51.7</td><td>8.9</td><td>220.5</td><td>25.8</td><td>130.9</td></tr><tr><td>LPS</td><td>567.2</td><td>110.2</td><td>690.5</td><td>223.1</td><td>587.9</td></tr><tr><td rowspan="4">IL-10</td><td rowspan="2">Monocyte</td><td>Basal</td><td>0.0</td><td>0.0</td><td>5.9</td><td>0.0</td><td>0.0</td></tr><tr><td>LPS</td><td>149.3</td><td>33.8</td><td>654.8</td><td>55.4</td><td>323.8</td></tr><tr><td rowspan="2">PBMC</td><td>Basal</td><td>0.0</td><td>0.0</td><td>11.8</td><td>0.0</td><td>0.0</td></tr><tr><td>LPS</td><td>129.1</td><td>47.0</td><td>274.1</td><td>102.7</td><td>195.6</td></tr></table> |
1bceb9c65aca6c4b40f8f884637ccfca2bb7f31e020e33bc6cdaf25ddd5fb5d5.png | complex | <table><tr><td colspan="2">Simulation set up</td><td>Time</td><td>Memory</td></tr><tr><td>Genome Simulation<sup>a</sup></td><td>One subclone with 100 SVs</td><td>0.98 h</td><td>9.1 Gb</td></tr><tr><td></td><td>One subclone with 200 SVs</td><td>1.34 h</td><td>9.9 Gb</td></tr><tr><td></td><td>One subclone with 300 SVs</td><td>1.73 h</td><td>11.6 Gb</td></tr><tr><td></td><td>Two subclones with 100 SVs</td><td>1.03 h</td><td>9.5 Gb</td></tr><tr><td></td><td>Three subclones with 100 SVs</td><td>1.28 h</td><td>10.2 Gb</td></tr><tr><td>Read generation<sup>b</sup></td><td>Mixing reads from 2 subclones and 1 normal genome (392 M reads)</td><td>2.76 h</td><td>6.2 Gb</td></tr><tr><td></td><td>GC-bias Introduction (130 M reads)</td><td>4.10 h</td><td>2.5 GB</td></tr></table> |
596ca40a7837d91be1aaa1e231b1fc35b77532823ac3ce176b34d3186cf1c84f.png | simple | <table><tr><td>Compound</td><td><i>k</i><sub>α</sub></td><td><i>k</i><sub>β</sub></td><td><i>k</i><sub>γ</sub></td><td><i>N</i><sub>α</sub></td><td><i>N</i><sub>β</sub></td><td><i>N</i><sub>1,9</sub></td><td><i>N</i><sub>2,8</sub></td><td><i>N</i><sub>o</sub></td><td><i>N</i><sub>m</sub></td><td><i>N</i><sub>p</sub></td><td><i>N</i></td><td><i>E</i><sub>HOMO</sub></td><td><i>E</i><sub>LUMO</sub></td><td>Δ<i>E</i><sub>HOMO-LUMO</sub></td><td><i>D</i></td></tr><tr><td>Penta-CDDs</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1,2,3,4,6</td><td>4.48 × 10<sup>−14</sup></td><td>9.83 × 10<sup>−13</sup></td><td>5.07 × 10<sup>−12</sup></td><td>3</td><td>2</td><td>1</td><td>1</td><td>3</td><td>2</td><td>1</td><td>5</td><td>−0.267</td><td>−0.028</td><td>0.240</td><td>3.14</td></tr><tr><td>1,2,3,4,7</td><td>4.09 × 10<sup>−14</sup></td><td>6.84 × 10<sup>−13</sup></td><td>7.14 × 10<sup>−12</sup></td><td>2</td><td>3</td><td>1</td><td>1</td><td>3</td><td>2</td><td>1</td><td>5</td><td>−0.265</td><td>−0.028</td><td>0.237</td><td>1.70</td></tr><tr><td>1,2,3,6,7</td><td>1.34 × 10<sup>−13</sup></td><td>2.34 × 10<sup>−13</sup></td><td>6.10 × 10<sup>−12</sup></td><td>2</td><td>3</td><td>1</td><td>1</td><td>3</td><td>1</td><td>0</td><td>5</td><td>−0.266</td><td>−0.028</td><td>0.238</td><td>1.51</td></tr><tr><td>1,2,3,6,8</td><td>2.05 × 10<sup>−13</sup></td><td>1.09 × 10<sup>−12</sup></td><td>7.71 × 10<sup>−12</sup></td><td>2</td><td>3</td><td>1</td><td>2</td><td>2</td><td>2</td><td>0</td><td>5</td><td>−0.267</td><td>−0.029</td><td>0.238</td><td>1.12</td></tr><tr><td>1,2,3,6,9</td><td>1.10 × 10<sup>−13</sup></td><td>6.93 × 10<sup>−13</sup></td><td>4.24 × 10<sup>−12</sup></td><td>3</td><td>2</td><td>2</td><td>1</td><td>2</td><td>1</td><td>1</td><td>5</td><td>−0.269</td><td>−0.028</td><td>0.240</td><td>2.49</td></tr><tr><td>1,2,3,7,8</td><td>1.49 × 10<sup>−13</sup></td><td>1.24 × 10<sup>−15</sup></td><td>5.21 × 10<sup>−12</sup></td><td>1</td><td>4</td><td>1</td><td>2</td><td>3</td><td>1</td><td>0</td><td>5</td><td>−0.265</td><td>−0.028</td><td>0.237</td><td>1.06</td></tr><tr><td>1,2,3,7,9</td><td>1.66 × 10<sup>−13</sup></td><td>7.56 × 10<sup>−13</sup></td><td>6.46 × 10<sup>−12</sup></td><td>2</td><td>3</td><td>2</td><td>1</td><td>2</td><td>2</td><td>0</td><td>5</td><td>−0.267</td><td>−0.029</td><td>0.238</td><td>1.84</td></tr><tr><td>1,2,3,8,9</td><td>1.01 × 10<sup>−13</sup></td><td>5.26 × 10<sup>−13</sup></td><td>6.51 × 10<sup>−12</sup></td><td>2</td><td>3</td><td>2</td><td>2</td><td>3</td><td>1</td><td>0</td><td>5</td><td>−0.266</td><td>−0.028</td><td>0.238</td><td>3.18</td></tr><tr><td>1,2,4,6,7</td><td>3.66 × 10<sup>−14</sup></td><td>1.98 × 10<sup>−12</sup></td><td>5.72 × 10<sup>−12</sup></td><td>3</td><td>2</td><td>1</td><td>1</td><td>2</td><td>1</td><td>1</td><td>5</td><td>−0.268</td><td>−0.030</td><td>0.239</td><td>1.39</td></tr><tr><td>1,2,4,6,8</td><td>2.38 × 10<sup>−13</sup></td><td>2.50 × 10<sup>−12</sup></td><td>1.17 × 10<sup>−11</sup></td><td>3</td><td>2</td><td>1</td><td>2</td><td>1</td><td>2</td><td>1</td><td>5</td><td>−0.267</td><td>−0.029</td><td>0.238</td><td>1.12</td></tr><tr><td>1,2,4,6,9</td><td>7.33 × 10<sup>−16</sup></td><td>1.56 × 10<sup>−12</sup></td><td>4.79 × 10<sup>−12</sup></td><td>4</td><td>1</td><td>2</td><td>1</td><td>1</td><td>1</td><td>2</td><td>5</td><td>−0.271</td><td>−0.030</td><td>0.241</td><td>1.51</td></tr><tr><td>1,2,4,7,8</td><td>7.27 × 10<sup>−14</sup></td><td>5.78 × 10<sup>−13</sup></td><td>4.89 × 10<sup>−12</sup></td><td>2</td><td>3</td><td>1</td><td>2</td><td>2</td><td>1</td><td>1</td><td>5</td><td>−0.267</td><td>−0.030</td><td>0.238</td><td>0.93</td></tr><tr><td>1,2,4,7,9</td><td>8.16 × 10<sup>−14</sup></td><td>2.05 × 10<sup>−12</sup></td><td>7.50 × 10<sup>−12</sup></td><td>3</td><td>2</td><td>2</td><td>1</td><td>1</td><td>2</td><td>1</td><td>5</td><td>−0.270</td><td>−0.031</td><td>0.239</td><td>1.02</td></tr><tr><td>1,2,4,8,9</td><td>3.71 × 10<sup>−14</sup></td><td>1.12 × 10<sup>−12</sup></td><td>6.03 × 10<sup>−12</sup></td><td>3</td><td>2</td><td>2</td><td>2</td><td>2</td><td>1</td><td>1</td><td>5</td><td>−0.268</td><td>−0.030</td><td>0.238</td><td>2.41</td></tr><tr><td>Hexa-CDDs</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1,2,3,4,6,7</td><td>1.60 × 10<sup>−14</sup></td><td>2.54 × 10<sup>−13</sup></td><td>6.16 × 10<sup>−12</sup></td><td>3</td><td>3</td><td>1</td><td>1</td><td>4</td><td>2</td><td>1</td><td>6</td><td>−0.270</td><td>−0.033</td><td>0.237</td><td>2.26</td></tr><tr><td>1,2,3,4,6,8</td><td>1.10 × 10<sup>−13</sup></td><td>8.46 × 10<sup>−13</sup></td><td>7.87 × 10<sup>−12</sup></td><td>3</td><td>3</td><td>1</td><td>2</td><td>3</td><td>3</td><td>1</td><td>6</td><td>−0.271</td><td>−0.034</td><td>0.237</td><td>1.19</td></tr><tr><td>1,2,3,4,6,9</td><td>7.74 × 10<sup>−16</sup></td><td>7.82 × 10<sup>−13</sup></td><td>4.45 × 10<sup>−12</sup></td><td>4</td><td>2</td><td>2</td><td>1</td><td>3</td><td>2</td><td>2</td><td>6</td><td>−0.273</td><td>−0.034</td><td>0.239</td><td>2.36</td></tr><tr><td>1,2,3,4,7,8</td><td>6.63 × 10<sup>−14</sup></td><td>9.51 × 10<sup>−16</sup></td><td>5.04 × 10<sup>−12</sup></td><td>2</td><td>4</td><td>1</td><td>2</td><td>4</td><td>2</td><td>1</td><td>6</td><td>−0.269</td><td>−0.033</td><td>0.236</td><td>0.19</td></tr><tr><td>1,2,3,6,7,8</td><td>2.56 × 10<sup>−13</sup></td><td>1.15 × 10<sup>−15</sup></td><td>6.27 × 10<sup>−12</sup></td><td>2</td><td>4</td><td>1</td><td>2</td><td>4</td><td>2</td><td>0</td><td>6</td><td>−0.270</td><td>−0.033</td><td>0.237</td><td>0.00</td></tr><tr><td>1,2,3,6,7,9</td><td>1.07 × 10<sup>−13</sup></td><td>6.23 × 10<sup>−13</sup></td><td>6.05 × 10<sup>−12</sup></td><td>3</td><td>3</td><td>2</td><td>1</td><td>3</td><td>2</td><td>1</td><td>6</td><td>−0.272</td><td>−0.034</td><td>0.237</td><td>0.97</td></tr><tr><td>1,2,3,6,8,9</td><td>1.20 × 10<sup>−13</sup></td><td>5.56 × 10<sup>−13</sup></td><td>6.32 × 10<sup>−12</sup></td><td>3</td><td>3</td><td>2</td><td>2</td><td>3</td><td>2</td><td>1</td><td>6</td><td>−0.272</td><td>−0.034</td><td>0.237</td><td>1.71</td></tr><tr><td>1,2,3,7,8,9</td><td>1.46 × 10<sup>−13</sup></td><td>1.13 × 10<sup>−15</sup></td><td>6.19 × 10<sup>−12</sup></td><td>2</td><td>4</td><td>2</td><td>2</td><td>4</td><td>2</td><td>0</td><td>6</td><td>−0.269</td><td>−0.033</td><td>0.237</td><td>2.01</td></tr><tr><td>1,2,4,6,7,9</td><td>6.30 × 10<sup>−16</sup></td><td>6.19 × 10<sup>−13</sup></td><td>6.07 × 10<sup>−12</sup></td><td>4</td><td>2</td><td>2</td><td>1</td><td>2</td><td>2</td><td>2</td><td>6</td><td>−0.274</td><td>−0.036</td><td>0.238</td><td>0.00</td></tr><tr><td>1,2,4,6,8,9</td><td>6.55 × 10<sup>−16</sup></td><td>1.22 × 10<sup>−12</sup></td><td>5.86 × 10<sup>−12</sup></td><td>4</td><td>2</td><td>2</td><td>2</td><td>2</td><td>2</td><td>2</td><td>6</td><td>−0.274</td><td>−0.036</td><td>0.238</td><td>1.02</td></tr><tr><td>Hepta-CDDs</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1,2,3,4,6,7,8</td><td>7.21 × 10<sup>−14</sup></td><td>9.28 × 10<sup>−16</sup></td><td>5.71 × 10<sup>−12</sup></td><td>3</td><td>4</td><td>1</td><td>2</td><td>5</td><td>3</td><td>1</td><td>7</td><td>−0.273</td><td>−0.038</td><td>0.236</td><td>0.95</td></tr><tr><td>1,2,3,4,6,7,9</td><td>6.81 × 10<sup>−16</sup></td><td>4.15 × 10<sup>−13</sup></td><td>5.41 × 10<sup>−12</sup></td><td>4</td><td>3</td><td>2</td><td>1</td><td>4</td><td>3</td><td>2</td><td>7</td><td>−0.276</td><td>−0.039</td><td>0.237</td><td>1.06</td></tr><tr><td>OCDD</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1,2,3,4,6,7,8,9</td><td>7.95 × 10<sup>−16</sup></td><td>7.51 × 10<sup>−16</sup></td><td>5.98 × 10<sup>−12</sup></td><td>4</td><td>4</td><td>2</td><td>2</td><td>6</td><td>4</td><td>2</td><td>8</td><td>−0.277</td><td>−0.043</td><td>0.235</td><td>0.00</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.